
<html lang="en"     class="pb-page"  data-request-id="9c020b32-70de-49c4-9243-8062785abfd6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b01961;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2016.59.issue-3;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid" /></meta><meta name="dc.Creator" content="Chi B.  Vu" /></meta><meta name="dc.Creator" content="Jean E.  Bemis" /></meta><meta name="dc.Creator" content="Ericka  Benson" /></meta><meta name="dc.Creator" content="Pradeep  Bista" /></meta><meta name="dc.Creator" content="David  Carney" /></meta><meta name="dc.Creator" content="Richard  Fahrner" /></meta><meta name="dc.Creator" content="Diana  Lee" /></meta><meta name="dc.Creator" content="Feng  Liu" /></meta><meta name="dc.Creator" content="Pallavi  Lonkar" /></meta><meta name="dc.Creator" content="Jill C.  Milne" /></meta><meta name="dc.Creator" content="Andrew J.  Nichols" /></meta><meta name="dc.Creator" content="Dominic  Picarella" /></meta><meta name="dc.Creator" content="Adam  Shoelson" /></meta><meta name="dc.Creator" content="Jesse  Smith" /></meta><meta name="dc.Creator" content="Amal  Ting" /></meta><meta name="dc.Creator" content="Allison  Wensley" /></meta><meta name="dc.Creator" content="Maisy  Yeager" /></meta><meta name="dc.Creator" content="Michael  Zimmer" /></meta><meta name="dc.Creator" content="Michael R.  Jirousek" /></meta><meta name="dc.Description" content="This report describes the synthesis and preliminary biological characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates. These molecular entities were created by ..." /></meta><meta name="Description" content="This report describes the synthesis and preliminary biological characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates. These molecular entities were created by ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 1, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01961" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01961" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01961" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01961" /></link>
        
    
    

<title>Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01961" /></meta><meta property="og:title" content="Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0001.jpeg" /></meta><meta property="og:description" content="This report describes the synthesis and preliminary biological characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates. These molecular entities were created by covalently linking two bioactive molecules, either niacin or salicylic acid, to an omega-3 fatty acid. This methodology allows the simultaneous intracellular delivery of two bioactives in order to elicit a pharmacological response that could not be replicated by administering the bioactives individually or in combination. The fatty acid niacin conjugate 5 has been shown to be an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1. On the other hand, the fatty acid salicylate conjugate 11 has been shown to have a unique anti-inflammatory profile based on its ability to modulate the NF-κB pathway through the intracellular release of the two bioactives." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01961"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01961">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01961&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01961&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01961&amp;href=/doi/10.1021/acs.jmedchem.5b01961" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1217-1231</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01910" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01702" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chi+B.++Vu">Chi B. Vu</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean+E.++Bemis">Jean E. Bemis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ericka++Benson">Ericka Benson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pradeep++Bista">Pradeep Bista</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Carney">David Carney</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Fahrner">Richard Fahrner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Lee">Diana Lee</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Liu">Feng Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pallavi++Lonkar">Pallavi Lonkar</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jill+C.++Milne">Jill C. Milne</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Nichols">Andrew J. Nichols</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dominic++Picarella">Dominic Picarella</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Shoelson">Adam Shoelson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jesse++Smith">Jesse Smith</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amal++Ting">Amal Ting</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allison++Wensley">Allison Wensley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maisy++Yeager">Maisy Yeager</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Zimmer">Michael Zimmer</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Jirousek">Michael R. Jirousek</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-475-2420. Fax: 617-273-2637. E-mail: <a href="/cdn-cgi/l/email-protection#7615000336151702171417051f055815191b"><span class="__cf_email__" data-cfemail="5734212217343623363536243e247934383a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01961&amp;href=/doi/10.1021%2Facs.jmedchem.5b01961" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1217–1231</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 19, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 December 2015</li><li><span class="item_label"><b>Published</b> online</span>1 February 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 February 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01961" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01961</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1217%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChi%2BB.%2BVu%252C%2BJean%2BE.%2BBemis%252C%2BEricka%2BBenson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D3%26contentID%3Dacs.jmedchem.5b01961%26title%3DSynthesis%2Band%2BCharacterization%2Bof%2BFatty%2BAcid%2BConjugates%2Bof%2BNiacin%2Band%2BSalicylic%2BAcid%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1231%26publicationDate%3DFebruary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01961"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1731</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01961" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chi&quot;,&quot;last_name&quot;:&quot;B. Vu&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;E. Bemis&quot;},{&quot;first_name&quot;:&quot;Ericka&quot;,&quot;last_name&quot;:&quot;Benson&quot;},{&quot;first_name&quot;:&quot;Pradeep&quot;,&quot;last_name&quot;:&quot;Bista&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Carney&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Fahrner&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Pallavi&quot;,&quot;last_name&quot;:&quot;Lonkar&quot;},{&quot;first_name&quot;:&quot;Jill&quot;,&quot;last_name&quot;:&quot;C. Milne&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Nichols&quot;},{&quot;first_name&quot;:&quot;Dominic&quot;,&quot;last_name&quot;:&quot;Picarella&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Shoelson&quot;},{&quot;first_name&quot;:&quot;Jesse&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Amal&quot;,&quot;last_name&quot;:&quot;Ting&quot;},{&quot;first_name&quot;:&quot;Allison&quot;,&quot;last_name&quot;:&quot;Wensley&quot;},{&quot;first_name&quot;:&quot;Maisy&quot;,&quot;last_name&quot;:&quot;Yeager&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Zimmer&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Jirousek&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;1217-1231&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01961&quot;},&quot;abstract&quot;:&quot;This report describes the synthesis and preliminary biological characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates. These molecular entities were created by covalently linking two bioactive molecules, either niacin or salicylic acid, to an omega-3 fatty acid. This methodology allows the simultaneous intracellular delivery of two bioactives in order to elicit a pharmacological response that could not be replicated by administering the bioactives individually or in combination. The fatty acid niacin conjugate 5 has been shown to be an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1. On the other hand, the fatty acid salicylate conjugate 11 has been shown to have a unique anti-inflammatory profile based on its ability to modulate the NF-κB pathway through the intracellular release of the two bioactives.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01961&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01961" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01961&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01961" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01961&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01961" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01961&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01961&amp;href=/doi/10.1021/acs.jmedchem.5b01961" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01961" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01961" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01961%26sid%3Dliteratum%253Aachs%26pmid%3D26784936%26genre%3Darticle%26aulast%3DVu%26date%3D2016%26atitle%3DSynthesis%2Band%2BCharacterization%2Bof%2BFatty%2BAcid%2BConjugates%2Bof%2BNiacin%2Band%2BSalicylic%2BAcid%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D3%26spage%3D1217%26epage%3D1231%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=291208" title="Hydrolysis">Hydrolysis</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/jmcmar.2016.59.issue-3/20160211/jmcmar.2016.59.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">This report describes the synthesis and preliminary biological characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates. These molecular entities were created by covalently linking two bioactive molecules, either niacin or salicylic acid, to an omega-3 fatty acid. This methodology allows the simultaneous intracellular delivery of two bioactives in order to elicit a pharmacological response that could not be replicated by administering the bioactives individually or in combination. The fatty acid niacin conjugate <b>5</b> has been shown to be an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1. On the other hand, the fatty acid salicylate conjugate <b>11</b> has been shown to have a unique anti-inflammatory profile based on its ability to modulate the NF-κB pathway through the intracellular release of the two bioactives.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In recent years, the traditional drug discovery paradigm of optimizing a lead candidate toward a single therapeutic target has been challenged by the successful implementation of a number of cases involving polypharmacology. This approach, sometimes referred to as network or pathway pharmacology,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> involves the targeting of multiple therapeutic targets in order to achieve a desired pharmacological outcome. Imatinib, for instance, was successfully developed as a kinase inhibitor of BCR-ABL, c-KIT, and PDGFRs for the treatment of chronic myeloid leukemia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Since then, numerous other kinase inhibitors have been introduced against a vast array of therapeutic targets.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> With these kinase inhibitors, pathway pharmacology was used to rationally target a small subset of kinases known to be up-regulated in certain forms of cancer. Outside of the oncology field, pathway pharmacology has also been used in the design of the antipsychotic agent ziprasidone and the bronchodilator GSK 961081. With ziprasidone, two small pharmacophores were merged into one single molecular entity in order to modulate multiple 5-HT and dopamine receptors (5-HT<sub>2A</sub>, 5-HT<sub>2c</sub>, 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, α<sub>1</sub>, D<sub>2</sub>, and D<sub>3</sub> receptors).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> With GSK 961081, a nonhydrolyzable linker was used to covalently join a muscarinic antagonist with a β<sub>2</sub> receptor agonist in order to modulate two distinct GPCR targets.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In this report, we describe a novel method of exploring pathway pharmacology involving the simultaneous intracellular delivery of two bioactives. With this methodology, the two bioactives are first joined covalently by the use of a plasma-stable linker. This process can provide a high level of extracellular selectivity because the two molecules have been rendered essentially inactive by the covalent linking process. However, once delivered inside cells, intracellular enzymes degrade the linker and thereby release the two bioactives, allowing them to exert their effect on the different therapeutic pathways or targets. Our conjugation methodology allows us to gain synergy by targeting multiple pathways in the same cells at the same time. Furthermore, it enables us to solve a difficult problem that arises with the simple coadministration of any two bioactive molecules, namely the different PK and tissue distribution profile of the two bioactives. When the two bioactive molecules are covalently linked, however, they are delivered inside cells at the same time in equimolar concentrations. What we have observed is that the pharmacological effect that could be produced by the simultaneous delivery of the bioactives is unique and cannot not be replicated by administering the individual components or a combination of the individual components. We will demonstrate the utility of our methodology with two examples. The first example involves the use of fatty acid niacin conjugates in the area of lipid synthesis, and the second example involves the use of fatty acid salicylate conjugates in the area of NF-κB inhibition to counteract inflammation.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fatty acid niacin conjugates are molecular entities created by covalently linking niacin to an omega-3 fatty acid, namely (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-eicosa-5,8,11,14,17-pentaenoic acid (EPA). Both niacin<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> and EPA<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> are well-known lipid lowering agents. EPA, in particular, has been shown to inhibit sterol regulatory element binding proteins (SREBPs) activity in a PPARα-independent manner.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> The SREBP pathway, in turn, is critical in modulating fatty acid synthesis and maintaining cholesterol homeostasis.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> SREBP-1 and SREBP-2 are the two different forms of SREBP proteins. SREBP-1 is known to regulate production of genes involved in fatty acid synthesis and oxidation such as FASN and SCD-1.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> SREBP-2, on the other hand, controls expression of genes involved in cholesterol homeostasis, which include HMG-CoA reductase, NPC1L1, and PCSK9.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> We hypothesized that if both niacin and EPA could be delivered together inside cells, a number of lipid synthesis pathways could be simultaneously affected to produce a unique biological response. To achieve simultaneous delivery to cells, the two drugs need to be covalently linked to form a single molecular conjugate. The resulting molecular conjugate also needs to be sufficiently stable in the plasma to remain intact during systemic circulation. Once delivered inside targeted cells, however, intracellular enzymes hydrolyze this molecular conjugate down to the individual components. As a fatty acid, when EPA is covalently linked to other moieties via an amide or ester bond, those bonds could be processed by intracellular enzymes such as fatty acid amide hydrolase (FAAH),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><i>N</i>-acylethanolamine hydrolyzing acid amidase (NAAA),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> or monacylglycerol lipase (MAGL).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p"><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> lists the five possible fatty acid niacin conjugates (<b>1</b>–<b>5</b>), each with a different linker that enables the covalent linkage of niacin to EPA. Compounds <b>1</b>–<b>4</b> were prepared by the straightforward steps outlined in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The diamide derivative <b>5</b> was prepared according to the general <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Nicotinic acid was reacted with <i>tert</i>-butyl (2-aminoethyl)carbamate in the presence of EDC/HOBT and Et<sub>3</sub>N to afford <i>tert</i>-butyl (2-(nicotinamido)ethyl)carbamate. Upon treatment with HCl in dioxane, the HCl salt of <i>N</i>-(2-aminoethyl)nicotinamide was obtained. This was then coupled with the fatty acid EPA using EDC/HOBT and Et<sub>3</sub>N to afford compound <b>5</b>. This general <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was also used to prepare a number of analogues that are pertinent to this report, namely the fatty acid niacin conjugates <b>7</b>–<b>10</b> and the fatty acid salicylate conjugates <b>11</b> and <b>12</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Fatty acid niacin conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0021.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) niacin or salicylic acid, EDC/HOBT, Hunig’s base, CH<sub>2</sub>Cl<sub>2</sub>; (b) HCl/1,4-dioxane; (c) R<sub>2</sub>CO<sub>2</sub>H, EDC/HOBT, Hunig’s base, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">Compounds <b>1</b>–<b>5</b> were first assessed for plasma stability. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, the diamide derivative <b>5</b> was the only analogue among the five tested that showed complete plasma stability across all four species. Even at the 2 h time point, essentially all of the parent compound was still present. We then investigated the cellular uptake of these fatty acid niacin conjugates using confocal microscopy. To facilitate the imaging process, we replaced the omega-3 fatty acid EPA in <b>5</b> with the fluorescent fatty acid <i>cis</i>-parinaric acid in order to form the corresponding fatty acid niacin conjugate <b>10</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> HuH-7 cells were treated with either <i>cis</i>-parinaric acid (25 μM) or the fluorescent fatty acid niacin conjugate <b>10</b> (25 μM) for 30 min, fixed with 4% formaldehyde, and mounted with antifade DAPI. <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A shows that the free fatty acid (i.e., <i>cis</i>-parinaric acid) does get into cells, but it is highly concentrated in the lysosomes and is not distributed to the endoplasmic reticulum (ER). In sharp contrast, the fatty acid niacin conjugate <b>10</b> exhibits an ER-like (perinuclear) pattern, with less distribution to the lysosomes (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Endocytosis is believed to be the cellular uptake mechanism for these fatty acid niacin conjugates. A preincubation experiment with Dynasore, a known endocytosis inhibitor, was carried out. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C, treatment with 80 μM of Dynasore abolished the ER cellular localization of compound <b>10</b>, indicating that these fatty acid niacin conjugates were taken up by cells by active endocytosis, likely via clathrin-coated vesicles.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This uptake mechanism for the fatty acid niacin conjugates is distinct from what has been reported with free fatty acids. When unsaturated omega-3 fatty acids, such as EPA, are applied to cells, they are usually incorporated first into the phospholipids and then released intracellularly by the rate-limiting action of phospholipase A1 (PLA1) and phospholipase A2 (PLA2).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Because the fatty acid niacin conjugates are taken up inside cells by active endocytosis, their intracellular distribution to the ER is different and so is the biological response that they could elicit.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mouse, rat, beagle, and human plasma stability studies for compounds <b>1</b>–<b>5</b>. Percentage of compounds <b>1</b>–<b>5</b> remaining upon incubation in mouse (A), rat (B), beagle (C), and human plasma (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) HuH-7 cells were treated with <i>cis</i>-parinaric acid (25 μM) and LysoTracker for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI (Molecular Probes). Images taken on a Zeiss 510 LSM confocal microscope. Three lasers were used for DAPI, <i>cis</i>-parinaric acid, and LyosoTracker. (B) HuH-7 cells were treated with CellLight ER-RFP, BacMam 2.0 (Molecular Probes) for 48 h. Cells were treated with Compound <b>10</b> (25 μM) for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI. Three lasers were used for DAPI, compound <b>10</b>, and CellLight. (C) HuH-7 cells were treated with CellLight ER-RFP for 48 h. Cells were then treated with 80 μM of Dynasore and compound <b>10</b> (25 μM) for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI. (D) HuH-7 cells were treated with CellLight ER-RFP, BacMam 2.0 (Molecular Probes) for 48 h. Cells were treated with compound <b>12</b> (25 μM) for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI. Three lasers were used for DAPI, compound <b>12</b>, and CellLight.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Distribution of the fatty acid niacin conjugate to the ER also allows it to be localized in the same subcellular compartment as the enzyme FAAH.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This would allow FAAH to hydrolyze the fatty acid niacin conjugate and release the individual components. The fatty acid niacin conjugate <b>5</b> was then evaluated in a number of assays to see if it could be hydrolyzed in targeted tissues down to the individual components. The rat liver lysate experiment was carried out initially to examine the hydrolysis of compound <b>5</b>. This hydrolysis experiment was carried out by incubating compound <b>5</b> in rat liver lysate at 37 °C and monitored for the disappearance of the starting material. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, there was a time-dependent hydrolysis of compound <b>5</b> in this assay. Furthermore, this hydrolysis is FAAH-dependent because addition of the FAAH inhibitor PF-3845<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> almost completely abrogated the hydrolysis of compound <b>5</b>. In humans, two forms of FAAH, FAAH1 and FAAH2, share 20% sequence homology and have different tissue distribution profiles.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We expressed and purified recombinant FAAH1 enzyme to determine its role in hydrolysis of compound <b>5</b>. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, recombinant FAAH1 hydrolyzed the amide bond between the fatty acid and the linker and released EPA in a time-dependent fashion. Again, the addition of the FAAH inhibitor PF-3845 also inhibited this particular hydrolysis.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hydrolysis of compound <b>5</b> in rat liver lysate. Percentage of compound <b>5</b> remaining upon incubation in rat liver lysate at 37 °C in the absence of and in the presence of the FAAH inhibitor PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hydrolysis of compound <b>5</b> using recombinant FAAH-1. Measurement of EPA that was being released over time upon hydrolysis of compound <b>5</b> using recombinant FAAH-1 in the absence of and in the presence of the FAAH inhibitor PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The hydrolysis of compound <b>5</b> and the formation of intracellular EPA were further confirmed in a cell-based assay using HepG2 cells. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, incubation of compound <b>5</b> in HepG2 cells resulted in a time-dependent hydrolysis. In this cell line, formation of intracellular EPA was monitored by using a deuterium-labeled EPA-<i>d</i><sub>5</sub> in order to distinguish the fatty acid that was being released from compound <b>5</b> over the endogenous EPA. Compound <b>9</b>, the EPA-<i>d</i><sub>5</sub> version of compound <b>5</b>, was prepared according to the same procedure outlined previously in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> using the appropriate deuterium-labeled fatty acid. The requisite EPA-<i>d</i><sub>5</sub> was prepared by total synthesis using the reaction sequence outlined by Sandri and Viala.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, there was a time-dependent rate of formation of EPA-<i>d</i><sub>5</sub> during the hydrolysis of compound <b>9</b> in human HepG2 cell lines.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hydrolysis of compound <b>5</b> in HepG2 Cells. Percentage of compound <b>5</b> remaining upon incubation in human HepG2 cells over a 20 h period.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hydrolysis of compound <b>9</b> in HepG2 Cells. Measurement of deuterium-labeled EPA-<i>d</i><sub>5</sub> that was being released over time upon incubation of compound <b>9</b> in HepG2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The assays described above represent some initial steps aimed at understanding the hydrolysis of compound <b>5</b>. The actual hydrolysis of compound <b>5</b> in an in vivo setting is most likely much more complex due to the large arrays of amidases and hydrolases that are available across various tissues and species. Thus, it is more appropriate to evaluate the oral bioavailability, tissue distribution, and hydrolysis of compound <b>5</b> in an actual animal model. When niacin is administered to rodents, dogs, monkeys, or humans, one of the major plasma metabolites is nicotinuric acid.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In a typical PK experiment where niacin was administered as a single oral dose of 30 mg/kg to Sprague–Dawley rats (plasma collection at <i>t</i> = 0.25, 0.5, 1, 2, 4, and 6 h), the <i>C</i><sub>max</sub> and AUC<sub>last</sub> of niacin were 7467 ± 2246 ng/mL and 6980 ± 3173 h·ng/mL, respectively. In the same PK experiment, the <i>C</i><sub>max</sub> and AUC<sub>last</sub> of nicotinuric acid were 369 ± 80 ng/mL and 466 ± 359 h·ng/mL, respectively. Both niacin and its nicotinuric acid metabolite were cleared fairly rapidly, and neither one was detected in the plasma after 2 h. When the fatty acid niacin conjugate <b>5</b> was dosed at 100 mg/kg po (i.e., the same molar equivalent as 30 mg/kg of niacin), a low level of the parent compound was detected in the plasma (for compound <b>5</b>, the <i>C</i><sub>max</sub> and AUC<sub>last</sub> were 212 ± 74 ng/mL and 172 ± 67 h·ng/mL, respectively). Interestingly, even though niacin was not detected in the plasma, the molar equivalent dose of compound <b>5</b> produced much higher plasma levels of nicotinuric acid (<i>C</i><sub>max</sub> and AUC<sub>last</sub> were 1131 ± 306 ng/mL and 3484 ± 1013 h·ng/mL, respectively). Furthermore, this type of fatty acid niacin conjugate allowed the delivery of nicotinuric acid over a much longer period; at the 6 h time point, a significant level of nicotinuric acid could still be detected in the plasma (>200 ng/mL). Compound <b>5</b> was then evaluated in a PK/tissue distribution study in order to further verify that the fatty acid niacin conjugate could be hydrolyzed down to the individual components in targeted tissues. Plasma and tissue samples were processed and analyzed by LC/MS/MS for the presence of (1) the parent compound, (2) the niacin linker metabolite <b>13</b>, (3) the linker-EPA metabolite <b>17</b>, (4) niacin, and (5) nicotinuric acid <b>16</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, low concentration of the parent compound <b>5</b> was detected in the plasma and liver. A significant quantity of the parent compound was, however, present in the intestine (6,747 ng/g). The desired hydrolysis of compound <b>5</b> did indeed take place and the key nicotinuric acid metabolite was detected not only in the plasma but also in both tissues (nicotinuric acid liver concentration = 1356 ng/g; nicotinuric acid intestine concentration = 1387 ng/g). The hydrolysis of the amide bond between EPA and the linker portion also occurred in targeted tissues, and the niacin linker metabolite was detected not only in plasma but also in both tissues (liver concentration of niacin linker metabolite = 10910 ng/g; intestine concentration of niacin linker metabolite = 23899 ng/g). Lower concentration of the linker EPA metabolite was detected in the plasma and the two isolated tissues. Even though niacin itself was not detected in the plasma and liver tissue, it was detected in intestinal tissues (concentration = 279 ng/g). This tissue distribution study showed that compound <b>5</b> was extensively hydrolyzed in the intestine and a lower level of the intact parent compound was delivered to the liver. Changing the nature of the linker group could also change the rate of hydrolysis of the corresponding fatty acid niacin conjugate and its tissue distribution considerably. In compounds <b>7</b> and <b>8</b>, the ethylenediamine linker has been replaced with (<i>S</i>)-pyrrolidin-3-amine and <i>N</i><sup>1</sup>-methylethane-1,2-diamine, respectively. This substitution should render the amide bond between the diamine linker and the fatty acid more resistant to hydrolysis by FAAH. <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a> shows the hydrolysis of compounds <b>5</b>, <b>7</b>, and <b>8</b> using the recombinant FAAH-1. Compound <b>7</b> was more resistant to FAAH-1 hydrolysis when compared to compound <b>5</b>. For compound <b>8</b>, there was essentially no hydrolysis of the fatty acid amide bond under the assay conditions. Because the fatty acid conjugates <b>7</b> and <b>8</b> are more resistant to hydrolysis, more of the intact parent compound should be delivered to the liver. PK studies using double-cannulated rats were carried out to compare the amount of parent compound that could potentially be delivered to the liver. For these PK studies, Sprague–Dawley rats that have been surgically implanted with indwelling jugular vein cannula (JVC) and portal vein cannula (PVC) were used and serial blood collection was carried out at both the portal and jugular vein (<i>t</i> = 10, 20, 40 min and 1, 2, 4, and 6 h post dose). <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> summarizes selected PK parameters for compounds <b>5</b>, <b>7</b>, and <b>8</b> in this double cannulated rat PK study.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Consistent with the tissue distribution study, we saw that compound <b>5</b> was extensively hydrolyzed in the intestine, as indicated by the higher portal concentration of the niacin-linker metabolite <b>13</b> (<i>C</i><sub>max</sub> = 2,061 ± 433 ng/mL) and a lower portal concentration of the parent compound (<i>C</i><sub>max</sub> = 418 ± 122 ng/mL). On the other hand, with the more hydrolysis-resistant compound <b>7</b> and <b>8</b>, we observed less metabolism of the parent compound in the intestine, and as a result, a higher portal concentration of the parent compound was observed along with a lower portal concentration of the niacin linker metabolite. Compared to compound <b>5</b>, a higher level of the parent compound was also observed in the peripheral circulation for the more hydrolysis-resistant compounds <b>7</b> and <b>8</b> (peripheral <i>C</i><sub>max</sub> = 564 ± 226 and 400 ± 100 ng/mL, respectively). Compound <b>8</b> was then evaluated in a rat tissue distribution study where animals (<i>n</i> = 6) were dosed with 100 mg/kg qd for 3 days. Four hours after the last dose, plasma and tissues were collected and analyzed for the parent compound <b>8</b> along with the metabolites <b>15</b>, <b>16</b>, and <b>19</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Even though compound <b>8</b> was dosed at a lower dose of 100 mg/kg, there was a significantly greater concentration of the corresponding parent compound (>60 fold increase) in the liver when compared with compound <b>5</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). This result demonstrated the dramatic shift in the tissue distribution of the intact parent compound upon decreasing the rate of hydrolysis of the amide bond between the fatty acid EPA and the linker.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. List of metabolites measured upon oral dosing with compounds <b>5</b>, <b>7</b>, and <b>8</b> in Sprague–Dawley rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of PK/Tissue Distribution for Compound <b>5</b> in Sprague–Dawley rats<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">concentration</th><th class="colsep0 rowsep0" align="center" char="±">compd <b>5</b></th><th class="colsep0 rowsep0" align="center">niacin</th><th class="colsep0 rowsep0" align="center" char="±">nicotinuric acid</th><th class="colsep0 rowsep0" align="center" char="±">niacin linker metabolite</th><th class="colsep0 rowsep0" align="center" char="±">linker EPA metabolite</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma (ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 17</td><td class="colsep0 rowsep0" align="center">below detection</td><td class="colsep0 rowsep0" align="char" char="±">3220 ± 810</td><td class="colsep0 rowsep0" align="char" char="±">2296 ± 924</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver (ng/g)</td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 0.5</td><td class="colsep0 rowsep0" align="center">below detection</td><td class="colsep0 rowsep0" align="char" char="±">1356 ± 197</td><td class="colsep0 rowsep0" align="char" char="±">10910 ± 4291</td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestine (ng/g)</td><td class="colsep0 rowsep0" align="char" char="±">6747 ± 4197</td><td class="colsep0 rowsep0" align="center">279 ± 198</td><td class="colsep0 rowsep0" align="char" char="±">1387 ± 146</td><td class="colsep0 rowsep0" align="char" char="±">23899 ± 5398</td><td class="colsep0 rowsep0" align="char" char="±">74 ± 15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Sprague–Dawley rats (<i>n</i> = 4) were dosed by oral gavage with 300 mg/kg of compound <b>5</b> (qd) over a period of 7 days. Plasma and indicated tissues were collected 2 h after the last dose.</p></div></div></div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Hydrolysis of compounds <b>5</b>, <b>7</b>, and <b>8</b> using recombinant FAAH-1. Measurement of EPA that was being released over time upon hydrolysis of compound <b>5</b>, <b>7</b>, and <b>8</b> using recombinant FAAH-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of PK Parameters for Compounds <b>5</b>, <b>7</b>, and <b>8</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">parent compd <b>5</b></th><th class="colsep0 rowsep0" align="center">niacin-linker metabolite <b>13</b> from dosing compd <b>5</b></th><th class="colsep0 rowsep0" align="center">nicotinuric acid <b>16</b> from dosing compd <b>5</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">portal</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 418 ± 122</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 2061 ± 433</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 125 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peripheral</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 35 ± 9</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 336 ± 61</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 135 ± 31</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">parent compd <b>7</b></th><th class="colsep0 rowsep0" align="center">niacin-linker metabolite <b>14</b> from dosing compd <b>7</b></th><th class="colsep0 rowsep0" align="center">nicotinuric acid <b>16</b> from dosing compd <b>7</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">portal</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 5315 ± 516</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 73 ± 9</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 13 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peripheral</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 564 ± 226</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 35 ± 10</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 11 ± 3</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">parent compd <b>8</b></th><th class="colsep0 rowsep0" align="center">niacin-linker metabolite <b>15</b> from dosing compd <b>8</b></th><th class="colsep0 rowsep0" align="center">nicotinuric acid <b>16</b> from dosing compd <b>8</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">portal</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 5061 ± 823</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = below detection</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 11 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peripheral</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 400 ± 100</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = below detection</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 28 ± 19</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Sprague–Dawley rats (<i>n</i> = 4) that have been surgically implanted with indwelling jugular vein cannula (JVC) and portal vein cannula (PVC) were used for the study. Serial blood collection was carried out at both the portal and jugular vein at the following time points: 10, 20, 40, 60, 90, 120, and 140 min post dose. The indicated <i>C</i><sub>max</sub> values are in ng/mL. Additional PK data for compounds <b>5</b>, <b>7</b>, and <b>8</b> are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div></div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Liver concentration of the corresponding parent compound upon dosing Sprague–Dawley rats with compounds <b>5</b> and <b>8</b>. Sprague–Dawley rats (<i>n</i> = 6) were dosed with either 300 mg/kg of compound <b>5</b> or 100 mg/kg of compound <b>8</b> once daily for three days. Four hours after the last dose, liver tissues were collected and analyzed for the corresponding parent compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because the components are only released intracellularly with the fatty acid niacin conjugate <b>5</b>, our approach could potentially allow one to avoid the unpleasant flushing side effect of niacin. It is widely known that niacin is capable of binding to and activating GPR109A, a Gi-coupled GPCR. This process, in turn, promotes the release of prostaglandin D<sub>2</sub> (PGD<sub>2</sub>) from skin cells. This eicosanoid is a vasodilator that is responsible for the cutaneous flushing. Our analyses demonstrated that the fatty acid niacin conjugate <b>5</b> did not interact with the GPR109A receptor. Interaction of conjugate <b>5</b> with the GPR109A receptor was tested using an adenylate cyclase inhibition assay in human epidermal A431 cell line that expressed GPR109A.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> One of the activities of niacin binding to GPR109A is the inhibition of adenylate cyclase. Adenylate cyclase converts ATP to cAMP, and this activity is stimulated by forskolin. As shown in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>, niacin inhibited forskolin-mediated cAMP production in a dose-dependent manner with an EC<sub>50</sub> of 0.73 μM. In this assay, niacin was able to inhibit approximately 50% of the cAMP signal produced by forskolin. In sharp contrast, compound <b>5</b> did not functionally activate GPR109A. No significant inhibition of cAMP production was observed when these epidermal cells were incubated with compound <b>5</b> over the same dose range. In essence, the molecules that are being covalently linked have been rendered inactive in the extracellular space. Covalently linking niacin to a fatty acid moiety using the plasma stable linker described above thus represents a potential new way of delivering the niacin component without inducing the flushing side effects.</div><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effect of niacin and compound <b>5</b> on the production of cAMP induced by forskolin in human epidermal A431 cells. Human epidermal A431 cells overexpressed with GPR109A were incubated with either niacin or compound <b>5</b> over the indicated dose range. Cellular cAMP production was induced by forskolin. The corresponding cAMP concentration was measured using the commercially available LANCE Ultra cAMP kit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After having confirmed that the fatty acid niacin conjugate <b>5</b> could undergo the appropriate hydrolysis to afford the desired components in targeted tissues, we then focused our attention on the biological effect that it could induce. The SREBP proteins have been known to be essential for cholesterol biosynthesis as well as for the uptake and biosynthesis of various fatty acids. HMG-CoA reductase and PCSK9 are two of the target genes that are known to be regulated by the mature form of the SREBP-2. Both EPA and niacin, at very high concentration, could affect SREBP-2 activity.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> At the lower concentration of 50 μM, however, both EPA and niacin showed little activity on SREBP-2 maturation when they were incubated in human HepG2 cells. In sharp contrast, when the fatty acid niacin conjugate <b>5</b> was incubated in human HepG2 cells, there was a decrease in the production of mature SREBP-2 protein. The effect was dose dependent, and the decrease in SREBP-2 protein could be observed at the 25 and 50 μM concentration (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). Statins have previously been shown to increase plasma level of PCSK9 through its effect on LDL levels and SREBP-2.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> In this cell assay, the effect of administering atorvastatin on SREBP-2 was also quite pronounced. As shown in <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>, when human HepG2 cells were incubated with 10 μM of atorvastatin, there was a significant increase in the production of mature SREBP-2 protein. However, treatment of human HepG2 cells with a combination of 10 μM of atorvastatin with 25 μM of the fatty acid niacin conjugate <b>5</b> resulted in a significant decrease in the production of mature SREBP-2 protein. Because PCSK9 is an immediate downstream gene of SREBP-2, a decrease in the production of the SREBP-2 protein would naturally lead to a decrease in the expression of PCSK9. A dose-dependent decrease in the expression of PCSK9 mRNA levels in HepG2 cells was observed when cells were treated with compound <b>5</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). This effect on the reduction of SREBP-2 maturation and reduced expression of PCSK9 mRNA should translate to a corresponding effect on the secretion of PCSK9. When human HepG2 cells are treated with compound <b>5</b>, the resulting cell culture supernatants can be analyzed for secreted PCSK9 levels using a human-specific PCSK9 ELISA kit. The results from this type of assay are shown in <a class="ref internalNav" href="#fig14A" aria-label="Figure 14">Figure 14</a>A, and they clearly demonstrated the unprecedented synergistic effect of compound <b>5</b> on secreted PCSK9 levels in human HepG2 cells. In this assay, EPA did not produce any effect on secreted PCSK9 levels at the highest tested concentration of 50 μM (when cells were incubated with EPA at doses that were greater than 50 μM, cellular toxicity was observed). Niacin, likewise, did not produce any noticeable effect at doses as high as 10 mM. The combination of EPA and niacin also did not produce any effect on secreted PCSK9 levels at the highest tested concentration of 50 μM. In sharp contrast with the individual components or the combination of the individual components, the fatty acid niacin conjugate <b>5</b> showed a synergistic inhibition on secreted PCSK9 and had an IC<sub>50</sub> value of 17 μM. In addition to its effects on PCSK9, high concentrations of niacin have been reported to inhibit the secretion of apolipoprotein B (ApoB). ApoB is the major apolipoprotein found in VLDL and low density lipoprotein (LDL) particles secreted from the liver into circulation. An assay was established to study the effects of compound <b>5</b> on ApoB secretion from the human hepatocyte line, HepG2. HepG2 cells were incubated with compound <b>5</b>, EPA, niacin, or EPA plus niacin. After 18 h, the amount of ApoB present in the cell culture supernatant was measured using a commercially available ELISA kit. As shown in <a class="ref internalNav" href="#fig14A" aria-label="Figure 14">Figure 14</a>B, compound <b>5</b> significantly inhibited ApoB secretion in a dose-dependent manner at a significantly lower concentrations than its component parts. (<a class="ref internalNav" href="#fig14A" aria-label="Figure 14">Figure 14</a>B, IC<sub>50</sub> of 27 μM). These data demonstrate a synergistic activity of compound <b>5</b> as compared to the combination of EPA and niacin in this assay. The measure of cellular toxicity by Alamar Blue was not significantly different across all treatment groups</div><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Synergistic inhibition of SREBP-2 upon incubation of HepG2 cells with compound <b>5</b>. HepG2 cells were treated overnight with compound <b>5</b> at 12.5, 25, and 50 μM as indicated, atorvastatin (10 μM), atorvastatin (10 μM)/compound <b>5</b> (25 μM), and EPA (50 μM)/niacin (50 μM). Immunoblotting of total cell lysates was performed using rabbit antihuman SREBP2 antibody (Abcam ab72856) and analyzed by chemoluminescence using Licor. (A) Representative immunoblot. Atorva = atorvastatin; Combi = combination having 10 μM of atorvastatin and 25 μM of compound <b>5</b>. 50 Nia EPA = 50 μM each of niacin and EPA. (B) Densitometry of mature SREBP2 was normalized such that the averaged target/actin ratio for vehicle control was set to 1. Significance was determined by and one-way ANOVA and <i>t</i> test in comparison to control. Error bars represent standard error of the mean (SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Effect of compound <b>5</b> on PCSK9 mRNA expression in HepG2 cells. HepG2 cells were incubated with compound <b>5</b> at the indicated doses. RNA was reverse-transcribed using the cells to cDNA reagents. Real-time PCR of transcripts was performed with Taqman assays for the specific gene PCSK9 and HPRT-VIC was used as a normalization control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14A" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0016.jpeg" id="GRAPHIC-d7e1601-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (A) Effect of compound <b>5</b>, EPA, niacin, or a combination of EPA and niacin on the secretion of PCSK9 in HepG2 cells. Human HepG2 cells were incubated with EPA, niacin, an equimolar mixture of EPA and niacin, or compound <b>5</b> for 16 h over the indicated dose range. Cell culture supernatants were analyzed for secreted PCSK9 using a commercially available PCSK9 ELISA kit. The ELISA was measured on a Victor X5 multilabel plate reader at an absorbance of 450 nm with background correction measured at 550 nm. (B) Effect of compound <b>5</b>, EPA, niacin, or a combination of EPA and niacin on the secretion of ApoB in HepG2 cells. Human HepG2 cells were incubated with EPA, niacin, an equimolar mixture of EPA and niacin, or compound <b>5</b> for 16 h over the indicated dose range. Cell culture supernatants were analyzed for secreted ApoB using a commercially available ELISA kit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig14A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>5</b> was evaluated orally in the ApoE*3-Leiden mice<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> for its ability to lower PCSK9 and other lipid parameters. These transgenic mice were generated using a genomic construct isolated from human ApoE*3 Leiden, a genetic mutation that is characterized by familial dysbetalipoproteinemia. ApoE*3 Leiden mice, when fed on a high cholesterol Western-type diet, have been shown to have a dramatic increase in total plasma cholesterol and triglyceride levels. Compound <b>5</b> was dosed over a 16-week period in order to assess plasma PCSK9, total cholesterol, and triglyceride levels, liver LDL-receptor protein level, lipoprotein profile as well as other atherosclerotic end points. At the conclusion of the study, ApoE*3-Leiden mice that have been treated with compound <b>5</b> showed a significant reduction in PCSK9 levels, LDL particles including VLDL and LDL cholesterol, as well as plasma triglycerides. The entire data set for this ApoE*3-Leiden study is presented in a separate communication, along with a more detailed discussion on the mechanism of action of compound <b>5</b>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">In addition to niacin, we have also explored the possibility of codelivering salicylic acid and an omega-3 fatty acid to cells using an analogous linker system. The fatty acid salicylate conjugate <b>11</b> was prepared by covalently linking salicylic acid to a different omega-3 fatty acid, namely (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoic acid (DHA). The same ethylenediamine linker used in the preparation of the fatty acid niacin conjugate <b>5</b> was employed in this particular example. By itself, salicylic acid, has been reported to be an inhibitor of NF-κB-mediated gene expression by suppressing IKK kinase activity.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> On the other hand, the omega-3 fatty acid DHA has been shown to inhibit NF-κB through multiple mechanisms. DHA has been shown to inhibit IκBα phosphorylation by binding to GPR120 and repartitioning TAB1 away from the TLR4 receptor that mediates the LPS signal.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> DHA has also been shown to induce cytoplasmic retention of pro-inflammatory NF-κB proteins through p105 overexpression, thereby favoring the nuclear translocation of the p50–p50 transcriptional repressor homodimer.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Additionally, DHA can be converted to the cyclopentanone ring containing A<sub>4</sub> and J<sub>4</sub>-neuroprostanes that are analogous in structure to PGJ2.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> PGJ2 has been shown to directly bind cysteine residues in the DNA binding domains of both the p50 and p65 subunits of NFkB, preventing them from binding to DNA.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> The simultaneous intracellular delivery of salicylic acid and DHA would therefore allow the modulation of the NF-κB axis via multiple pathways. We have evaluated the fatty acid salicylate conjugate <b>11</b> in a number of cellular assays and have observed a pattern of cellular uptake and hydrolysis that is similar to that observed previously with the fatty acid niacin conjugate <b>5</b>. To assess the cellular uptake of fatty acid salicylate conjugates by confocal microscopy, we have prepared the fatty acid conjugate <b>12</b>, wherein the DHA portion has been replaced with the fluorescent <i>cis</i>-parinaric acid. <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D shows that the fatty acid salicylate conjugates are taken up into cells and are colocalized in the ER compartment, similar to what was previously observed with the fatty acid niacin conjugate <b>5</b>. Distribution of the fatty acid salicylate conjugate <b>11</b> to the ER also facilitated its hydrolysis by FAAH. We have studied the hydrolysis of <b>11</b> in a rat liver lysate assay and have observed that its hydrolysis was FAAH-dependent. As shown in <a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>, the addition of the FAAH inhibitor PF-3845 almost completely abrogated the hydrolysis of <b>11</b>.</div><figure id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Hydrolysis of compound <b>11</b> in rat liver lysate. Percentage of compound <b>11</b> remaining upon incubation in rat liver lysate at 37 °C in the absence of and in the presence of the FAAH inhibitor PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The hydrolysis of the fatty acid salicylate <b>11</b> has also been studied in vivo in the appropriate PK and tissue distribution studies. When salicylic acid is dosed orally to rodents, dogs, monkeys, and humans, salicyluric acid <b>21</b> is detected as a major metabolite (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> This observation is consistent with the fatty acid salicylate conjugate <b>11</b> being hydrolyzed intracellularly in targeted tissues down to the individual components (i.e., salicylic acid), resulting in salicyluric acid as one of the major metabolites. In a PK experiment, compound <b>11</b> was dosed orally to Sprague–Dawley rats at 300 mg/kg and plasma was collected at <i>t</i> = 0, 0.5, 1, 2, 4, 8, and 24 h for analysis of the parent compound of the potential metabolites shown in <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>. Compound <b>11</b> was orally bioavailable and <i>C</i><sub>max</sub> for the parent compound was 477 ± 193 ng/mL, along with an AUC<sub>last</sub> of 1945 ± 1027 h·ng/mL. Even though the linker-DHA metabolite <b>22</b> could not be detected in the plasma, the salicylate-linker metabolite <b>20</b> was detected in the plasma (<i>C</i><sub>max</sub> = 484 ± 80 ng/mL; AUC<sub>last</sub> = 2611 ± 501 h·ng/mL). In this oral rat PK study, we also observed the presence of salicylic acid (<i>C</i><sub>max</sub> = 75 ± 125 ng/mL; AUC<sub>last</sub> = 229 ± 132 h·ng/mL) which indicated that the amide bond between salicylate and the ethylenediamine linker is degradable in cells and targeted tissues. Concurrent with the release of salicylic acid, we also observed the presence of the salicyluric acid metabolite <b>21</b> (<i>C</i><sub>max</sub> = 563 ± 76.8 ng/mL; AUC<sub>last</sub> = 2937 ± 493 h·ng/mL).</div><figure id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Potential metabolites deriving from the hydrolysis of the fatty acid salicylate conjugate <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>11</b> was then evaluated in a rat tissue accumulation study over a 21 day period. In this study, male Sprague–Dawley rats, in groups of 4, were dosed orally with 300 mg/kg of compound <b>11</b> once a day for 14 days. Animals were sacrificed on days 1, 3, 7 and 14; plasma and tissues were collected 4 h after dosing in order to determine the levels of the parent compound <b>11</b>, salicylic acid, and salicyluric acid <b>21</b>. The tissues examined included brain, epididymal fat, liver, and muscle. Another group of animals was dosed orally with 300 mg/kg of compound <b>11</b> for 14 days and then subjected to a 7-day washout cycle, after which plasma and tissues were collected on day 21. As shown in <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>A, steady state levels of the parent compound were achieved in the various tissues and plasma after 7 days of dosing with the fatty acid salicylate conjugate <b>11</b>. Higher concentration of the parent compound was detected in the tissues than in the plasma. Among the tissues that were examined, epididymal fat contained the highest tissue concentration of the parent compound <b>11</b> (concentration = 771.96 ± 176.92 ng/g). This was followed by the muscle and liver, wherein the tissue concentration of the parent compound <b>11</b> was 425 ± 88.87 and 330.74 ± 118.82 ng/g, respectively. There was no significant level of the parent compound <b>11</b> measured in the brain tissue at any of the time points tested. The corresponding plasma concentration of the parent compound <b>11</b> at this 7-day time point was 115.51 ± 28.45 ng/mL. After 14 days of dosing, animals were subjected to a 7-day washout cycle. Our data indicate that the parent compound <b>11</b> was completely cleared out of plasma and tissues within 7 days (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>A).</div><figure id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Tissue distribution study for compound <b>11</b> in Sprague–Dawley rats. Sprague–Dawley rats, in groups of four, were dosed orally with 300 mg/kg of compound <b>11</b> once a day for 14 days. On days 1, 3, 7, and 14, plasma and the indicated tissues were collected 4 h after dosing. Another group of animals was subjected to a 7-day washout cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Complete hydrolysis of the fatty acid salicylate conjugate <b>11</b> occurred, and salicylic acid was detectable both in the plasma and tissues. <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>B shows the plasma and tissue concentration of salicylic acid over the course of the 21 day study. Steady state levels of salicylic acid were achieved after 7 days of dosing with <b>11</b>, and a plasma concentration of 154.20 ± 65.43 ng/mL was observed. During this period, steady state levels were also achieved in the tissues, and a higher concentration of salicylic acid was observed in the liver (235.91 ± 95.14 ng/g) and muscle (265.73 ± 73.0 ng/g). Low levels of salicylic acid were detected both in the epididymal fat (65.03 ± 65.02 ng/g) and in the brain (53.32 ± 26.95 ng/g).</div><div class="NLM_p">Salicyluric acid is a phase 2 metabolite formed through the intracellular conjugation of salicylic acid and glycine. The levels of the metabolite salicyluric acid achieved a relatively constant state after 7 days of dosing across the tissues sampled (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>C). As with salicylic acid, the highest concentrations were observed in plasma (764.41 ± 21.98 ng/mL) and liver tissues (506.48 ± 82.44 ng/g), with lower salicyluric acid measured in fat (203.71 ± 80.19 ng/g), muscle (165.21 ± 14.0 ng/g), and brain tissues (114.43 ± 8.87 ng/g). As observed previously with the parent compound <b>11</b>, both salicylic acid and salicyluric acid were completely cleared from the plasma and tissues after a 7-day washout cycle.</div><div class="NLM_p">Having confirmed that the individual components could be released intracellularly, we then turned our attention to the pharmacological response that could be produced by the fatty acid salicylate conjugate <b>11</b>. In an NF-κB reporter assay, compound <b>11</b> showed significantly more potent and synergistic inhibition of NF-κB than salicylic acid or DHA, its two major components. As shown in <a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>, salicylic acid only showed inhibition of NF-κB at high concentration of 3.2 mM, which is consistent with the previously reported values.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Likewise, DHA could only modestly inhibit NF-κB at a concentration of 78.7 μM. In sharp contrast, compound <b>11</b> was able to inhibit NF-κB with an IC<sub>50</sub> value of 25.4 μM. This synergistic inhibition of NF-κB could not be replicated with the individual components or a combination of the individual components, even at much higher concentration. Inhibition of NF-κB could have many potential therapeutic applications, particularly in the area involving the enhancement of muscle regeneration in injured and diseased skeletal muscle.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> Serum levels of many NF-kB dependent pro-inflammatory chemokines including MMP-9,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and cytokines including TNF-α<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> have been reported to be elevated relative to controls in boys with Duchenne muscular dystrophy, underscoring the potential utility of NF-κB modulation in this disease. We have since evaluated compound <b>11</b> in a number of preclinical models of Duchenne muscular dystrophy. These included the <i>mdx</i> mouse model and the golden retriever model. Detailed discussion of the results from those studies can be found in an upcoming communication.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig18" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Synergistic inhibition of NF-κB by compound <b>11</b> in RAW 264.7 macrophages. RAW 264.7 macrophage cells stably transfected with an NF-κB response element linked to a luciferase reporter were treated with salicylate, DHA, an equimolar mixture of DHA and salicylate, or compound <b>11</b> for 2 h and then with LPS (200 ng/mL, 3 h). NF-κB activity was normalized to LPS-treated vehicle (Sal = salicylic acid).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have described a novel method of exploring pathway pharmacology through the use of fatty acid niacin and fatty acid salicylate conjugates. In our methodology, conjugates comprised of two covalently linked bioactives are activated by specific intracellular enzymes in order to release the two bioactives inside cells and thereby allow them to simultaneously modulate multiple therapeutic pathways. Compared to the simple coadministration of the two bioactives, our conjugation methodology offers a number of advantages such as extracellular selectivity and mechanistic synergy by the simultaneous delivery of the two bioactives to the various intracellular targets. Both fatty acid conjugates of niacin and salicylate were able to produce a pharmacological effect that could not be replicated by administering the individual components or a combination of the individual components. For the fatty acid niacin conjugate <b>5</b>, a distinctive effect on SREBP inhibition was observed, along with a down-regulation of cholesterol and other lipid metabolism genes, including PCSK9. For the fatty acid salicylate conjugate <b>11</b>, the intracellular release of a salicylic acid and a DHA molecule produced an unprecedented and synergistic inhibition of NF-κB. The fatty acid niacin conjugate <b>5</b> has since been advanced into human clinical trials in order to evaluate its effect on the various lipid parameters. The fatty acid salicylate conjugate <b>11</b> has also been advanced into the clinic and is currently being evaluated in patients with Duchenne muscular dystrophy. The results from those clinical trials will be disclosed in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> General Information</h3><div class="NLM_p last">All chemical reagents and solvents were commercially available and used as received. Fatty acids and acid chlorides were purchased from Nu-Chek Prep. Reactions were generally run under argon or nitrogen. <sup>1</sup>H NMR (400 MHz) and <sup>13</sup>C NMR (100 MHz) spectra were recorded on a Varian 400 MHz Unity Inova system in CDCl<sub>3</sub> unless otherwise noted. Chemical shifts are expressed in parts per million (ppm, δ); coupling constants are in hertz (Hz). Splitting patterns describe multiplicities s (singlet), d (double), t (triplet), q (quartet), m (multiplet), and br (broad). High resolution mass spectroscopy data was analyzed by direct flow injection, utilizing electrospray ionization (ESI) on a Waters Qtof API US instrument in the positive mode. Analytical and other mass spectra were collected on an Agilent Technologies 1200 series system with an Agilent Technologies 6120 quadruple LC-MS detector in positive mode. A SiliCycle C18 XDB, 3 mm × 100 mm column was used with a gradient of H<sub>2</sub>O and acetonitrile each with 0.1% formic acid; UV detection at 254 and 210 nm. Normal phase flash chromatography was accomplished on Teledyne Isco systems using prepacked silica gel columns. Sample purity was determined by LC-MS; all compounds were of >95% purity, as determined by at least two different HPLC methods. For the hydrolysis experiments and PK/tissue distribution study, the samples were analyzed on the Agilent 6410 triple quad LC/MS mass spectrometer. Separation was achieved using a Gemini 3 μM C6 phenyl column with a gradient using water containing 0.1% formic acid (solvent A) and methanol containing 0.1% formic acid (solvent B).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> General Procedure Used to Prepare <i>N</i>-(2-((5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-Icosa-5,8,11,14,17-pentaenamido)ethyl)nicotinamide (<b>5</b>) and Other Fatty Acid Conjugates (<b>6</b>–<b>12</b>)</h3><div class="NLM_p">In a typical run, a mixture containing <i>tert</i>-butyl (2-aminoethyl)carbamate (1 g, 6.24 mmol), niacin (730 mg, 5.93 mmol), EDC (1.45 g, 7.50 mmol), HOBT (1.25 g, 7.50 mmol), and Et<sub>3</sub>N (1.8 mL, 12.50 mmol) in 20 mL of CH<sub>2</sub>Cl<sub>2</sub> was stirred at rt for 18 h. The resulting reaction mixture was washed with half-saturated NH<sub>4</sub>Cl and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. Purification by silica gel chromatography (gradient elution, CH<sub>2</sub>Cl<sub>2</sub> to 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded <i>tert</i>-butyl (2-(nicotinamido)ethyl)carbamate (1.4 g, 85%). This material was taken up in 5 mL of THF along with 8 mL of 4 N HCl in dioxane (32 mmol). The resulting reaction mixture was stirred at rt for 8 h and then concentrated under reduced pressure to afford the HCl salt of <i>N</i>-(2-aminoethyl)nicotinamide in essentially quantitative yield. This material was then taken up in 20 mL of CH<sub>2</sub>Cl<sub>2</sub> along with (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-eicosa-5,8,11,14,17-pentaenoic acid (>95% purity, 1.5 g, 5.04 mmol), EDC (1.22 g, 6.36 mmol), HOBT (1.1 g, 6.36 mmol), and Et<sub>3</sub>N (4.4 mL, 31.8 mmol). The resulting reaction mixture was stirred at rt for 16 h. It was then washed with half-saturated NH<sub>4</sub>Cl and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (gradient elution, CH<sub>2</sub>Cl<sub>2</sub> to 6% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford 1.68 g of <i>N</i>-(2-((5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-icosa-5,8,11,14,17-pentaenamido)ethyl)nicotinamide (compound <b>5</b>, 60% overall yield, >95% purity by LC/MS). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (d, <i>J</i> = 2.3 Hz, 1H), 8.72 (dd, <i>J</i> = 4.9, 1.7 Hz, 1H), 8.11 (dt, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.64 (s, 1H), 7.38 (ddd, <i>J</i> = 7.9, 4.9, 0.9 Hz, 1H), 6.10 (d, <i>J</i> = 6.3 Hz, 1H), 5.46–5.25 (m, 9H), 3.65–3.49 (m, 4H), 2.90–2.73 (m, 8H), 2.22 (dd, <i>J</i> = 8.4, 6.9 Hz, 2H), 2.14–1.98 (m, 4H), 1.70 (p, <i>J</i> = 7.4 Hz, 2H), 0.97 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>) δ 20.0, 25.1, 26.2, 34.9, 38.1, 38.8, 39.1, 39.3, 39.5, 39.7, 39.9, 123.3, 128.9, 127.6, 127.7, 127.8, 127.9, 127.9, 128.0, 128.1, 129.4, 129.9, 131.5, 134.8, 148.4, 151.7, 164.9, 172.3. HRMS (ES<sup>+</sup>) calcd for C<sub>28</sub>H<sub>40</sub>N<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>) <i>m</i>/<i>z</i>, 450.3121; found, 450.3121.</div><div class="NLM_p last">The same general experimental procedure was employed for the synthesis of fatty acid salicylate conjugate <b>11</b>, substituting niacin for salicylic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.44 (br s, 1 H), 8.01 (m, 1H), 7.52 (dd, <i>J</i> = 1.3, 7.6 Hz, 1H), 7.36 (m, 1H), 6.95 (m, 1H), 6.84 (m, 1H), 6.36 (m, 1H), 5.29–5.37 (m, 12H), 3.49–3.53 (m, 4H), 2.72–2.85 (m, 4H), 2.77–2.85 (m, 10H), 2.06–2.42 (m, 3H), 0.97 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i>) δ 14.3, 20.6, 23.4, 25.5, 25.6, 25.7, 36.3, 39.4, 41.6, 76.8, 77.1, 77.4, 114.2, 118.3, 118.9, 126.2, 127.0, 127.7, 127.9, 128.1, 128.6, 129.7, 132.1, 134.2, 161.5, 170.8, 175.0. High resolution MS (ES<sup>+</sup>) calcd for C<sub>31</sub>H<sub>42</sub>N<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>) <i>m</i>/<i>z</i>, 491.3274; found, 491.3278.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Fluorescent Imaging Using HuH-7 Cells</h3><div class="NLM_p last">Human hepatocellular carcinoma cells (HuH-7) were obtained from the Japan Cell Research Bank (JCRB). Two million cells were plated overnight in 10% FBS DMEM on a 4-well slide chamber (Nunc Lab-Tek II chamber slide system, Thermo-Scientific). Cells were infected with CellLight ER-RFP, BacMam 2.0 (Molecular Probes, C10591), or CellLight Late Endosomes-RFP, BacMam 2.0 (Molecular Probes, C10589) for 48 h. Cell medium was replaced with DMEM plus compound <b>10</b> (prepared in 10% FBS) or compound <b>12</b> for 30 min and fixed with 4% paraformaldehyde for 2 min at 37 °C and washed two times with phosphate buffered saline for 5 min per wash. Slides were mounted with ProLong Gold antifade reagent with DAPI (Molecular Probes). Images were taken with a Zeiss 510 LSM confocal microscope with a 63× lens. Three lasers at 408, 488 and 561 nm were used for DAPI, fatty acid conjugates <b>10</b> or <b>12</b>, and ER/lysosome/endosomes-tracker, respectively. For the endocytosis imaging, HuH-7 cells were infected with CellLight ER-RFP, BacMam 2.0 (Molecular Probes), for 48 h. Cells were pretreated with 80 μM dynasore and then treated with compound <b>10</b> for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI (Molecular Probes). Images were taken on a Zeiss 510 LSM confocal microscope with 63× lens.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Plasma Stability Studies</h3><div class="NLM_p last">The in vitro stability of compounds <b>1</b>–<b>5</b> was studied in human, mouse, beagle, and rat plasma. The plasma from the different species was diluted to 50% with 0.05 M PBS (pH 7.4) at 37 °C. Test compounds were dissolved in DMSO to a final concentration of 10 mM and then diluted to 1 mM in MeOH. The reactions were initiated by the addition of the test compounds to 500 μL of preheated plasma in a 96-well plate to yield a final concentration of 5 μM. The assays were performed at 37 °C and conducted in triplicate. Samples (50 μL) were taken at 0, 30, 60, and 120 min, and 200 μL of acetonitrile containing an appropriate internal standard (200 ng/mL) was added. The samples were subjected to vortex mixing for 1 min and then centrifugation at 4 °C for 30 min at 4000 rpm. The clear supernatants were then analyzed by LC-MS-MS under electrospray ionization in the positive multiple reactions monitoring (MRM) mode.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Hydrolysis Experiment Using Rat Liver Lysate</h3><div class="NLM_p last">The rat liver lysate hydrolysis experiment was performed in Eppendorf tubes by adding the necessary amount of water for the assay first. A 10× buffer solution with final concentrations of HEPES and EDTA of 50 and 1 mM, respectively, was prepared from 500 mM HEPES and 10 mM EDTA in water. Rat liver lysate was removed from −80 °C storage, thawe,d and centrifuged at 4000<i>g</i> for 5 min. A volume of the supernatant was transferred to the Eppendorf tube, yielding a final concentration in the assay of 3 mg/mL rat liver lysate. The tube was gently inverted to mix the components. The reactions are then place in a 37 °C incubator for 20 min, allowing the reaction mixture to reach 37 °C before the reaction was initiated. To initiate the hydrolysis reaction, the samples were removed from the incubator and the compounds of the invention were added, as a DMSO solution, prepared in a manner to allow for <1% final DMSO concentration and 5 μM final compound concentration. The contents were mixed and then at time point = 0 immediately transferred into an acetonitrile crash buffer for analysis on the LC/MS/MS in the linear range of the analyte of interest. This process was then repeated for additional time points as needed. This protocol was repeated in the presence of 5 μM of the FAAH inhibitor PF-3845.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Hydrolysis Experiment Using FAAH1</h3><div class="NLM_p last">FAAH1-32-579 (the N-term transmembrane region truncated) was cloned into pFastBacI (Invitrogen) with N-terminal FLAG and C-terminal His tags and then expressed in SF9 insect cells at 27 °C for 48 h. The cells were harvested and resuspended in lysis buffer (300 mM NaCl, 10% glycerol, 0.1% NP-40, 50 mM Tris-HCl, pH 7.8, with protease inhibitor cocktail, Roche), incubated for 30 min at 4 °C, and lysed by sonication. The supernatant was incubated with Anti-FLAG M2 affinity gel (Sigma) that pre-equilibrated with binding buffer (300 mM NaCl, 10% glycerol, 0.1% NP-40, 50 mM Tris-HCl, pH 7.8) for 1.5 h at 4 °C. The Anti-FLAG M2 affinity gel was then put into a column and washed with 20 CVs of binding buffer and then washed with 10 CV of washing buffer (150 mM NaCl, 5% glycerol, 5 mM ATP, 20 mM Tris-HCl, pH 7.8). The FAAH1 protein was eluted with 100 μg/mL of FLAG peptide in 150 mM NaCl, 5% glycerol, 10 mM Tris-HCl, pH 7.4, and dialyzed against 300 mM NaCl, 20% glycerol, 2 mM DTT, 25 mM Tris-HCl, pH 7.8. The target protein was concentrated to ∼0.5 mg/mL by ultrafiltration tube with the molecular cutoff of 30 kDa and frozen with liquid nitrogen for storage at −80 °C. Compound <b>5</b> was tested in a hydrolysis experiment using this recombinant FAAH1 at an enzyme concentration of 1 nM and substrate concentration of 25 μM. For the hydrolysis portion, compound <b>5</b> and enzyme were incubated for 2 h at 37 °C. For the quantification portion, the samples were analyzed on the Agilent 6410 triple quad LC/MS mass spectrometer using the appropriate standard curves. Separation on the LC/MS was achieved using the general protocols detailed above.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Hydrolysis Experiments in HepG2 Cells</h3><div class="NLM_p last">HepG2 cells (from ATCC, catalogue no. HB-8065) were suspended in PBS (1 × 10<sup>5</sup>/mL) and preincubated at 37 °C for 30 min. Compound <b>9</b> was added to the reaction tubes at a concentration of 50 μM in DMSO (1% final concentration of DMSO). Following the addition of compound <b>9</b>, an aliquot was immediately transferred from the reaction tube and quenched into a 1.5 mL microcentrifuge tube containing acetonitrile and an internal standard. All reaction tubes were then returned to the 37 °C incubator. Additional aliquots were withdrawn at the following time points and processed in the same manner: 30 min, 1 h, 3 h, and 4 h. The microcentrifuge tubes containing the quenched reaction were vortexed for 30 s and then centrifuged for 5 min at 14800<i>g</i>. The supernatant was analyzed by LC/MS/MS for EPA-<i>d</i><sub>5</sub>. The standard curve for EPA-<i>d</i><sub>5</sub> was generated at a concentration range from 1 to 500 nM in HepG2 cell suspension (1 × 10<sup>5</sup>/mL). Analytically pure EPA-<i>d</i><sub>5</sub> is commercially available from Caymen Chemicals.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Assay Used to Assess Activation of GPR109A</h3><div class="NLM_p last">The human epidermoid A431 cell line expresses GPR109A and was used in these studies. On the day of the assay, fresh stimulation buffer was made with HBSS containing 5 mM HEPES, 0.5 mM IBMX, and 0.1% BSA. A 3 μM forskolin solution prepared in stimulation buffer was used in the assay. The cells were trypsinized and washed off the flask in HBSS and spun down. The cells were then resuspended in stimulation buffer and brought up to a concentration of 100 cells/μL. Then 10 μL of this cell suspension was added into each well of a 96-well half area plate for a total of 1000 cells/well in the assay. Then 5 μL of 4× compound or vehicle only was added to each well. Following this, 5 μL of the 4× forskolin solution was added to each well for a total final volume of 20 μL. The plate was incubated at room temperature for 30 min. The cellular cAMP concentration was measured with the LANCE Ultra cAMP kit: the Eu-cAMP tracer and ULight-anti-cAMP antibody were diluted in detection buffer at 1/50 and 1/150 dilutions, respectively. Then 10 μL each of the Eu-cAMP and ULight-anti-cAMP were added to each well. The plate was then incubated at room temperature for 60 min. The plate was read on a Victor X5 multilabel plate reader (PerkinElmer) at an excitation of 340 nm and emission of 615 and 665 nm. A ratio of 665/615 nm was calculated from this reading. The data were represented as the percent inhibition of cAMP produced by forskolin.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Immunoblotting for SREBP-2</h3><div class="NLM_p last">HepG2 cells were plated in DMEM 10% FBS overnight. Compound <b>5</b>, atorvastatin, and EPA stock solutions were prepared at 50 mM in 100% ethanol, and dilutions (10× of final concentration) were made in 100% FBS. HepG2 cells were replaced with fresh DMEM plus drugs for overnight. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (20 mM) Tris-HCl (pH 7.5), 150 mM NaCl,1 mM Na<sub>2</sub>EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 μg/mL leupeptin), and cell lysates were separated on 4–20% precast polyacrylamide gels (Biorad) and transferred to Immobilon PVDF membranes (Millipore). The membrane were blocked with Odyssey blocking buffer and incubated with anti-SREBP2 antibody (Abcam ab72856 at 1–500 dilution) and anti-Actin (Abcam ab3280 at 10000 dilution) overnight and were incubated with LI-COR secondary antibodies. Images were scanned using LI-COR Odyssey imaging system and quantified by LI-COR software. Data were analyzed by GraphPad Prism.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Determination of IC<sub>50</sub> for Inhibition of PCSK9 Secretion in HepG2 Cells</h3><div class="NLM_p last">HepG2 cells (from ATCC, catalogue no. HB-8065) were maintained in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen). The day prior to the PCSK9 assay, cells were seeded in 96-well collagen coated plates at 25000 cells/well. The test compounds were stored at −20 °C until used. The test article compound was dissolved in 100% ethanol to a 50 mM stock solution. This was then diluted in FBS to a final concentration of 1 mM. This solution was placed in a sonicating water bath for 30 min. Subsequent dilutions were then made in FBS supplemented with an equivalent volume of ethanol and mixed by vortexing. Once HepG2 cells were seeded onto a collagen coated 96-well plate (Becton Dickinson, catalogue no. 35-4407), the assay was performed as follows: the cell medium was removed, washed once with 100 μL of serum-free DMEM to remove any residual PCSK9, and replaced with 90 μL of serum-free DMEM. Then 10 μL of each compound concentration prepared in FBS was then added. Each concentration of compound was tested in triplicate. The compound was incubated with the cells overnight for 16 h. Following this incubation, 10 μL of AlamarBlue was added to each well and cells incubated for another 2 h. The plates were then removed, and AlamarBlue fluorescence was measured (excitation 550 nm and excitation 590 nm) to assess cell viability. Cell culture supernatant was then diluted 1:5 in 1× RD5P calibrator diluent, and PCSK9 ELISA was then performed with 50 μL of this diluted sample as per the manufacturer’s instructions. The ELISA was measured on a Victor X5 multilabel plate reader (PerkinElmer) at an absorbance of 450 nm with background correction measured at 550 nm (The PCSK9 Elisa kits can be purchased from R&D System, catalogue no. DPC900). Six test concentrations were used to generate the IC<sub>50</sub> value.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Assay for Inhibition of ApoB in HepG2 Cells</h3><div class="NLM_p last">HepG2 cells (ATCC) were seeded at 10000 cells per well in 96-well plates. After adhering overnight, cells were then treated with the test compounds at six concentrations (2-fold dilutions starting at 50 μM for compound <b>5</b>, EPA, the combination of EPA plus niacin, or at 10 mM for niacin alone). The fatty acid conjugate <b>5</b> was dissolved along with FBS according to the procedure outlined above. Media supernatants were removed and ApoB concentrations measured by ELISA following manufacturer’s protocol (Mabtech AB). Percent inhibition of ApoB secretion was determined by normalizing data to vehicle treated wells. For a given compound, an IC<sub>50</sub> (concentration at which 50% of ApoB secretion is inhibited) was determined by using a four-parameter fit inhibition curve model (Graph Pad Prism). In each experiment, cell viability was determined using Alamar Blue (Invitrogen no. DAL1100).</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Assay for Inhibition of NF-κB</h3><div class="NLM_p last">RAW 264.7 macrophages stably transfected with 3× NF-κB-luciferase reporter were used for the assay.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Cells were plated into 96-well plates and incubated overnight. The next day, cells were treated with vehicle (0.1% ethanol) or test compounds for 2 h. Then 10 μM dexamethasone was used as a positive control on NF-κB inhibition. Cell viability reagent Alamar Blue was then added to every well and cells challenged with 200 ng/mL LPS for 3 h. Cell viability was assessed using a Victor 5 plate reader measuring fluorescence with an excitation filter of 550 nm and an emission filter of 590 nm. Data is expressed as percent of vehicle control after correcting for background fluorescence. Wells were then aspirated and 100 uL Brite Lite Plus luciferase reagent (PerkinElmer no. 6016761) was added to each well. Luminescence was measured using a Victor 5 plate reader. Data is presented as percent of LPS stimulated control calculated as 100(CPS sample – average CPS unstimulated control)/(average CPS LPS stimulated control – average CPS unstimulated control). Error bars represent standard error of the mean (SEM) for experiment performed in triplicate.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> PK Study in Rats</h3><div class="NLM_p last">Male Sprague–Dawley rats (<i>n</i> = 4/treatment group) were administered with a single oral dose of either niacin (30 mg/kg) or compound <b>5</b> (100 mg/kg). Compounds were formulated as an aqueous emulsion using Tween, Peceol, PEG400, and tocopherol. Compound <b>5</b> (170 mg) was formulated in 2.38 g of the oil mixture containing 40% Tween, 50% Peceol, 10% PEG400, and 0.2% tocopherol. The concentration of <b>5</b> in oil was 66 mg/g of oil. For oral dosing, this oil formulation was then diluted with 14.25 mL of water to form a 10 mg/mL drug emulsion and dosed as an oral gavage. Collection time points were 5, 15, and 30 min 1, 2, 4, 6, and 8 h postdose. Blood samples were collected via saphenous vein and placed in tubes containing paraoxon (10 μL of a 200 μM solution in DMSO) and stored on an ice block until centrifuged at 8000 rpm for 6 min at 2–8 °C. The resulting plasma was kept frozen at −80 °C until analysis. Compound <b>5</b>, nicotinic acid, and nicotinuric acid standard curves were generated to allow for quantitative analysis of plasma samples. Standard curves were generated by adding 10 μL of a given compound in methanol (50 μg/mL) to 50 μL of blank plasma in a 96-well microplate, resulting in the following final concentration range: 8333, 2083, 521, 130.2, 32.5, 8.1, 2.0, and 0.5 ng/mL. Then 300 μL of acetonitrile containing 100 ng/mL of an internal standard was added to each sample. The 96-well microplate was vortexed for 30 s and was then centrifuged for 45 min at 2300<i>g</i>. Then 100 μL of supernatant was transferred from each sample to an empty 96-well microplate for analysis by LC/MS/MS. The instrument used was an Agilent (Agilent Technologies Inc. USA) liquid chromatograph equipped with a binary pump (1200 series), an autosampler (1200 series), and a degasser (1200 series). Mass spectrometric analysis was performed using an Agilent 6410 triple quadrupole with an ESI interface. The data acquisition and quantitation was done with Agilent Masshunter software. The column used was a Phenomenex Gemini C6 Phenyl 110A 50 mm × 4.6 mm, 1.8 μm. The following mobile phase gradient was used (water = solvent A; methanol = solvent B): 0.01 min = 45%A/55%B; 0.5 min = 45%A/55%B; 1 min = 5%A/95%B; 3.5 min = 5%A/95%B; 3.51 min = 45%A/55%B; 4 min = 45%A/55%B.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> PK/Tissue Distribution Study in Sprague–Dawley Rats</h3><div class="NLM_p last">Male Sprague–Dawley rats (<i>n</i> = 4) with a median age of 6–8 weeks were used for the study. Animals were dosed with 300 mg/kg of compound <b>5</b> qd for 7 days (formulated as an aqueous emulsion using Tween, Peceol, PEG400, and tocopherol in the same manner as detailed above, with the ratio of API in oil adjusted to 500 mg/g of oil). Body weight was measured and recorded daily for each rat. Two hours after the last dose, animals were euthanized and tissues were collected as follows: The left and right lobes of the liver, as well as the remaining liver (three portions per rat) were rinsed in saline, weighed, and snap frozen in separate 50 mL conical centrifuge tubes. The small intestine was dissected from the stomach to the cecum. The ileum was defined as the 10 cm proximal to the cecum. The ileum was dissected and frozen in a separate tube. The remaining small intestine composed of the jejunum and duodenum was weighed and snap frozen in separate tubes. A maximum obtainable blood volume was also collected at termination 2 h post last dose using sodium heparin as an anticoagulant. To quantify the amount of compound <b>5</b> (or any of the metabolites shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) in the intestine, all three dissected sections (ileum, jejunum, and duodenum) were pooled together and homogenized in PBS (2×). A portion of the homogenized mixture was quenched in acetonitrile containing the appropriate internal standard and analyzed by LC/MS/MS. Standard curves in the appropriate tissues were generated in the same manner as described above.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01961">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01961" class="ext-link">10.1021/acs.jmedchem.5b01961</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional PK data for compounds <b>5</b>, <b>7</b>, and <b>8</b>, along with the detailed procedures for preparing compounds <b>1</b>–<b>4</b> and spectroscopic data for compounds <b>5</b> and <b>11</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_001.pdf">jm5b01961_si_001.pdf (1.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_002.csv">jm5b01961_si_002.csv (0.81 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01961" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi B. Vu</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a9cadfdce9cac8ddc8cbc8dac0da87cac6c4"><span class="__cf_email__" data-cfemail="385b4e4d785b594c595a594b514b165b5755">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean E. Bemis</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ericka Benson</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pradeep Bista</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Carney</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Fahrner</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Lee</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Liu</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pallavi Lonkar</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jill C. Milne</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Nichols</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominic Picarella</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Shoelson</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesse Smith</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amal Ting</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allison Wensley</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maisy Yeager</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Zimmer</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Jirousek</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2460-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Steven Shoelson for helpful discussion regarding the role of salicylates in NF-κB inhibition.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> Abbreviations Used</h2><tr><td class="NLM_term">PCSK9</td><td class="NLM_def"><p class="first last">proprotein convertase subtilisin/kexin type 9</p></td></tr><tr><td class="NLM_term">SREBP</td><td class="NLM_def"><p class="first last">sterol regulatory element binding protein</p></td></tr><tr><td class="NLM_term">EPA</td><td class="NLM_def"><p class="first last">(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-eicosa-5,8,11,14,17-pentaenoic acid</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86578" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86578" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">Polypharmacology-Foe or Friend?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8955</span><span class="NLM_x">–</span> <span class="NLM_lpage">8971</span><span class="refDoi"> DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology-Foe+or+Friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0lisWxRV44dsUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology-Foe%2520or%2520Friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can We Rationally Design Promiscuous Drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.sbi.2006.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+We+Rationally+Design+Promiscuous+Drugs%3F&doi=10.1016%2Fj.sbi.2006.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0lihTd6PERbYmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520We%2520Rationally%2520Design%2520Promiscuous%2520Drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136%26doi%3D10.1016%2Fj.sbi.2006.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resta, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno-Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1056/NEJM200104053441401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1056%2FNEJM200104053441401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=11287972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1031-1037&author=B.+J.+Drukerauthor=M.+Talpazauthor=D.+J.+Restaauthor=B.+Pengauthor=E.+Buchdungerauthor=J.+M.+Fordauthor=N.+B.+Lydonauthor=H.+Kantarjianauthor=R.+Capdevilleauthor=S.+Ohno-Jonesauthor=C.+L.+Sawyers&title=Efficacy+and+Safety+of+a+Specific+Inhibitor+of+the+BCR-ABL+Tyrosine+Kinase+in+Chronic+Myeloid+Leukemia&doi=10.1056%2FNEJM200104053441401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia</span></div><div class="casAuthors">Druker, Brian J.; Talpaz, Moshe; Resta, Debra J.; Peng, Bin; Buchdunger, Elisabeth; Ford, John M.; Lydon, Nicholas B.; Kantarjian, Hagop; Capdeville, Renaud; Ohno-Jones, Sayuri; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1031-1037</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML).  Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML.  Methods: We conducted a phase 1, dose-escalating trial of STI571 (formerly known as CGP 57148B), a specific inhibitor of the BCR-ABL tyrosine kinase.  STI571 was administered orally to 83 patients with CML in the chronic phase in whom treatment with interferon alpha had failed.  Patients were successively assigned to 1 of 14 doses ranging from 25 to 1000 mg per day.  Results: Adverse effects of STI571 were minimal; the most common were nausea, myalgias, edema, and diarrhea.  A maximal tolerated dose was not identified.  Complete hematol. responses were obsd. in 53 of 54 patients treated with daily doses of 300 mg or more and typically occurred in the first four weeks of therapy.  Of the 54 patients treated with doses of 300 mg or more, cytogenetic responses occurred in 29, including 17 (31 percent of the 54 patients who received this dose) with major responses (0 to 35 percent of cells in metaphase pos. for the Philadelphia chromosome); 7 of these patients had complete cytogenetic remissions.  Conclusion: STI571 is well tolerated and has significant antileukemic activity in patients with CML in whom treatment with interferon alpha had failed.  Our results provide evidence of the essential role of BCR-ABL tyrosine kinase activity in CML and demonstrate the potential for the development of anticancer drugs based on the specific mol. abnormality present in a human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrprbDzKoC0ubVg90H21EOLACvtfcHk0lihTd6PERbYmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D&md5=1554407678838243a753aa056ffd4f7c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM200104053441401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200104053441401%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DResta%26aufirst%3DD.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DOhno-Jones%26aufirst%3DS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520a%2520Specific%2520Inhibitor%2520of%2520the%2520BCR-ABL%2520Tyrosine%2520Kinase%2520in%2520Chronic%2520Myeloid%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1031%26epage%3D1037%26doi%3D10.1056%2FNEJM200104053441401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Azmi, A. S.</span><span> </span><span class="NLM_article-title">Network Pharmacology for Cancer Drug Discovery: Are We There Yet?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.4155/fmc.12.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.4155%2Ffmc.12.44" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=931-941&author=A.+S.+Azmi&title=Network+Pharmacology+for+Cancer+Drug+Discovery%3A+Are+We+There+Yet%3F&doi=10.4155%2Ffmc.12.44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.44%26sid%3Dliteratum%253Aachs%26aulast%3DAzmi%26aufirst%3DA.%2BS.%26atitle%3DNetwork%2520Pharmacology%2520for%2520Cancer%2520Drug%2520Discovery%253A%2520Are%2520We%2520There%2520Yet%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D931%26epage%3D941%26doi%3D10.4155%2Ffmc.12.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Seeger, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J. A.,  3rd</span><span> </span><span class="NLM_article-title">Ziprasidone (CP-88,059): A New Antipsychotic with Combined Dopamine and Serotonin Receptor Antagonist Activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=7562537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADyaK2MXovVKntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=101-113&author=T.+F.+Seegerauthor=P.+A.+Seymourauthor=A.+W.+Schmidtauthor=S.+H.+Zornauthor=D.+W.+Schulzauthor=L.+A.+Lebelauthor=S.+McLeanauthor=V.+Guanowskyauthor=H.+R.+Howardauthor=J.+A.+Lowe&title=Ziprasidone+%28CP-88%2C059%29%3A+A+New+Antipsychotic+with+Combined+Dopamine+and+Serotonin+Receptor+Antagonist+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity</span></div><div class="casAuthors">Seeger, T. F.; Seymour, P. A.; Schmidt, A. W.; Zorn, S. H.; Schulz, D. W.; Lebel, L. A.; McLean, S.; Guanowsky, V.; Howard, H. R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-13</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Ziprasidone (CP-88,059) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects in preclin. assays predictive of antipsychotic activity.  Whereas the compd. is a dopamine antagonist in vitro and in vivo, its most potent action is antagonism of 5-HT2A receptors, where its affinity is an order of magnitude greater than that obsd. for dopamine D2 sites.  Lab. and clin. findings have led to a hypothesis that antagonism of 5-HT2A receptors in the brain limits the undesirable motor side effects assocd. with dopamine receptor blockade and improves efficacy against the neg. symptoms of schizophrenia.  Siprasidone possesses an in vitro 5-HT2A/dopamine D2 receptor affinity ratio higher than any clin. available antipsychotic agent.  In vivo, ziprasidone antagonizes 5-HT2A receptor-induced head twitch with 6-fold higher potency than for blockade of d-amphetamine-induced hyperactivity, a measure of central dopamine D2 receptor antagonism.  Ziprasidone also has high affinity for the 5-HT1A, 5-HT1D and 5-HT2C receptor subtypes, which may further enhance its therapeutic potential.  The prediction of antipsychotic efficacy without severe motor side effects is supported by the relatively weak potency of ziprasidone to produce catalepsy in animals, contrasted with its potent antagonism of conditioned avoidance responding and dopamine agonist-induced locomotor activation and stereotypy.  The compd. is well tolerated in animals at doses producing effective dopamine antagonism in the brain.  Ziprasidone should be a valuable addn. to the treatment of psychotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8EaD7ygyZbbVg90H21EOLACvtfcHk0lihTd6PERbYmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovVKntbw%253D&md5=8d747dd236e65f0ba876e47f27f3ee3f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeger%26aufirst%3DT.%2BF.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DZorn%26aufirst%3DS.%2BH.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DHoward%26aufirst%3DH.%2BR.%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26atitle%3DZiprasidone%2520%2528CP-88%252C059%2529%253A%2520A%2520New%2520Antipsychotic%2520with%2520Combined%2520Dopamine%2520and%2520Serotonin%2520Receptor%2520Antagonist%2520Activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hegde, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinfeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulido-Rios, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammen, M.</span><span> </span><span class="NLM_article-title">Pharmacologic Characterization of GSK-961081 (TD-5959), a First-In-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1124/jpet.114.216861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1124%2Fjpet.114.216861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=25100753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yksbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=190-199&author=S.+S.+Hegdeauthor=A.+D.+Hughesauthor=Y.+Chenauthor=T.+Steinfeldauthor=J.+R.+Jasperauthor=T.-W.+Leeauthor=A.+McNamaraauthor=W.+J.+Martinauthor=M.+T.+Pulido-Riosauthor=M.+Mammen&title=Pharmacologic+Characterization+of+GSK-961081+%28TD-5959%29%2C+a+First-In-Class+Inhaled+Bifunctional+Bronchodilator+Possessing+Muscarinic+Receptor+Antagonist+and+%CE%B22-Adrenoceptor+Agonist+Properties&doi=10.1124%2Fjpet.114.216861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties</span></div><div class="casAuthors">Hegde, Sharath S.; Hughes, Adam D.; Chen, Yan; Steinfeld, Tod; Jasper, Jeffrey R.; Lee, Tae-Weon; McNamara, Alexander; Martin, William J.; Pulido-Rios, M. Teresa; Mammen, Mathai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-199, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present studies was to characterize the pharmacol. properties of GSK-961081 [TD-5959; (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl) piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate], a novel first-in-class inhaled bifunctional compd. possessing both muscarinic antagonist (MA) and β2-adrenoceptor agonist (BA) properties (MABA).  In competition radioligand binding studies at human recombinant receptors, GSK-961081 displayed high affinity for hM2 (Ki = 1.4 nM), hM3 muscarinic receptors (Ki = 1.3 nM) and hβ2-adrenoceptors (Ki = 3.7 nM).  GSK-961081 behaved as a potent hβ2-adrenoceptor agonist (EC50 = 0.29 nM for stimulation of cAMP levels) with 440- and 320-fold functional selectivity over hβ1- and hβ3-adrenoceptors, resp.  In guinea pig isolated tracheal tissues, GSK-961081 produced smooth muscle relaxation through MA (EC50 = 50.2 nM), BA (EC50 = 24.6 nM), and MABA (EC50 = 11 nM) mechanisms.  In the guinea pig bronchoprotection assay, inhaled GSK-961081 produced potent, dose-dependent inhibition of bronchoconstrictor responses via MA (ED50 = 33.9 μg/mL), BA (ED50 = 14.1 μg/mL), and MABA (ED50 = 6.4 μg/mL) mechanisms.  Significant bronchoprotective effects of GSK-961081 were evident in guinea pigs via MA, BA, and MABA mechanisms for up to 7 days after dosing.  The lung selectivity index of GSK-961081 in guinea pigs was 55- to 110-fold greater than that of tiotropium with respect to systemic antimuscarinic antisialagogue effects and was 10-fold greater than that of salmeterol with respect to systemic β2-adrenoceptor hypotensive effects.  These preclin. findings studies suggest that GSK-961081 has the potential to be a promising next-generation inhaled lung-selective bronchodilator for the treatment of airway diseases, including chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7s7-fKs3E47Vg90H21EOLACvtfcHk0ljOyqnbxz6yCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yksbfJ&md5=f2b92f897950afedc02c62c056824c17</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.216861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.216861%26sid%3Dliteratum%253Aachs%26aulast%3DHegde%26aufirst%3DS.%2BS.%26aulast%3DHughes%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSteinfeld%26aufirst%3DT.%26aulast%3DJasper%26aufirst%3DJ.%2BR.%26aulast%3DLee%26aufirst%3DT.-W.%26aulast%3DMcNamara%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DPulido-Rios%26aufirst%3DM.%2BT.%26aulast%3DMammen%26aufirst%3DM.%26atitle%3DPharmacologic%2520Characterization%2520of%2520GSK-961081%2520%2528TD-5959%2529%252C%2520a%2520First-In-Class%2520Inhaled%2520Bifunctional%2520Bronchodilator%2520Possessing%2520Muscarinic%2520Receptor%2520Antagonist%2520and%2520%25CE%25B22-Adrenoceptor%2520Agonist%2520Properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D190%26epage%3D199%26doi%3D10.1124%2Fjpet.114.216861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Altschul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephen, J. D.</span><span> </span><span class="NLM_article-title">Influence of Nicotinic Acid on Serum Cholesterol in Man</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1016/0003-9861(55)90070-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2F0003-9861%2855%2990070-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1955&pages=558-559&author=R.+Altschulauthor=A.+Hofferauthor=J.+D.+Stephen&title=Influence+of+Nicotinic+Acid+on+Serum+Cholesterol+in+Man&doi=10.1016%2F0003-9861%2855%2990070-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2855%2990070-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252855%252990070-9%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DR.%26aulast%3DHoffer%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DJ.%2BD.%26atitle%3DInfluence%2520of%2520Nicotinic%2520Acid%2520on%2520Serum%2520Cholesterol%2520in%2520Man%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1955%26volume%3D54%26spage%3D558%26epage%3D559%26doi%3D10.1016%2F0003-9861%2855%2990070-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Villines, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. J.</span><span> </span><span class="NLM_article-title">Niacin: The Evidence, Clinical Use, and Future Directions</span> <span class="citation_source-journal">Curr. Atheroscler. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.1007/s11883-011-0212-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs11883-011-0212-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22037771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=49-59&author=T.+C.+Villinesauthor=A.+S.+Kimauthor=R.+S.+Goreauthor=A.+J.+Taylor&title=Niacin%3A+The+Evidence%2C+Clinical+Use%2C+and+Future+Directions&doi=10.1007%2Fs11883-011-0212-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Niacin: The Evidence, Clinical Use, and Future Directions</span></div><div class="casAuthors">Villines, Todd C.; Kim, Andrew S.; Gore, Rosco S.; Taylor, Allen J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Atherosclerosis Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-59</span>CODEN:
                <span class="NLM_cas:coden">CARUCZ</span>;
        ISSN:<span class="NLM_cas:issn">1523-3804</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The use of FDA-approved niacin (nicotinic acid or vitamin B3) formulations at therapeutic doses, alone or in combination with statins or other lipid therapies, is safe, improves multiple lipid parameters, and reduces atherosclerosis progression.  Niacin is unique as the most potent available lipid therapy to increase high-d. lipoprotein (HDL) cholesterol and it significantly reduces lipoprotein(a).  Through its action on the GPR109A receptor, niacin may also exert beneficial pleiotropic effects independent of changes in lipid levels, such as improving endothelial function and attenuating vascular inflammation.  Studies evaluating the impact of niacin in statin-naive patients on cardiovascular outcomes, or alone and in combination with statins or other lipid therapies on atherosclerosis progression, have been universally favorable.  However, the widespread use of niacin to treat residual lipid abnormalities such as low HDL cholesterol, when used in combination with statins among patients achieving very low (<75 mg/dL) low-d. lipoprotein cholesterol levels, is currently not supported by clin. outcome trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAt6OXedtaK7Vg90H21EOLACvtfcHk0ljOyqnbxz6yCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVeisQ%253D%253D&md5=cfb8d6299c688eb2156e84180052bfe1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11883-011-0212-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11883-011-0212-1%26sid%3Dliteratum%253Aachs%26aulast%3DVillines%26aufirst%3DT.%2BC.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DGore%26aufirst%3DR.%2BS.%26aulast%3DTaylor%26aufirst%3DA.%2BJ.%26atitle%3DNiacin%253A%2520The%2520Evidence%252C%2520Clinical%2520Use%252C%2520and%2520Future%2520Directions%26jtitle%3DCurr.%2520Atheroscler.%2520Rep.%26date%3D2012%26volume%3D14%26spage%3D49%26epage%3D59%26doi%3D10.1007%2Fs11883-011-0212-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gille, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodor, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermanns, S.</span><span> </span><span class="NLM_article-title">Nicotinic Acid: Pharmacological Effects and Mechanisms of Action</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.48.113006.094746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1146%2Fannurev.pharmtox.48.113006.094746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=17705685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFynurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=79-106&author=A.+Gilleauthor=E.+T.+Bodorauthor=K.+Ahmedauthor=S.+Offermanns&title=Nicotinic+Acid%3A+Pharmacological+Effects+and+Mechanisms+of+Action&doi=10.1146%2Fannurev.pharmtox.48.113006.094746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acid: pharmacological effects and mechanisms of action</span></div><div class="casAuthors">Gille, Andreas; Bodor, Erik T.; Ahmed, Kashan; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79-106</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Pharmacol. doses of nicotinic acid induce a profound change in the plasma levels of various lipids and lipoproteins.  The ability of nicotinic acid to strongly increase the plasma concn. of high-d. lipoprotein (HDL) cholesterol has in recent years led to an increased interest in the pharmacol. potential of nicotinic acid.  There is increasing evidence that nicotinic acid alone or in addn. to LDL cholesterol-lowering drugs can reduce the progression of atherosclerosis and reduce the risk of cardiovascular events.  The clin. use of nicotinic acid is, however, hindered by harmless but unpleasant side effects, esp. by a strong cutaneous vasodilation called flushing.  The recent discovery of the G protein-coupled receptor GPR109A (HM74A or PUMA-G) as a receptor for nicotinic acid has allowed for better understanding of the mechanisms underlying the metabolic and vascular effects of nicotinic acid.  On the basis of recent progress in understanding the pharmacol. effects of nicotinic acid, new strategies are in development to better exploit the pharmacol. potential of nicotinic acid.  New drugs acting via the nicotinic acid receptor or related receptors, as well as new co-medications that suppress unwanted effects of nicotinic acid, will most likely be introduced as new therapeutic options in the treatment of dyslipidemia and the prevention of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_g9LIPLsMCLVg90H21EOLACvtfcHk0ljOyqnbxz6yCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFynurY%253D&md5=d5f5bc77aeadb5b3bc8845e06be89003</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.48.113006.094746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.48.113006.094746%26sid%3Dliteratum%253Aachs%26aulast%3DGille%26aufirst%3DA.%26aulast%3DBodor%26aufirst%3DE.%2BT.%26aulast%3DAhmed%26aufirst%3DK.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DNicotinic%2520Acid%253A%2520Pharmacological%2520Effects%2520and%2520Mechanisms%2520of%2520Action%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2008%26volume%3D48%26spage%3D79%26epage%3D106%26doi%3D10.1146%2Fannurev.pharmtox.48.113006.094746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Von Schacky, G.</span><span> </span><span class="NLM_article-title">The Role of Omega-3 Fatty Acids in Cardiovascular Disease</span> <span class="citation_source-journal">Curr. Atheroscler. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1007/s11883-003-0086-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs11883-003-0086-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=12573200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fmtlentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=139-145&author=G.+Von+Schacky&title=The+Role+of+Omega-3+Fatty+Acids+in+Cardiovascular+Disease&doi=10.1007%2Fs11883-003-0086-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of omega-3 fatty acids in cardiovascular disease</span></div><div class="casAuthors">von Schacky Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Current atherosclerosis reports</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-45</span>
        ISSN:<span class="NLM_cas:issn">1523-3804</span>.
    </div><div class="casAbstract">Plant-derived alpha-linolenic acid has been studied in a limited number of investigations.  So far, some epidemiologic and a few mechanistic studies suggest a potential of protection from cardiovascular disease, but this potential remains to be proven in intervention studies.  In contrast, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are prevalent in fish and fish oils, have been studied in thousands of investigations.  A consistent body of evidence has been elaborated in various types of investigations, ultimately demonstrating reduction in total mortality, cardiovascular mortality, and morbidity by ingestion of roughly 1 g/d of EPA plus DHA.  Current guidelines, however, do not discern between the omega-3 fatty acids mentioned; in fact, most even do not differentiate polyunsaturated fatty acids at all.  Unfortunately, this complicates efficient implementation of an effective means of prophylaxis of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPR7KHQfpOttj_Vg2vObihfW6udTcc2eYkiIS6VZ8AJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fmtlentw%253D%253D&md5=7244bc322975f99340770875fa7a536a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs11883-003-0086-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11883-003-0086-y%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BSchacky%26aufirst%3DG.%26atitle%3DThe%2520Role%2520of%2520Omega-3%2520Fatty%2520Acids%2520in%2520Cardiovascular%2520Disease%26jtitle%3DCurr.%2520Atheroscler.%2520Rep.%26date%3D2003%26volume%3D5%26spage%3D139%26epage%3D145%26doi%3D10.1007%2Fs11883-003-0086-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sekiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakakuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osuga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, H.</span><span> </span><span class="NLM_article-title">Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis in Obese Mice by SREBP-1 Suppression</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1529</span><span class="NLM_x">–</span> <span class="NLM_lpage">1539</span><span class="refDoi"> DOI: 10.1016/j.hep.2003.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.hep.2003.09.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=1529-1539&author=M.+Sekiyaauthor=M.+Yahagiauthor=T.+Matsuzakaauthor=Y.+Najimaauthor=M.+Nakakukiauthor=R.+Nagaiauthor=S.+Ishibashiauthor=J.+Osugaauthor=N.+Yamadaauthor=H.+Shimano&title=Polyunsaturated+Fatty+Acids+Ameliorate+Hepatic+Steatosis+in+Obese+Mice+by+SREBP-1+Suppression&doi=10.1016%2Fj.hep.2003.09.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.hep.2003.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hep.2003.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DSekiya%26aufirst%3DM.%26aulast%3DYahagi%26aufirst%3DM.%26aulast%3DMatsuzaka%26aufirst%3DT.%26aulast%3DNajima%26aufirst%3DY.%26aulast%3DNakakuki%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DR.%26aulast%3DIshibashi%26aufirst%3DS.%26aulast%3DOsuga%26aufirst%3DJ.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DShimano%26aufirst%3DH.%26atitle%3DPolyunsaturated%2520Fatty%2520Acids%2520Ameliorate%2520Hepatic%2520Steatosis%2520in%2520Obese%2520Mice%2520by%2520SREBP-1%2520Suppression%26jtitle%3DHepatology%26date%3D2003%26volume%3D38%26spage%3D1529%26epage%3D1539%26doi%3D10.1016%2Fj.hep.2003.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanbe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, T.</span><span> </span><span class="NLM_article-title">Eicosapentaenoic Acid Improves Hepatic Steatosis Independent of PPAR alpha Activation through Inhibition of SREBP-1 Maturation in Mice</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.07.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.bcp.2010.07.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1601-1612&author=N.+Tanakaauthor=X.+Zhangauthor=E.+Sugiyamaauthor=H.+Konoauthor=A.+Horiuchiauthor=T.+Nakajimaauthor=H.+Kanbeauthor=E.+Tanakaauthor=F.+J.+Gonzalezauthor=T.+Aoyama&title=Eicosapentaenoic+Acid+Improves+Hepatic+Steatosis+Independent+of+PPAR+alpha+Activation+through+Inhibition+of+SREBP-1+Maturation+in+Mice&doi=10.1016%2Fj.bcp.2010.07.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.07.031%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSugiyama%26aufirst%3DE.%26aulast%3DKono%26aufirst%3DH.%26aulast%3DHoriuchi%26aufirst%3DA.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DKanbe%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DAoyama%26aufirst%3DT.%26atitle%3DEicosapentaenoic%2520Acid%2520Improves%2520Hepatic%2520Steatosis%2520Independent%2520of%2520PPAR%2520alpha%2520Activation%2520through%2520Inhibition%2520of%2520SREBP-1%2520Maturation%2520in%2520Mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1601%26epage%3D1612%26doi%3D10.1016%2Fj.bcp.2010.07.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Moon, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank-Kamenetsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koteliansky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, J. D.</span><span> </span><span class="NLM_article-title">The Scap/SREBP Pathway is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1016/j.cmet.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.cmet.2011.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22326225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=240-246&author=Y.+A.+Moonauthor=G.+Liangauthor=X.+Xieauthor=M.+Frank-Kamenetskyauthor=K.+Fitzgeraldauthor=V.+Kotelianskyauthor=M.+S.+Brownauthor=J.+L.+Goldsteinauthor=J.+D.+Horton&title=The+Scap%2FSREBP+Pathway+is+Essential+for+Developing+Diabetic+Fatty+Liver+and+Carbohydrate-Induced+Hypertriglyceridemia+in+Animals&doi=10.1016%2Fj.cmet.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals</span></div><div class="casAuthors">Moon, Young-Ah; Liang, Guosheng; Xie, Xuefen; Frank-Kamenetsky, Maria; Fitzgerald, Kevin; Koteliansky, Victor; Brown, Michael S.; Goldstein, Joseph L.; Horton, Jay D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-246</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Insulin resistance leads to hypertriglyceridemia and hepatic steatosis and is assocd. with increased SREBP-1c, a transcription factor that activates fatty acid synthesis.  Here, we show that steatosis in insulin-resistant ob/ob mice was abolished by deletion of Scap, an escort protein necessary for generating nuclear isoforms of all three SREBPs.  Scap deletion reduced lipid synthesis and prevented fatty livers despite persistent obesity, hyperinsulinemia, and hyperglycemia.  Scap deficiency also prevented steatosis in mice fed high-fat diets.  Steatosis was also prevented when siRNAs were used to silence Scap in livers of sucrose-fed hamsters, a model of diet-induced steatosis and hypertriglyceridemia.  This silencing reduced all three nuclear SREBPs, decreasing lipid biosynthesis and abolishing sucrose-induced hypertriglyceridemia.  These results demonstrate that SREBP activation is essential for development of diabetic hepatic steatosis and carbohydrate-induced hypertriglyceridemia, but not insulin resistance.  Inhibition of SREBP activation has therapeutic potential for treatment of hypertriglyceridemia and fatty liver disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_UAlxnbdBULVg90H21EOLACvtfcHk0liF0k4BLlTk0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVajsrY%253D&md5=2313f31aa9fca6ea00bec1261688db48</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DY.%2BA.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DFrank-Kamenetsky%26aufirst%3DM.%26aulast%3DFitzgerald%26aufirst%3DK.%26aulast%3DKoteliansky%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DM.%2BS.%26aulast%3DGoldstein%26aufirst%3DJ.%2BL.%26aulast%3DHorton%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520Scap%252FSREBP%2520Pathway%2520is%2520Essential%2520for%2520Developing%2520Diabetic%2520Fatty%2520Liver%2520and%2520Carbohydrate-Induced%2520Hypertriglyceridemia%2520in%2520Animals%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26spage%3D240%26epage%3D246%26doi%3D10.1016%2Fj.cmet.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Eberle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegarty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foufelle, F.</span><span> </span><span class="NLM_article-title">SREBP Transcription Factors: Master Regulators of Lipid Homeostasis</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1016/j.biochi.2004.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.biochi.2004.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=15589694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKksLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2004&pages=839-848&author=D.+Eberleauthor=B.+Hegartyauthor=P.+Bossardauthor=P.+Ferreauthor=F.+Foufelle&title=SREBP+Transcription+Factors%3A+Master+Regulators+of+Lipid+Homeostasis&doi=10.1016%2Fj.biochi.2004.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SREBP transcription factors: master regulators of lipid homeostasis</span></div><div class="casAuthors">Eberle, Delphine; Hegarty, Bronwyn; Bossard, Pascale; Ferre, Pascal; Foufelle, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">839-848</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sterol regulatory element binding proteins (SREBPs) are a family of transcription factors that regulate lipid homeostasis by controlling the expression of a range of enzymes required for endogenous cholesterol, fatty acid (FA), triacylglycerol and phospholipid synthesis.  The three SREBP isoforms, SREBP-1a, SREBP-1c and SREBP-2, have different roles in lipid synthesis.  In vivo studies using transgenic and knockout mice suggest that SREBP-1c is involved in FA synthesis and insulin-induced glucose metab. (particularly in lipogenesis), whereas SREBP-2 is relatively specific to cholesterol synthesis.  The SREBP-1a isoform seems to be implicated in both pathways.  SREBP transcription factors are synthesized as inactive precursors bound to the endoplasmic reticulum (ER) membranes.  Upon activation, the precursor undergoes a sequential two-step cleavage process to release the NH2-terminal active domain in the nucleus (designated nSREBPs).  SREBP processing is mainly controlled by cellular sterol content.  When sterol levels decrease, the precursor is cleaved to activate cholesterogenic genes and maintain cholesterol homeostasis.  This sterol-sensitive process appears to be a major point of regulation for the SREBP-1a and SREBP-2 isoforms but not for SREBP-1c.  Moreover, the SREBP-1c isoform seems to be mainly regulated at the transcriptional level by insulin.  The unique regulation and activation properties of each SREBP isoform facilitate the coordinate regulation of lipid metab.; however, further studies are needed to understand the detailed regulation pathways that specifically regulate each SREBP isoform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLdcYSlGLnmbVg90H21EOLACvtfcHk0lhdI4xtY1SXpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKksLfM&md5=f48f242bb3fbf519e80d64f27923d65f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2004.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2004.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DEberle%26aufirst%3DD.%26aulast%3DHegarty%26aufirst%3DB.%26aulast%3DBossard%26aufirst%3DP.%26aulast%3DFerre%26aufirst%3DP.%26aulast%3DFoufelle%26aufirst%3DF.%26atitle%3DSREBP%2520Transcription%2520Factors%253A%2520Master%2520Regulators%2520of%2520Lipid%2520Homeostasis%26jtitle%3DBiochimie%26date%3D2004%26volume%3D86%26spage%3D839%26epage%3D848%26doi%3D10.1016%2Fj.biochi.2004.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Van Rooyen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, G. C.</span><span> </span><span class="NLM_article-title">SREBP-2: A Link between Insulin Resistance, Hepatic Cholesterol, and Inflammation in NASH</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1111/j.1440-1746.2011.06704.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1111%2Fj.1440-1746.2011.06704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=21488942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=789-792&author=D.+M.+Van+Rooyenauthor=G.+C.+Farrell&title=SREBP-2%3A+A+Link+between+Insulin+Resistance%2C+Hepatic+Cholesterol%2C+and+Inflammation+in+NASH&doi=10.1111%2Fj.1440-1746.2011.06704.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH</span></div><div class="casAuthors">Van Rooyen, Derrick M.; Farrell, Geoff C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">789-795</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The research of Zhao et al. (2011) entitled 'Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis' is reviewed with commentary and refs.  Zhao et al. describe the effect of inflammation on hepatic SREBP-2, and subsequent LDLR and HMGR expression in both in vivo and in vitro systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqniTDw4s9PrVg90H21EOLACvtfcHk0lhdI4xtY1SXpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlygs7k%253D&md5=787a799ea24dd8447a4d66b1ccaa54c0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2011.06704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2011.06704.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRooyen%26aufirst%3DD.%2BM.%26aulast%3DFarrell%26aufirst%3DG.%2BC.%26atitle%3DSREBP-2%253A%2520A%2520Link%2520between%2520Insulin%2520Resistance%252C%2520Hepatic%2520Cholesterol%252C%2520and%2520Inflammation%2520in%2520NASH%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2011%26volume%3D26%26spage%3D789%26epage%3D792%26doi%3D10.1111%2Fj.1440-1746.2011.06704.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, Ml</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=Ml+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+Characterization+of+a+Highly+Selective+FAAH+Inhibitor+that+Reduces+Inflammatory+Pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0lhdI4xtY1SXpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DMl%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520a%2520Highly%2520Selective%2520FAAH%2520Inhibitor%2520that%2520Reduces%2520Inflammatory%2520Pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Enzymatic Pathways that Regulate Endocannabinoid Signaling in the Nervous System</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span><span class="refDoi"> DOI: 10.1021/cr0782067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0782067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFKhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1687-1707&author=K.+Ahnauthor=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Enzymatic+Pathways+that+Regulate+Endocannabinoid+Signaling+in+the+Nervous+System&doi=10.1021%2Fcr0782067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic pathways that regulate endocannabinoid signaling in the nervous system</span></div><div class="casAuthors">Ahn, Kay; McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1687-1707</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of the compn. and regulation of endocannabinoid metabolic pathways, esp. with respect to the nervous system, are reviewed.  The current state of the understanding of the 4 major pathways for endocannabinoid metab. are discussed.  These include (1) anandamide degrdn.; (2) anandamide biosynthesis; (3) 2-arachidonoylglycerol (2-AG) degrdn.; and (4) 2-AG biosynthesis.  Some of these pathways, such as anandamide degrdn., are relatively well characterized, at least in terms of the participating enzymes, esp. fatty acid amide hydrolase (FAAH), and the advent of specific research tools to probe their function in vivo.  For the other pathways, candidate enzymes have been identified, but the specific roles that these proteins play in regulating endocannabinoid metab. in vivo remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcfjZNs7jWWrVg90H21EOLACvtfcHk0ljcVLdWicnMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFKhs7s%253D&md5=4c74194ab87393de8f0fcbab198d089c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcr0782067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0782067%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEnzymatic%2520Pathways%2520that%2520Regulate%2520Endocannabinoid%2520Signaling%2520in%2520the%2520Nervous%2520System%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1687%26epage%3D1707%26doi%3D10.1021%2Fcr0782067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">A Review on the Monoacylglycerol Lipase: at the Interface between Fat and Endocannabinoid Signaling</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2607</span><span class="refDoi"> DOI: 10.2174/092986710791859414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.2174%2F092986710791859414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=20491633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2588-2607&author=G.+Labarauthor=J.+Woutersauthor=D.+M.+Lambert&title=A+Review+on+the+Monoacylglycerol+Lipase%3A+at+the+Interface+between+Fat+and+Endocannabinoid+Signaling&doi=10.2174%2F092986710791859414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling</span></div><div class="casAuthors">Labar, G.; Wouters, J.; Lambert, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2588-2607</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Together with anandamide, 2-arachidonoylglycerol (2-AG) constitutes one of the main representatives of a family of endogenous lipids known as endocannabinoids.  These act by binding to CB1 and CB2 cannabinoid receptors, the mol. target of the psychoactive compd. Δ9-THC, both in the periphery and in the central nervous system, where they behave as retrograde messengers to modulate synaptic transmission.  These last years, evidence has accumulated to demonstrate the lead role played by the monoacylglycerol lipase (MAGL) in the regulation of 2-arachidonoylglycerol (2-AG) levels.  Considering the numerous physiol. functions played by this endocannabinoid, MAGL is now considered a promising target for therapeutics, as inhibitors of this enzyme could reveal useful for the treatment of pain and inflammatory disorders, as well as in cancer research, among others.  Here we review the milestones that punctuated MAGL history, from its discovery to recent advances in the field of inhibitors development.  An emphasis is given on the recent elucidation of the tridimensional structure of the enzyme, which could offer new opportunities for rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUHXu1GAauLVg90H21EOLACvtfcHk0ljcVLdWicnMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK&md5=bff89a0988768b26b17604ec38bf70df</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F092986710791859414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859414%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DA%2520Review%2520on%2520the%2520Monoacylglycerol%2520Lipase%253A%2520at%2520the%2520Interface%2520between%2520Fat%2520and%2520Endocannabinoid%2520Signaling%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2588%26epage%3D2607%26doi%3D10.2174%2F092986710791859414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starodub, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kier, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, F.</span><span> </span><span class="NLM_article-title">Liver Fatty Acid-Binding Protein Targets Fatty Acids to the Nucleus, Real Time Confocal and Multiphoton Fluorescence Imaging in Living Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">29139</span><span class="NLM_x">–</span> <span class="NLM_lpage">29151</span><span class="refDoi"> DOI: 10.1074/jbc.M202923200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M202923200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=29139-29151&author=H.+Huangauthor=O.+Starodubauthor=A.+McIntoshauthor=A.+B.+Kierauthor=F.+Schroeder&title=Liver+Fatty+Acid-Binding+Protein+Targets+Fatty+Acids+to+the+Nucleus%2C+Real+Time+Confocal+and+Multiphoton+Fluorescence+Imaging+in+Living+Cells&doi=10.1074%2Fjbc.M202923200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M202923200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M202923200%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DStarodub%26aufirst%3DO.%26aulast%3DMcIntosh%26aufirst%3DA.%26aulast%3DKier%26aufirst%3DA.%2BB.%26aulast%3DSchroeder%26aufirst%3DF.%26atitle%3DLiver%2520Fatty%2520Acid-Binding%2520Protein%2520Targets%2520Fatty%2520Acids%2520to%2520the%2520Nucleus%252C%2520Real%2520Time%2520Confocal%2520and%2520Multiphoton%2520Fluorescence%2520Imaging%2520in%2520Living%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D29139%26epage%3D29151%26doi%3D10.1074%2Fjbc.M202923200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kirchhausen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelish, H. E.</span><span> </span><span class="NLM_article-title">Use of Dynasore, the Small Molecule Inhibitor of Dynamin, in the Regulation of Endocytosis</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/S0076-6879(07)38006-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2FS0076-6879%2807%2938006-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=18413242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntF2htLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2008&pages=77-93&author=T.+Kirchhausenauthor=E.+Maciaauthor=H.+E.+Pelish&title=Use+of+Dynasore%2C+the+Small+Molecule+Inhibitor+of+Dynamin%2C+in+the+Regulation+of+Endocytosis&doi=10.1016%2FS0076-6879%2807%2938006-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis</span></div><div class="casAuthors">Kirchhausen, Tom; Macia, Eric; Pelish, Henry E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">Small GTPases in Disease, Part A</span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The large GTPase dynamin is essential for clathrin-dependent coated-vesicle formation.  Dynasore is a cell-permeable small mol. that inhibits the GTPase activity of dynamin1, dynamin2 and Drp1, the mitochondrial dynamin.  Dynasore was discovered in a screen of ∼16,000 compds. for inhibitors of the dynamin2 GTPase.  Dynasore is a noncompetitive inhibitor of dynamin GTPase activity and blocks dynamin-dependent endocytosis in cells, including neurons.  It is fast acting (seconds) and its inhibitory effect in cells can be reversed by washout.  Here we present a detailed synthesis protocol for dynasore, and describe a series of expts. used to analyze the inhibitory effects of dynasore on dynamin in vitro and to study the effects of dynasore on endocytosis in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3fjSAdqyqZLVg90H21EOLACvtfcHk0ljcVLdWicnMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntF2htLY%253D&md5=3a8c5101903595e3a54df410f3bfad75</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2807%2938006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252807%252938006-3%26sid%3Dliteratum%253Aachs%26aulast%3DKirchhausen%26aufirst%3DT.%26aulast%3DMacia%26aufirst%3DE.%26aulast%3DPelish%26aufirst%3DH.%2BE.%26atitle%3DUse%2520of%2520Dynasore%252C%2520the%2520Small%2520Molecule%2520Inhibitor%2520of%2520Dynamin%252C%2520in%2520the%2520Regulation%2520of%2520Endocytosis%26jtitle%3DMethods%2520Enzymol.%26date%3D2008%26volume%3D438%26spage%3D77%26epage%3D93%26doi%3D10.1016%2FS0076-6879%2807%2938006-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McMahon, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucrot, E.</span><span> </span><span class="NLM_article-title">Molecular Mechanism of Physiological Function of Clathrin-Mediated Endocytosis</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.1038/nrm3151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1038%2Fnrm3151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=21779028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1aqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=517-533&author=H.+T.+McMahonauthor=E.+Boucrot&title=Molecular+Mechanism+of+Physiological+Function+of+Clathrin-Mediated+Endocytosis&doi=10.1038%2Fnrm3151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism and physiological functions of clathrin-mediated endocytosis</span></div><div class="casAuthors">McMahon, Harvey T.; Boucrot, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">517-533</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Clathrin-mediated endocytosis is the endocytic portal into cells through which cargo is packaged into vesicles with the aid of a clathrin coat.  It is fundamental to neurotransmission, signal transduction and the regulation of many plasma membrane activities and is thus essential to higher eukaryotic life.  Morphol. stages of vesicle formation are mirrored by progression through various protein modules (complexes).  The process involves the formation of a putative FCH domain only (FCHO) initiation complex, which matures through adaptor protein 2 (AP2)-dependent cargo selection, and subsequent coat building, dynamin-mediated scission and finally auxilin- and heat shock cognate 70 (HSC70)-dependent uncoating.  Some modules can be used in other pathways, and addns. or substitutions confer cell specificity and adaptability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI8oygEoVS9bVg90H21EOLACvtfcHk0liHp8Lk51R86w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1aqtr4%253D&md5=e402d2c18d475b7949a6ebdfada6f633</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnrm3151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3151%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DH.%2BT.%26aulast%3DBoucrot%26aufirst%3DE.%26atitle%3DMolecular%2520Mechanism%2520of%2520Physiological%2520Function%2520of%2520Clathrin-Mediated%2520Endocytosis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D517%26epage%3D533%26doi%3D10.1038%2Fnrm3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Masui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urade, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kito, M.</span><span> </span><span class="NLM_article-title">Selective Incorporation of n-3 and n-6 Unsaturated Fatty Acids into Animal Cells Phospholipids</span> <span class="citation_source-journal">Biosci., Biotechnol., Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span><span class="refDoi"> DOI: 10.1271/bbb.59.644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1271%2Fbbb.59.644" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1995&pages=644-647&author=H.+Masuiauthor=R.+Uradeauthor=M.+Kito&title=Selective+Incorporation+of+n-3+and+n-6+Unsaturated+Fatty+Acids+into+Animal+Cells+Phospholipids&doi=10.1271%2Fbbb.59.644"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1271%2Fbbb.59.644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.59.644%26sid%3Dliteratum%253Aachs%26aulast%3DMasui%26aufirst%3DH.%26aulast%3DUrade%26aufirst%3DR.%26aulast%3DKito%26aufirst%3DM.%26atitle%3DSelective%2520Incorporation%2520of%2520n-3%2520and%2520n-6%2520Unsaturated%2520Fatty%2520Acids%2520into%2520Animal%2520Cells%2520Phospholipids%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D1995%26volume%3D59%26spage%3D644%26epage%3D647%26doi%3D10.1271%2Fbbb.59.644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Franson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waite, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVia, M.</span><span> </span><span class="NLM_article-title">Identification of Phospholipase A1 and A2 in the Soluble Fraction of Rat Liver Lysosomes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1942</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.1021/bi00786a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00786a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1971&pages=1942-1946&author=R.+Fransonauthor=M.+Waiteauthor=M.+LaVia&title=Identification+of+Phospholipase+A1+and+A2+in+the+Soluble+Fraction+of+Rat+Liver+Lysosomes&doi=10.1021%2Fbi00786a031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fbi00786a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00786a031%26sid%3Dliteratum%253Aachs%26aulast%3DFranson%26aufirst%3DR.%26aulast%3DWaite%26aufirst%3DM.%26aulast%3DLaVia%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Phospholipase%2520A1%2520and%2520A2%2520in%2520the%2520Soluble%2520Fraction%2520of%2520Rat%2520Liver%2520Lysosomes%26jtitle%3DBiochemistry%26date%3D1971%26volume%3D10%26spage%3D1942%26epage%3D1946%26doi%3D10.1021%2Fbi00786a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Fatty Acid Amide Hydrolase, an Enzyme with many Bioactive Substrates. Possible Therapeutic Implications</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.2174/1381612023395655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.2174%2F1381612023395655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=11945157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Omtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=533-547&author=T.+Bisognoauthor=L.+De+Petrocellisauthor=V.+Di+Marzo&title=Fatty+Acid+Amide+Hydrolase%2C+an+Enzyme+with+many+Bioactive+Substrates.+Possible+Therapeutic+Implications&doi=10.2174%2F1381612023395655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications</span></div><div class="casAuthors">Bisogno, Tiziana; De Petrocellis, Luciano; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">533-547</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 116 refs.  During the last 8 yr, a no. of bioactive lipid mediators, the amides or esters of long chain fatty acids, have been discovered or re-discovered.  These include: anandamide (N-arachidonoylethanolamine) and 2-arachidonoylglycerol, 2 endogenous agonists of cannabinoid receptors; oleamide (cis-9-octadecenoamide), a putative endogenous sleep-inducing factor; and N-palmitoylethanolamine, a compd. with promising anti-inflammatory and immune-modulatory activity.  These compds. are all substrates for the same hydrolytic enzyme, fatty acid amide hydrolase (I), whose mol. characterization was obtained in 1996.  The mol. and enzymic properties, tissue distribution, substrate recognition properties, physiol. regulation, and biol. role of I are discussed here with special emphasis on the possible pharmacol. manipulation of the activity of this enzyme with therapeutic purpose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolw6cvuB972LVg90H21EOLACvtfcHk0liHp8Lk51R86w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Omtro%253D&md5=8692b343a81c11fb8ea86dfbf6ed2166</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1381612023395655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023395655%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DFatty%2520Acid%2520Amide%2520Hydrolase%252C%2520an%2520Enzyme%2520with%2520many%2520Bioactive%2520Substrates.%2520Possible%2520Therapeutic%2520Implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D533%26epage%3D547%26doi%3D10.2174%2F1381612023395655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Discovery and Molecular Basis of Potent Noncovalent Inhibitors of Fatty Acid Amide Hydrolyase (FAAH)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">7379</span><span class="NLM_x">–</span> <span class="NLM_lpage">7384</span><span class="refDoi"> DOI: 10.1073/pnas.1016167108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1073%2Fpnas.1016167108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7379-7384&author=X.+Minauthor=S.+T.+Thibaultauthor=A.+C.+Porterauthor=D.+I.+Gustinauthor=T.+I.+Carlsonauthor=H.+Xuauthor=M.+Lindstromauthor=G.+Xuauthor=C.+Uyedaauthor=Z.+Maauthor=Y.+Liauthor=F.+Kayserauthor=N.+P.+Walkerauthor=Z.+Wang&title=Discovery+and+Molecular+Basis+of+Potent+Noncovalent+Inhibitors+of+Fatty+Acid+Amide+Hydrolyase+%28FAAH%29&doi=10.1073%2Fpnas.1016167108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016167108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016167108%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DX.%26aulast%3DThibault%26aufirst%3DS.%2BT.%26aulast%3DPorter%26aufirst%3DA.%2BC.%26aulast%3DGustin%26aufirst%3DD.%2BI.%26aulast%3DCarlson%26aufirst%3DT.%2BI.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DUyeda%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DDiscovery%2520and%2520Molecular%2520Basis%2520of%2520Potent%2520Noncovalent%2520Inhibitors%2520of%2520Fatty%2520Acid%2520Amide%2520Hydrolyase%2520%2528FAAH%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7379%26epage%3D7384%26doi%3D10.1073%2Fpnas.1016167108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wei, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">36569</span><span class="NLM_x">–</span> <span class="NLM_lpage">36578</span><span class="refDoi"> DOI: 10.1074/jbc.M606646200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M606646200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=17015445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=36569-36578&author=B.+Q.+Weiauthor=T.+S.+Mikkelsenauthor=M.+K.+McKinneyauthor=E.+S.+Landerauthor=B.+F.+Cravatt&title=A+Second+Fatty+Acid+Amide+Hydrolase+with+Variable+Distribution+among+Placental+Mammals&doi=10.1074%2Fjbc.M606646200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals</span></div><div class="casAuthors">Wei, Binqing Q.; Mikkelsen, Tarjei S.; McKinney, Michele K.; Lander, Eric S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">36569-36578</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fatty acid amides constitute a large and diverse class of lipid transmitters that includes the endogenous cannabinoid anandamide and the sleep-inducing substance oleamide.  The magnitude and duration of fatty acid amide signaling are controlled by enzymic hydrolysis in vivo.  Fatty acid amide hydrolase (FAAH) activity in mammals has been primarily attributed to a single integral membrane enzyme of the amidase signature (AS) family.  Here, we report the functional proteomic discovery of a second membrane-assocd. AS enzyme in humans that displays FAAH activity.  The gene that encodes this second FAAH enzyme was found in multiple primate genomes, marsupials, and more distantly related vertebrates, but, remarkably, not in a no. of lower placental mammals, including mouse and rat.  The two human FAAH enzymes, which share 20% sequence identity and are referred to hereafter as FAAH-1 and FAAH-2, hydrolyzed primary fatty acid amide substrates (e.g., oleamide) at equiv. rates, whereas FAAH-1 exhibited much greater activity with N-acyl ethanolamines (e.g., anandamide) and N-acyl taurines.  Both enzymes were sensitive to the principal classes of FAAH inhibitors synthesized to date, including O-aryl carbamates and α-keto heterocycles.  These data coupled with the overlapping, but distinct tissue distributions of FAAH-1 and FAAH-2 suggest that these proteins may collaborate to control fatty acid amide catabolism in primates.  The apparent loss of the FAAH-2 gene in some lower mammals should be taken into consideration when extrapolating genetic or pharmacol. findings on the fatty acid amide signaling system across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuV_6Ew68-CbVg90H21EOLACvtfcHk0lg6OO5t0Dr2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP&md5=16273562700ac4fe3ef10c9917f0d3aa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606646200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606646200%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DB.%2BQ.%26aulast%3DMikkelsen%26aufirst%3DT.%2BS.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520Second%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520with%2520Variable%2520Distribution%2520among%2520Placental%2520Mammals%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D36569%26epage%3D36578%26doi%3D10.1074%2Fjbc.M606646200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sandri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viala, J.</span><span> </span><span class="NLM_article-title">Synthesis of all-(Z)-5,8,11,14,17-Eicosapentaenoic Acid and all-(Z)-4,7,10,13,16,19-Docosahexaenoic Acid from (Z)-1,1,6,6-Tetraisopropoxy-2-hexene</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6627</span><span class="NLM_x">–</span> <span class="NLM_lpage">6630</span><span class="refDoi"> DOI: 10.1021/jo00125a065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00125a065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=6627-6630&author=J.+Sandriauthor=J.+Viala&title=Synthesis+of+all-%28Z%29-5%2C8%2C11%2C14%2C17-Eicosapentaenoic+Acid+and+all-%28Z%29-4%2C7%2C10%2C13%2C16%2C19-Docosahexaenoic+Acid+from+%28Z%29-1%2C1%2C6%2C6-Tetraisopropoxy-2-hexene&doi=10.1021%2Fjo00125a065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00125a065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00125a065%26sid%3Dliteratum%253Aachs%26aulast%3DSandri%26aufirst%3DJ.%26aulast%3DViala%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520all-%2528Z%2529-5%252C8%252C11%252C14%252C17-Eicosapentaenoic%2520Acid%2520and%2520all-%2528Z%2529-4%252C7%252C10%252C13%252C16%252C19-Docosahexaenoic%2520Acid%2520from%2520%2528Z%2529-1%252C1%252C6%252C6-Tetraisopropoxy-2-hexene%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D6627%26epage%3D6630%26doi%3D10.1021%2Fjo00125a065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Menon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolbert, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cefali, E. A.</span><span> </span><span class="NLM_article-title">Plasma and Urine Pharmacokinetics of Niacin and its Metabolites from an Extended-Release Niacin Formulation</span> <span class="citation_source-journal">Int. J. Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.5414/CPP45448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.5414%2FCPP45448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=17725178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=448-454&author=R.+M.+Menonauthor=M.+H.+Adamsauthor=M.+A.+Gonz%C3%A1lezauthor=D.+S.+Tolbertauthor=J.+H.+Leuauthor=E.+A.+Cefali&title=Plasma+and+Urine+Pharmacokinetics+of+Niacin+and+its+Metabolites+from+an+Extended-Release+Niacin+Formulation&doi=10.5414%2FCPP45448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation</span></div><div class="casAuthors">Menon, R. M.; Adams, M. H.; Gonzalez, M. A.; Tolbert, D. S.; Leu, J. H.; Cefali, E. A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">448-454</span>CODEN:
                <span class="NLM_cas:coden">ICTHEK</span>;
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    
            (<span class="NLM_cas:orgname">Dustri-Verlag Dr. Karl Feistle</span>)
        </div><div class="casAbstract">Objective: To characterize plasma and urine pharmacokinetics of niacin and its metabolites after oral administration of 2,000 mg of extended-release (ER) niacin in healthy male volunteers.  Methods: Niacin ER was administered to 12 healthy male subjects following a low-fat snack.  Plasma was collected for 12 h post dose and was analyzed for niacin, nicotinuric acid (NUA), nicotinamide (NAM) and nicotinamide-N-oxide (NNO).  Urine was collected for 96 h post dose and analyzed for niacin and its metabolites, NUA, NAM, NNO, N-methylnicotinamide (MNA) and N-methyl-2-pyridone-5-carboxamide (2PY).  Results: Mean niacin Cmax and AUC0-t values were 9.3 μg/mL and 26.2 μg × h/mL and were the highest of all analytes measured.  Peak niacin and NUA levels occurred at 4.6 h (median) while tmax for NAM and NNO were 8.6 and 11.1 h, resp.  The mean plasma terminal half-life for niacin (0.9 h) and NUA (1.3 h) was shorter as compared to NAM (4.3 h).  Urine recovery of niacin and metabolites accounted for 69.5% of the administered dose; only 3.2% was excreted as niacin.  The highest recovery was for 2PY (37.9%), followed by MNA (16.0%) and NUA (11.6%).  Mean half-lives for 2PY and MNA calcd. in urine were 12.6 and 12.8 h, resp.  Conclusions: Niacin was extensively metabolized following oral administration, and about 70% of the administered dose is recovered in urine in 96 h as niacin, NUA, MNA, NNO, NAM and 2PY.  The plasma levels of the parent niacin were higher than its metabolites though only about 3% of the unchanged drug is recovered in urine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogOOw0jIa_9bVg90H21EOLACvtfcHk0lg6OO5t0Dr2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqsLrK&md5=f6964e508a7dba0d6c3f4dbd8f2487d1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5414%2FCPP45448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5414%252FCPP45448%26sid%3Dliteratum%253Aachs%26aulast%3DMenon%26aufirst%3DR.%2BM.%26aulast%3DAdams%26aufirst%3DM.%2BH.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%2BA.%26aulast%3DTolbert%26aufirst%3DD.%2BS.%26aulast%3DLeu%26aufirst%3DJ.%2BH.%26aulast%3DCefali%26aufirst%3DE.%2BA.%26atitle%3DPlasma%2520and%2520Urine%2520Pharmacokinetics%2520of%2520Niacin%2520and%2520its%2520Metabolites%2520from%2520an%2520Extended-Release%2520Niacin%2520Formulation%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D45%26spage%3D448%26epage%3D454%26doi%3D10.5414%2FCPP45448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Detailed rat PK data for compounds <b>5</b>, <b>7</b>, and <b>8</b> are shown in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">For the tissue distribution study involving compound <b>8</b>, liver, duodenum, and ileum exposure was assessed over a 3, 7, 10, 14, and 21 days, including a 3-day washout. The entire data set is presented in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span> </span><span class="NLM_article-title">Human Epidermoid A431 Cells Express Funtional Nicotinic Acid Receptor HM74a</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1007/s11010-006-9150-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs11010-006-9150-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2007&pages=243-248&author=L.+Zhouauthor=Y.+Tangauthor=E.+V.+Cryanauthor=K.+T.+Demarest&title=Human+Epidermoid+A431+Cells+Express+Funtional+Nicotinic+Acid+Receptor+HM74a&doi=10.1007%2Fs11010-006-9150-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs11010-006-9150-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-006-9150-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DCryan%26aufirst%3DE.%2BV.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26atitle%3DHuman%2520Epidermoid%2520A431%2520Cells%2520Express%2520Funtional%2520Nicotinic%2520Acid%2520Receptor%2520HM74a%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D294%26spage%3D243%26epage%3D248%26doi%3D10.1007%2Fs11010-006-9150-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Moon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, B. S.</span><span> </span><span class="NLM_article-title">Up-Regulation of Hepatic Low-Density Lipoprotein Receptor-Related Protein 1: A Possible Mechanism of Antiatherogenic Activity of Hydroymethylglutaryl-Coenzyme A Reductase Inhibitor Atorvastatin and Hepatic LRP1 Expression</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.1016/j.metabol.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.metabol.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=20951395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslKmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=930-940&author=J.+H.+Moonauthor=S.+B.+Kangauthor=J.+S.+Parkauthor=B.+W.+Leeauthor=E.+S.+Kangauthor=C.+W.+Ahnauthor=H.+C.+Leeauthor=B.+S.+Cha&title=Up-Regulation+of+Hepatic+Low-Density+Lipoprotein+Receptor-Related+Protein+1%3A+A+Possible+Mechanism+of+Antiatherogenic+Activity+of+Hydroymethylglutaryl-Coenzyme+A+Reductase+Inhibitor+Atorvastatin+and+Hepatic+LRP1+Expression&doi=10.1016%2Fj.metabol.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor</span></div><div class="casAuthors">Moon, Jae Hoon; Kang, Saet Byol; Park, Jong Suk; Lee, Byung Wan; Kang, Eun Seok; Ahn, Chul Woo; Lee, Hyun Chul; Cha, Bong Soo</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">930-940</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Low-d. lipoprotein receptor-related protein 1 (LRP1) binds to apolipoprotein E and serves as a receptor for remnant lipoproteins in the liver, thus playing an important role in clearing these atherogenic particles.  In this study, we investigated the effect of atorvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, on hepatic LRP1 expression.  We used HepG2 and Hep3B cells for in vitro study, and Otsuka Long-Evans Tokushima fatty and Sprague-Dawley rats for in vivo study.  We used relatively high pharmacol. dose of atorvastatin in this study (in vitro, 0.5 μmol/L in culture media, for 48 h; in vivo, 20 mg/[kg d], for 6 wk).  Atorvastatin increased LRP1 and low-d. lipoprotein (LDL) receptor expression in HepG2 and Hep3B cells and induced hepatic LRP1 and LDL receptor expression in chow diet-fed Sprague-Dawley rats and high-fat diet-fed Otsuka Long-Evans Tokushima fatty rats.  Atorvastatin decreased intracellular sterol level and increased the amt. of the nuclear form of sterol response element-binding protein-2 (SREBP-2) in both HepG2 and Hep3B cells as well as in two animal models.  Treatment of HepG2 cells with LDL increased intracellular sterol level and reduced LRP1, LDL receptor, and SREBP-2.  When SREBP-2 in HepG2 cells was knocked down by small interfering RNA, the induction of LRP1 expression by atorvastatin did not take place.  In conclusion, up-regulation of hepatic LRP1 might be a novel mechanism by which statin treatment decreases remnant lipoproteins.  In addn., SREBP-2 acts as a mediator of atorvastatin-induced up-regulation of hepatic LRP1.  Future studies using std. doses of atorvastatin in humans are needed to elucidate clin. relevance of these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOTpsiEbEmArVg90H21EOLACvtfcHk0ljTpGYYn6CQYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslKmtrk%253D&md5=517c3f76a48395264a2f74ed89ebb0f1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BB.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DB.%2BW.%26aulast%3DKang%26aufirst%3DE.%2BS.%26aulast%3DAhn%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DCha%26aufirst%3DB.%2BS.%26atitle%3DUp-Regulation%2520of%2520Hepatic%2520Low-Density%2520Lipoprotein%2520Receptor-Related%2520Protein%25201%253A%2520A%2520Possible%2520Mechanism%2520of%2520Antiatherogenic%2520Activity%2520of%2520Hydroymethylglutaryl-Coenzyme%2520A%2520Reductase%2520Inhibitor%2520Atorvastatin%2520and%2520Hepatic%2520LRP1%2520Expression%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2011%26volume%3D60%26spage%3D930%26epage%3D940%26doi%3D10.1016%2Fj.metabol.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Davignon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubuc, G.</span><span> </span><span class="NLM_article-title">Statins and Ezetimibe Modulate Plasma Proprotein Convertase Subtilisin Kexin-9 (PCSK9) Levels</span> <span class="citation_source-journal">Trans. Am. Clin. Climatol. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=19768174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A280%3ADC%252BD1Mnjs1ejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2009&pages=163-173&author=J.+Davignonauthor=G.+Dubuc&title=Statins+and+Ezetimibe+Modulate+Plasma+Proprotein+Convertase+Subtilisin+Kexin-9+%28PCSK9%29+Levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels</span></div><div class="casAuthors">Davignon Jean; Dubuc Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Transactions of the American Clinical and Climatological Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-73</span>
        ISSN:<span class="NLM_cas:issn">0065-7778</span>.
    </div><div class="casAbstract">PCSK9 is a natural inhibitor of the LDL receptor.  Gain-of-function mutations may cause the familial hypercholesterolemia phenotype, whereas loss-of-function variants associate with reduced LDL-C levels and lower coronary risk.  Statins up-regulate PCSK9 in hepatocytes.  We developed an assay to measure total PCSK9 in human plasma and evaluated the effect of statins and ezetimibe on PCSK9 in vivo and in vitro.  In 254 normal subjects, the mean plasma PCSK9 was 89 +/- 32 ng/ml.  PCSK9 levels correlated with plasma cholesterol, LDL-C, triglycerides, fasting glucose, age and body mass index.  Sequencing PCSK9 from subjects at the extremes of plasma distribution revealed new variants.  In 200 hypercholesterolemic patients, circulating PCSK9 was higher than in controls, increased with increasing statin dose, and further increased when ezetimibe was added.  However, ezetimibe treatment of HepG2 (hepatocytes) and Caco-2 (enterocytes) cells caused a slight increase in PCSK9 and NPC1L1 mRNA, but no significant rise in PCSK9 protein secretion, suggesting that these transformed cells are not ideal model cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0wfF2aDcoc2HOrQ6qeX-mfW6udTcc2eZ2EG9nhWcDX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mnjs1ejtQ%253D%253D&md5=e90bbfd919182fe660137ba0db6d8120</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavignon%26aufirst%3DJ.%26aulast%3DDubuc%26aufirst%3DG.%26atitle%3DStatins%2520and%2520Ezetimibe%2520Modulate%2520Plasma%2520Proprotein%2520Convertase%2520Subtilisin%2520Kexin-9%2520%2528PCSK9%2529%2520Levels%26jtitle%3DTrans.%2520Am.%2520Clin.%2520Climatol.%2520Assoc.%26date%3D2009%26volume%3D120%26spage%3D163%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Dubuc, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassef, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davignon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span> </span><span class="NLM_article-title">Statins Upregulate PCSK9, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1459</span><span class="refDoi"> DOI: 10.1161/01.ATV.0000134621.14315.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1161%2F01.ATV.0000134621.14315.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=15178557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtValtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=1454-1459&author=G.+Dubucauthor=A.+Chamberlandauthor=H.+Wassefauthor=J.+Davignonauthor=N.+G.+Seidahauthor=L.+Bernierauthor=A.+Prat&title=Statins+Upregulate+PCSK9%2C+the+Gene+Encoding+the+Proprotein+Convertase+Neural+Apoptosis-Regulated+Convertase-1+Implicated+in+Familial+Hypercholesterolemia&doi=10.1161%2F01.ATV.0000134621.14315.43"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Statins Upregulate PCSK9, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia</span></div><div class="casAuthors">Dubuc, Genevieve; Chamberland, Ann; Wassef, Hanny; Davignon, Jean; Seidah, Nabil G.; Bernier, Lise; Prat, Annik</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1454-1459</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- Neural apoptosis-regulated convertase (NARC)-1 is the newest member of the proprotein convertase family implicated in the cleavage of a variety of protein precursors.  The NARC-1 gene, PCSK9, has been identified recently as the third locus implicated in autosomal dominant hypercholesterolemia (ADH).  The 2 other known genes implicated in ADH encode the low-d. lipoprotein receptor and apolipoprotein B.  As an approach toward the elucidation of the physiol. role(s) of NARC-1, we studied its transcriptional regulation.  Methods and Results- Using quant. RT-PCR, we assessed NARC-1 regulation under conditions known to regulate genes involved in cholesterol metab. in HepG2 cells and in human primary hepatocytes.  We found that NARC-1 expression was strongly induced by statins in a dose-dependent manner and that this induction was efficiently reversed by mevalonate.  NARC-1 mRNA level was increased by cholesterol depletion but insensitive to liver X receptor activation.  Human, mouse, and rat PCSK9 promoters contain 2 typical conserved motifs for cholesterol regulation: a sterol regulatory element (SRE) and an Sp1 site.  Conclusions- PCSK9 regulation is typical of that of the genes implicated in lipoprotein metab.  In vivo, PCSK9 is probably a target of SRE-binding protein (SREBP)-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql59KqiJ7LMrVg90H21EOLACvtfcHk0lh4TJdD34AOEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtValtLY%253D&md5=b7731e8a31ff459af5fd8bf016637541</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000134621.14315.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000134621.14315.43%26sid%3Dliteratum%253Aachs%26aulast%3DDubuc%26aufirst%3DG.%26aulast%3DChamberland%26aufirst%3DA.%26aulast%3DWassef%26aufirst%3DH.%26aulast%3DDavignon%26aufirst%3DJ.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DBernier%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26atitle%3DStatins%2520Upregulate%2520PCSK9%252C%2520the%2520Gene%2520Encoding%2520the%2520Proprotein%2520Convertase%2520Neural%2520Apoptosis-Regulated%2520Convertase-1%2520Implicated%2520in%2520Familial%2520Hypercholesterolemia%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D1454%26epage%3D1459%26doi%3D10.1161%2F01.ATV.0000134621.14315.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">van den Maagdenberg, A. M. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofker, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimpenfort, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruijn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Vlijmen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Boom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havekes, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frants, R. R.</span><span> </span><span class="NLM_article-title">Transgenic Mice Carrying the Apolipoprotein E3-Leiden Gene Exhibit Hyperlipoproteinemia</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">10540</span><span class="NLM_x">–</span> <span class="NLM_lpage">10545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=10540-10545&author=A.+M.+J.+M.+van+den+Maagdenbergauthor=M.+H.+Hofkerauthor=P.+J.+A.+Krimpenfortauthor=I.+de+Bruijnauthor=B.+van+Vlijmenauthor=H.+van+der+Boomauthor=L.+M.+Havekesauthor=R.+R.+Frants&title=Transgenic+Mice+Carrying+the+Apolipoprotein+E3-Leiden+Gene+Exhibit+Hyperlipoproteinemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BMaagdenberg%26aufirst%3DA.%2BM.%2BJ.%2BM.%26aulast%3DHofker%26aufirst%3DM.%2BH.%26aulast%3DKrimpenfort%26aufirst%3DP.%2BJ.%2BA.%26aulast%3Dde%2BBruijn%26aufirst%3DI.%26aulast%3Dvan%2BVlijmen%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BBoom%26aufirst%3DH.%26aulast%3DHavekes%26aufirst%3DL.%2BM.%26aulast%3DFrants%26aufirst%3DR.%2BR.%26atitle%3DTransgenic%2520Mice%2520Carrying%2520the%2520Apolipoprotein%2520E3-Leiden%2520Gene%2520Exhibit%2520Hyperlipoproteinemia%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D10540%26epage%3D10545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zimmer, M.; Picarella, D.; Liu, F.; Bista, P.; Lee, D.; Vu, C.; Jirousek, M.</span> In <span> </span><span class="NLM_article-title">CAT-2003 is a Novel Small Molecule that Inhibits Proprotein Convertase Subtilisin/Kexin Type 9 Production and Lowers Non-High Density Lipoprotein Cholesterol</span>. <span class="NLM_conf-name">Arteriosclerosis, Thrombosis and Vascular Biology</span>, <span class="NLM_conf-loc">Toronto, Ontario, Canada</span>, <span class="NLM_conf-date">May 1–3, 2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zimmer%2C+M.%3B+Picarella%2C+D.%3B+Liu%2C+F.%3B+Bista%2C+P.%3B+Lee%2C+D.%3B+Vu%2C+C.%3B+Jirousek%2C+M.+In+CAT-2003+is+a+Novel+Small+Molecule+that+Inhibits+Proprotein+Convertase+Subtilisin%2FKexin+Type+9+Production+and+Lowers+Non-High+Density+Lipoprotein+Cholesterol.+Arteriosclerosis%2C+Thrombosis+and+Vascular+Biology%2C+Toronto%2C+Ontario%2C+Canada%2C+May+1%E2%80%933%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DM.%26atitle%3DCAT-2003%2520is%2520a%2520Novel%2520Small%2520Molecule%2520that%2520Inhibits%2520Proprotein%2520Convertase%2520Subtilisin%252FKexin%2520Type%25209%2520Production%2520and%2520Lowers%2520Non-High%2520Density%2520Lipoprotein%2520Cholesterol" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wu, K. K.</span><span> </span><span class="NLM_article-title">Novel Mechanism of Aspirin Pharmacologic Actions: A Model for Studying Herbal Natural Products</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/j.thromres.2005.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.thromres.2005.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=16045971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wjur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=61-64&author=K.+K.+Wu&title=Novel+Mechanism+of+Aspirin+Pharmacologic+Actions%3A+A+Model+for+Studying+Herbal+Natural+Products&doi=10.1016%2Fj.thromres.2005.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanisms of aspirin pharmacologic actions: A model for studying herbal natural products</span></div><div class="casAuthors">Wu, Kenneth K.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aspirin and its principal in vivo metabolite, salicylic acid, exhibit concn.-dependent inhibition of gene expressions.  At high concns., they inhibit NF-κB-mediated gene expressions by suppressing IKK kinase activity whereas at therapeutic concns., they inhibit C/EBPβ-mediated gene expression by suppressing RSK kinase activity.  NF-KB and C/EBPβ are key transactivators that drive the promoter activities of pro-inflammatory genes.  Thus, the transcriptional control properties of aspirin may account for its diverse therapeutic actions.  We speculate that natural products isolated from herbal plants exhibit antiinflammatory and antineoplastic actions by a pharmacol. paradigm exemplified by aspirin and salicylate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIXy4mETCcQbVg90H21EOLACvtfcHk0lh4TJdD34AOEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wjur3M&md5=8441fea8468955726560cdf7e03dd7d2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2005.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2005.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%2BK.%26atitle%3DNovel%2520Mechanism%2520of%2520Aspirin%2520Pharmacologic%2520Actions%253A%2520A%2520Model%2520for%2520Studying%2520Herbal%2520Natural%2520Products%26jtitle%3DThromb.%2520Res.%26date%3D2005%26volume%3D117%26spage%3D61%26epage%3D64%26doi%3D10.1016%2Fj.thromres.2005.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kopp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span> </span><span class="NLM_article-title">Inhibition of NF-kappa B by Sodium Salicylate and Aspirin</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span><span class="refDoi"> DOI: 10.1126/science.8052854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1126%2Fscience.8052854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1994&pages=956-959&author=E.+Koppauthor=S.+Ghosh&title=Inhibition+of+NF-kappa+B+by+Sodium+Salicylate+and+Aspirin&doi=10.1126%2Fscience.8052854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscience.8052854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8052854%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DE.%26aulast%3DGhosh%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520NF-kappa%2520B%2520by%2520Sodium%2520Salicylate%2520and%2520Aspirin%26jtitle%3DScience%26date%3D1994%26volume%3D265%26spage%3D956%26epage%3D959%26doi%3D10.1126%2Fscience.8052854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Amann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskar, B. A.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Effects of Aspirin and Sodium Salicylate</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/S0014-2999(02)01828-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2FS0014-2999%2802%2901828-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=12106797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFWjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2002&pages=1-9&author=R.+Amannauthor=B.+A.+Peskar&title=Anti-Inflammatory+Effects+of+Aspirin+and+Sodium+Salicylate&doi=10.1016%2FS0014-2999%2802%2901828-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory effects of aspirin and sodium salicylate</span></div><div class="casAuthors">Amann, Rainer; Peskar, Bernhard A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Aspirin (acetylsalicylic acid) is one of the most widely used drugs worldwide.  It acetylates cyclooxygenases thereby irreversibly blocking the conversion of arachidonic acid to prostanoids.  Biotransformation of aspirin yields salicylate, a compd. that possesses similar anti-inflammatory potency as aspirin but lacks aspirin's inhibitory effect on the activity of isolated cyclooxygenase.  This article is aimed at providing an overview about the often conflicting results concerning the mechanisms of action of aspirin and sodium salicylate.  At present, there is no common agreement about the extent to which salicylate contributes to aspirin's anti-inflammatory properties, as well as there is still no final conclusion reached about the mechanisms of action of sodium salicylate.  Several possible sites of action of salicylate have been suggested: It has been shown that in intact cells-but not in purified enzyme prepns.-, sodium salicylate inhibits prostanoid biosynthesis.  This effect seems to be prevented in the presence of high concns. of arachidonic acid, which has been shown to interfere with inhibition by salicylate of cyclooxygenase-2-mediated prostanoid formation in vitro.  Other possible sites of action that are not directly related to cyclooxygenase inhibition have been suggested based on observations made in vitro using high concns. of aspirin and sodium salicylate.  These effects target intracellular signaling mechanisms such as kinases, including the mitogen activated protein-kinases (MAPK) cascade.  With the exception of reported salicylate-induced activation of p38 MAPK, obsd. effects are usually inhibitory.  This may be one reason for the observation that, downstream to kinases, inhibitory effects of salicylates have been obsd. on several nuclear transcription factors, such as nuclear transcription factor kappa B (NF-kB) or activator protein 1 (AP-1).  Several reports have also shown interference by salicylates with the expression of cyclooxygenase-2, which, depending on exptl. models, can be obsd. as inhibitory but also stimulatory effects.  Antioxidant properties of salicylates, adenosine release induced by sodium salicylate and aspirin-triggered lipoxin formation are addnl. mechanisms that may contribute to anti-inflammatory properties of aspirin and/or sodium salicylate.  An addnl. focus of this review is the discussion of interactions between aspirin, sodium salicylate and other non-steroidal anti-inflammatory drugs (NSAIDs), which are of particular relevance in the gastro-intestinal and cardiovascular systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh6lEc-GBWgbVg90H21EOLACvtfcHk0lgD9fG0NWy89Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFWjsrs%253D&md5=9667f1d781f5d2a82db4e3d9fe38e5f1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901828-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901828-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmann%26aufirst%3DR.%26aulast%3DPeskar%26aufirst%3DB.%2BA.%26atitle%3DAnti-Inflammatory%2520Effects%2520of%2520Aspirin%2520and%2520Sodium%2520Salicylate%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D447%26spage%3D1%26epage%3D9%26doi%3D10.1016%2FS0014-2999%2802%2901828-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talukdar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinaga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span> </span><span class="NLM_article-title">GPR120 is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-Inflammatory and Insulin Sensitizing Effects</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.07.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.cell.2010.07.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=687-698&author=D.+Y.+Ohauthor=S.+Talukdarauthor=E.+J.+Baeauthor=T.+Imamuraauthor=H.+Morinagaauthor=W.+Fanauthor=P.+Liauthor=W.+J.+Luauthor=S.+Watkinsauthor=J.+M.+Olefsky&title=GPR120+is+an+Omega-3+Fatty+Acid+Receptor+Mediating+Potent+Anti-Inflammatory+and+Insulin+Sensitizing+Effects&doi=10.1016%2Fj.cell.2010.07.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.07.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.07.041%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DTalukdar%26aufirst%3DS.%26aulast%3DBae%26aufirst%3DE.%2BJ.%26aulast%3DImamura%26aufirst%3DT.%26aulast%3DMorinaga%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DW.%2BJ.%26aulast%3DWatkins%26aufirst%3DS.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3DGPR120%2520is%2520an%2520Omega-3%2520Fatty%2520Acid%2520Receptor%2520Mediating%2520Potent%2520Anti-Inflammatory%2520and%2520Insulin%2520Sensitizing%2520Effects%26jtitle%3DCell%26date%3D2010%26volume%3D142%26spage%3D687%26epage%3D698%26doi%3D10.1016%2Fj.cell.2010.07.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Martinez-Micaelo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Abuín, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terra, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardèvol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blay, M.</span><span> </span><span class="NLM_article-title">Omega-3 Docosahexaenoic Acid and Procyanidins Inhibit Cyclo-Oxygenase Activity and Attenuate NF-κB Activation through a p105/p50 Regulatory Mechanism in Macrophage Inflammation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1042/BJ20110967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1042%2FBJ20110967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=653-663&author=N.+Martinez-Micaeloauthor=N.+Gonz%C3%A1lez-Abu%C3%ADnauthor=X.+Terraauthor=C.+Richartauthor=A.+Ard%C3%A8volauthor=M.+Pinentauthor=M.+Blay&title=Omega-3+Docosahexaenoic+Acid+and+Procyanidins+Inhibit+Cyclo-Oxygenase+Activity+and+Attenuate+NF-%CE%BAB+Activation+through+a+p105%2Fp50+Regulatory+Mechanism+in+Macrophage+Inflammation&doi=10.1042%2FBJ20110967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1042%2FBJ20110967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110967%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Micaelo%26aufirst%3DN.%26aulast%3DGonz%25C3%25A1lez-Abu%25C3%25ADn%26aufirst%3DN.%26aulast%3DTerra%26aufirst%3DX.%26aulast%3DRichart%26aufirst%3DC.%26aulast%3DArd%25C3%25A8vol%26aufirst%3DA.%26aulast%3DPinent%26aufirst%3DM.%26aulast%3DBlay%26aufirst%3DM.%26atitle%3DOmega-3%2520Docosahexaenoic%2520Acid%2520and%2520Procyanidins%2520Inhibit%2520Cyclo-Oxygenase%2520Activity%2520and%2520Attenuate%2520NF-%25CE%25BAB%2520Activation%2520through%2520a%2520p105%252Fp50%2520Regulatory%2520Mechanism%2520in%2520Macrophage%2520Inflammation%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26spage%3D653%26epage%3D663%26doi%3D10.1042%2FBJ20110967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Musiek, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunoldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span> </span><span class="NLM_article-title">Electrophilic Cyclopentenone Neuroprostanes are Anti-Inflammatory Mediators Formed from the Peroxidation of the ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">19927</span><span class="NLM_x">–</span> <span class="NLM_lpage">19935</span><span class="refDoi"> DOI: 10.1074/jbc.M803625200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M803625200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=19927-19935&author=E.+S.+Musiekauthor=J.+D.+Brooksauthor=M.+Jooauthor=E.+Brunoldiauthor=A.+Portaauthor=G.+Zanoniauthor=G.+Vidariauthor=T.+S.+Blackwellauthor=T.+J.+Montineauthor=G.+L.+Milneauthor=B.+McLaughlinauthor=J.+D.+Morrow&title=Electrophilic+Cyclopentenone+Neuroprostanes+are+Anti-Inflammatory+Mediators+Formed+from+the+Peroxidation+of+the+%CF%89-3+Polyunsaturated+Fatty+Acid+Docosahexaenoic+Acid&doi=10.1074%2Fjbc.M803625200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803625200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803625200%26sid%3Dliteratum%253Aachs%26aulast%3DMusiek%26aufirst%3DE.%2BS.%26aulast%3DBrooks%26aufirst%3DJ.%2BD.%26aulast%3DJoo%26aufirst%3DM.%26aulast%3DBrunoldi%26aufirst%3DE.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DVidari%26aufirst%3DG.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DMcLaughlin%26aufirst%3DB.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26atitle%3DElectrophilic%2520Cyclopentenone%2520Neuroprostanes%2520are%2520Anti-Inflammatory%2520Mediators%2520Formed%2520from%2520the%2520Peroxidation%2520of%2520the%2520%25CF%2589-3%2520Polyunsaturated%2520Fatty%2520Acid%2520Docosahexaenoic%2520Acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D19927%26epage%3D19935%26doi%3D10.1074%2Fjbc.M803625200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Fam, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphey, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zackert, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandalai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span> </span><span class="NLM_article-title">Formation of Highly Reactive A-ring and J-ring Isoprostane-like Compounds (A<sub>4</sub>/J<sub>4</sub>-neuroprostanes) <i>in Vivo</i> from Docosahexaenoic Acid</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">36076</span><span class="NLM_x">–</span> <span class="NLM_lpage">36084</span><span class="refDoi"> DOI: 10.1074/jbc.M205638200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M205638200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=36076-36084&author=S.+S.+Famauthor=L.+J.+Murpheyauthor=E.+S.+Terryauthor=W.+E.+Zackertauthor=Y.+Chenauthor=L.+Gaoauthor=S.+Pandalaiauthor=G.+L.+Milneauthor=L.+J.+Robertsauthor=N.+A.+Porterauthor=T.+J.+Montineauthor=J.+D.+Morrow&title=Formation+of+Highly+Reactive+A-ring+and+J-ring+Isoprostane-like+Compounds+%28A4%2FJ4-neuroprostanes%29+in+Vivo+from+Docosahexaenoic+Acid&doi=10.1074%2Fjbc.M205638200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205638200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205638200%26sid%3Dliteratum%253Aachs%26aulast%3DFam%26aufirst%3DS.%2BS.%26aulast%3DMurphey%26aufirst%3DL.%2BJ.%26aulast%3DTerry%26aufirst%3DE.%2BS.%26aulast%3DZackert%26aufirst%3DW.%2BE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DPandalai%26aufirst%3DS.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DRoberts%26aufirst%3DL.%2BJ.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26atitle%3DFormation%2520of%2520Highly%2520Reactive%2520A-ring%2520and%2520J-ring%2520Isoprostane-like%2520Compounds%2520%2528A4%252FJ4-neuroprostanes%2529%2520in%2520Vivo%2520from%2520Docosahexaenoic%2520Acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D36076%26epage%3D36084%26doi%3D10.1074%2Fjbc.M205638200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Straus, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengchanthalangsy, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. K.</span><span> </span><span class="NLM_article-title">15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> Inhibits Multiple Steps in the NF-κB Signaling Pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">4844</span><span class="NLM_x">–</span> <span class="NLM_lpage">4849</span><span class="refDoi"> DOI: 10.1073/pnas.97.9.4844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1073%2Fpnas.97.9.4844" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4844-4849&author=D.+S.+Strausauthor=G.+Pascualauthor=M.+Liauthor=J.+S.+Welchauthor=M.+Ricoteauthor=C.-H.+Hsiangauthor=L.+L.+Sengchanthalangsyauthor=G.+Ghoshauthor=C.+K.+Glass&title=15-Deoxy-%CE%9412%2C14-prostaglandin+J2+Inhibits+Multiple+Steps+in+the+NF-%CE%BAB+Signaling+Pathway&doi=10.1073%2Fpnas.97.9.4844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.9.4844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.9.4844%26sid%3Dliteratum%253Aachs%26aulast%3DStraus%26aufirst%3DD.%2BS.%26aulast%3DPascual%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWelch%26aufirst%3DJ.%2BS.%26aulast%3DRicote%26aufirst%3DM.%26aulast%3DHsiang%26aufirst%3DC.-H.%26aulast%3DSengchanthalangsy%26aufirst%3DL.%2BL.%26aulast%3DGhosh%26aufirst%3DG.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26atitle%3D15-Deoxy-%25CE%259412%252C14-prostaglandin%2520J2%2520Inhibits%2520Multiple%2520Steps%2520in%2520the%2520NF-%25CE%25BAB%2520Signaling%2520Pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4844%26epage%3D4849%26doi%3D10.1073%2Fpnas.97.9.4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Cernuda-Morollón, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda-Molina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caňada, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Sala, D.</span><span> </span><span class="NLM_article-title">15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> Inhibition of NF-κB-DNA Binding through Covalent Modification of the p50 Subunit</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">35530</span><span class="NLM_x">–</span> <span class="NLM_lpage">35536</span><span class="refDoi"> DOI: 10.1074/jbc.M104518200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M104518200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=35530-35536&author=E.+Cernuda-Moroll%C3%B3nauthor=E.+Pineda-Molinaauthor=F.+J.+Ca%C5%88adaauthor=D.+P%C3%A9rez-Sala&title=15-Deoxy-%CE%9412%2C14-prostaglandin+J2+Inhibition+of+NF-%CE%BAB-DNA+Binding+through+Covalent+Modification+of+the+p50+Subunit&doi=10.1074%2Fjbc.M104518200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M104518200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M104518200%26sid%3Dliteratum%253Aachs%26aulast%3DCernuda-Moroll%25C3%25B3n%26aufirst%3DE.%26aulast%3DPineda-Molina%26aufirst%3DE.%26aulast%3DCa%25C5%2588ada%26aufirst%3DF.%2BJ.%26aulast%3DP%25C3%25A9rez-Sala%26aufirst%3DD.%26atitle%3D15-Deoxy-%25CE%259412%252C14-prostaglandin%2520J2%2520Inhibition%2520of%2520NF-%25CE%25BAB-DNA%2520Binding%2520through%2520Covalent%2520Modification%2520of%2520the%2520p50%2520Subunit%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D35530%26epage%3D35536%26doi%3D10.1074%2Fjbc.M104518200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Liu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. C.</span><span> </span><span class="NLM_article-title">Direct Analysis of Salicylic Acid, Salicyl Acyl Glucuronide, Salicyluric Acid and Gentisic Acid in Human Plasma and Urine by High-Performance Liquid Chromatography</span> <span class="citation_source-journal">J. Chromatogr., Biomed. Appl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">675</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/0378-4347(95)00337-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2F0378-4347%2895%2900337-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=8634769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADyaK28XnslSjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=675&publication_year=1996&pages=61-70&author=J.+H.+Liuauthor=P.+C.+Smith&title=Direct+Analysis+of+Salicylic+Acid%2C+Salicyl+Acyl+Glucuronide%2C+Salicyluric+Acid+and+Gentisic+Acid+in+Human+Plasma+and+Urine+by+High-Performance+Liquid+Chromatography&doi=10.1016%2F0378-4347%2895%2900337-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography</span></div><div class="casAuthors">Liu, Jian-Hua; Smith, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography, B: Biomedical Applications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">675</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-70</span>CODEN:
                <span class="NLM_cas:coden">JCBBEP</span>;
        ISSN:<span class="NLM_cas:issn">0378-4347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A method for the simultaneous direct detn. of salicylate (SA), its labile, reactive metabolite, salicyl acyl glucuronide (SAG), and two other major metabolites, salicyluric acid and gentisic acid in plasma and urine is described.  Isocratic reversed-phase high performance liq. chromatog. (HPLC) employed a 15-cm C18 column using methanol-acetonitrile-25 mM acetic acid as the mobile phase, resulting in HPLC anal. time of less than 20 min.  UV detection at 310 nm permitted anal. of SAG in plasma, but did not provide sensitivity for measurement of salicyl phenol glucuronide.  Plasma or urine samples are stabilized immediately upon collection by adjustment of pH to 3-4 to prevent degrdn. of the labile acyl glucuronide metabolite.  Plasma is then deproteinated with acetonitrile, dried and reconstituted for injection, whereas urine samples are simply dild. prior to injection on HPLC. m-Hydroxybenzoic acid served as the internal std.  Recoveries from plasma were greater than 85% for all four compds. over a range of 0.2-20 μg/mL and linearity was obsd. from 0.1-200 μg/mL and 5-2000 μg/mL for SA in plasma and urine, resp.  The method was validated to 0.2 μg/mL, thus allowing accurate measurement of SA, and three major metabolites in plasma and urine of subjects and small animals administered salicylates.  The method is unique by allowing quantitation of reactive SAG in plasma at levels well below 1% that of the parent compd., SA, as is obsd. in patients administered salicylates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ97SsqvuzwrVg90H21EOLACvtfcHk0lh1sze_4fxI9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnslSjsg%253D%253D&md5=033bd2a6be6d4693fc6da42dcd3d0a78</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0378-4347%2895%2900337-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4347%252895%252900337-1%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BC.%26atitle%3DDirect%2520Analysis%2520of%2520Salicylic%2520Acid%252C%2520Salicyl%2520Acyl%2520Glucuronide%252C%2520Salicyluric%2520Acid%2520and%2520Gentisic%2520Acid%2520in%2520Human%2520Plasma%2520and%2520Urine%2520by%2520High-Performance%2520Liquid%2520Chromatography%26jtitle%3DJ.%2520Chromatogr.%252C%2520Biomed.%2520Appl.%26date%3D1996%26volume%3D675%26spage%3D61%26epage%3D70%26doi%3D10.1016%2F0378-4347%2895%2900337-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Kiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervinka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeberényi, J.</span><span> </span><span class="NLM_article-title">Sodium Salicylate Inhibits NF-kappa B and Induces Apoptosis in PC12 Cells</span> <span class="citation_source-journal">J. Biochem. Biophys. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1016/j.jbbm.2004.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.jbbm.2004.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=15560939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=229-240&author=K.+Kissauthor=J.+Kissauthor=E.+Rudolfauthor=M.+Cervinkaauthor=J.+Szeber%C3%A9nyi&title=Sodium+Salicylate+Inhibits+NF-kappa+B+and+Induces+Apoptosis+in+PC12+Cells&doi=10.1016%2Fj.jbbm.2004.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium salicylate inhibits NF-κB and induces apoptosis in PC12 cells</span></div><div class="casAuthors">Kiss, K.; Kiss, J.; Rudolf, E.; Cervinka, M.; Szeberenyi, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Biophysical Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">229-240</span>CODEN:
                <span class="NLM_cas:coden">JBBMDG</span>;
        ISSN:<span class="NLM_cas:issn">0165-022X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sodium salicylate (NaSal) is an effective analgetic and antiinflammatory drug.  Beside its well-known inhibitory effect on the cyclooxygenase enzymes, it influences the activity of other signal transduction proteins including nuclear factor kappa B (NF-κB) transcription factor.  NF-κB is found in the cytoplasm bound to an inhibitory protein, inhibitory kappa B (IκB).  After its phosphorylation, IκB is degraded and the released NF-κB translocates into the nucleus.  Sodium salicylate inhibits the degrdn. of IκB, thus, NF-κB activation cannot occur.  According to previous observations, the inhibition of this activation can lead to apoptosis.  The main goals of this study were to demonstrate that inhibition of NF-κB by sodium salicylate decreases the viability of rat phaeochromocytoma PC12 cells and to investigate the nature of cell damage and death.  PC12 cells were treated with different concns. of sodium salicylate (1-20 mM).  Higher concns. (10-20 mM) killed PC12 cells in a dose-dependent manner.  The assessments were done by direct cell counting in a Buerker chamber and by the WST-1 cytotoxicity assay.  The authors also found a decreased NF-κB activity after sodium salicylate treatment by electrophoretic mobility shift assay (EMSA).  The cells treated with sodium salicylate were undergoing apoptosis as seen on the authors' records obtained by time-lapse videomicroscopy as well as shown by DNA fragmentation expts.  The decreased DNA binding activity of NF-κB indicates that the inhibition of NF-κB can play a role in these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7u03Oaq4317Vg90H21EOLACvtfcHk0lh1sze_4fxI9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr%252FK&md5=57239af5f759830d05e66929cbfc7758</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jbbm.2004.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbbm.2004.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DK.%26aulast%3DKiss%26aufirst%3DJ.%26aulast%3DRudolf%26aufirst%3DE.%26aulast%3DCervinka%26aufirst%3DM.%26aulast%3DSzeber%25C3%25A9nyi%26aufirst%3DJ.%26atitle%3DSodium%2520Salicylate%2520Inhibits%2520NF-kappa%2520B%2520and%2520Induces%2520Apoptosis%2520in%2520PC12%2520Cells%26jtitle%3DJ.%2520Biochem.%2520Biophys.%2520Methods%26date%3D2004%26volume%3D61%26spage%3D229%26epage%3D240%26doi%3D10.1016%2Fj.jbbm.2004.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavasani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilstra, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedernhofer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttridge, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, J.</span><span> </span><span class="NLM_article-title">NF-κB Negatively Impacts the Myogenic Potential of Muscle-Derived Stem Cells</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span><span class="refDoi"> DOI: 10.1038/mt.2011.261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1038%2Fmt.2011.261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22158056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SkurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=661-668&author=A.+Luauthor=J.+D.+Protoauthor=L.+Guoauthor=Y.+Tangauthor=M.+Lavasaniauthor=J.+S.+Tilstraauthor=L.+J.+Niedernhoferauthor=B.+Wangauthor=D.+C.+Guttridgeauthor=P.+D.+Robbinsauthor=J.+Huard&title=NF-%CE%BAB+Negatively+Impacts+the+Myogenic+Potential+of+Muscle-Derived+Stem+Cells&doi=10.1038%2Fmt.2011.261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB Negatively Impacts the Myogenic Potential of Muscle-derived Stem Cells</span></div><div class="casAuthors">Lu, Aiping; Proto, Jonathan D.; Guo, Lulin; Tang, Ying; Lavasani, Mitra; Tilstra, Jeremy S.; Niedernhofer, Laura J.; Wang, Bing; Guttridge, Denis C.; Robbins, Paul D.; Huard, Johnny</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-668</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of the inhibitor of kappa B kinase (IKK)/nuclear factor-kappa B (NF-κB) pathway enhances muscle regeneration in injured and diseased skeletal muscle, but it is unclear exactly how this pathway contributes to the regeneration process.  In this study, we examd. the role of NF-κB in regulating the proliferation and differentiation of muscle-derived stem cells (MDSCs).  MDSCs isolated from the skeletal muscles of p65+/- mice (haploinsufficient for the p65 subunit of NF-κB) had enhanced proliferation and myogenic differentiation compared to MDSCs isolated from wild-type (wt) littermates.  In addn., selective pharmacol. inhibition of IKKβ, an upstream activator of NF-κB, enhanced wt MDSC differentiation into myotubes in vitro.  The p65+/- MDSCs also displayed a higher muscle regeneration index than wt MDSCs following implantation into adult mice with muscular dystrophy.  Addnl., using a muscle injury model, we obsd. that p65+/- MDSC engraftments were assocd. with reduced inflammation and necrosis.  These results suggest that inhibition of the IKK/NF-κB pathway represents an effective approach to improve the myogenic regenerative potential of MDSCs and possibly other adult stem cell populations.  Moreover, our results suggest that the improved muscle regeneration obsd. following inhibition of IKK/NF-κB, is mediated, at least in part, through enhanced stem cell proliferation and myogenic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbnLi2i0T_bVg90H21EOLACvtfcHk0ljJ7u7imlKJoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SkurvF&md5=fc050d8c8add4238785bb0cb2e5bf9a4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fmt.2011.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2011.261%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DA.%26aulast%3DProto%26aufirst%3DJ.%2BD.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLavasani%26aufirst%3DM.%26aulast%3DTilstra%26aufirst%3DJ.%2BS.%26aulast%3DNiedernhofer%26aufirst%3DL.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DGuttridge%26aufirst%3DD.%2BC.%26aulast%3DRobbins%26aufirst%3DP.%2BD.%26aulast%3DHuard%26aufirst%3DJ.%26atitle%3DNF-%25CE%25BAB%2520Negatively%2520Impacts%2520the%2520Myogenic%2520Potential%2520of%2520Muscle-Derived%2520Stem%2520Cells%26jtitle%3DMol.%2520Ther.%26date%3D2012%26volume%3D20%26spage%3D661%26epage%3D668%26doi%3D10.1038%2Fmt.2011.261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Mourkioti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, N.</span><span> </span><span class="NLM_article-title">NF-κB Signaling in Skeletal Muscle: Prospects for Intervention in Muscle Diseases</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">759</span><span class="refDoi"> DOI: 10.1007/s00109-008-0308-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs00109-008-0308-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=18246321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnslGkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=747-759&author=F.+Mourkiotiauthor=N.+Rosenthal&title=NF-%CE%BAB+Signaling+in+Skeletal+Muscle%3A+Prospects+for+Intervention+in+Muscle+Diseases&doi=10.1007%2Fs00109-008-0308-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB signaling in skeletal muscle: prospects for intervention in muscle diseases</span></div><div class="casAuthors">Mourkioti, Foteini; Rosenthal, Nadia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">747-759</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Muscle remodeling is an important physiol. process that promotes adaptive changes in cytoarchitecture and protein compn. after exercise, aging, or disease conditions.  Numerous transcription factors have been reported to regulate skeletal muscle homeostasis.  NF-κB is a major pleiotropic transcription factor modulating immune, inflammatory, cell survival, and proliferating responses; however, its role in muscle development, physiol., and disease has just started to be elucidated.  The current review article aims to summarize the literature on the role of NF-κB signaling in skeletal muscle pathophysiol., investigated over the last years using in vitro and more recently in vivo systems.  Understanding the exact role of NF-κB in muscle cells will allow better therapeutic manipulations in the setting of human muscle diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqezTJ833RQH7Vg90H21EOLACvtfcHk0ljJ7u7imlKJoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnslGkur8%253D&md5=621d469a8d8964d3e5a809f91ab60a02</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00109-008-0308-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-008-0308-4%26sid%3Dliteratum%253Aachs%26aulast%3DMourkioti%26aufirst%3DF.%26aulast%3DRosenthal%26aufirst%3DN.%26atitle%3DNF-%25CE%25BAB%2520Signaling%2520in%2520Skeletal%2520Muscle%253A%2520Prospects%2520for%2520Intervention%2520in%2520Muscle%2520Diseases%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2008%26volume%3D86%26spage%3D747%26epage%3D759%26doi%3D10.1007%2Fs00109-008-0308-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Nadarajah, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Putten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaouch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochmüller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginjaar, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aartsma-Rus, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ommen, G. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">den Dunnen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">’t Hoen, P. A. C.</span><span> </span><span class="NLM_article-title">Serum Matrix Metalloprotease-9 (MMP-9) as a Biomarker for Monitoring Disease Progression in Duchenne Muscular Dystrophy (DMD)</span> <span class="citation_source-journal">Neuromuscular Disorders</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span><span class="refDoi"> DOI: 10.1016/j.nmd.2011.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.nmd.2011.05.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=569-578&author=V.+D.+Nadarajahauthor=M.+van+Puttenauthor=A.+Chaouchauthor=P.+Garroodauthor=V.+Straubauthor=H.+Lochm%C3%BCllerauthor=H.+B.+Ginjaarauthor=A.+M.+Aartsma-Rusauthor=G.+J.+B.+van+Ommenauthor=J.+T.+den+Dunnenauthor=P.+A.+C.+%E2%80%99t+Hoen&title=Serum+Matrix+Metalloprotease-9+%28MMP-9%29+as+a+Biomarker+for+Monitoring+Disease+Progression+in+Duchenne+Muscular+Dystrophy+%28DMD%29&doi=10.1016%2Fj.nmd.2011.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.nmd.2011.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nmd.2011.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DNadarajah%26aufirst%3DV.%2BD.%26aulast%3Dvan%2BPutten%26aufirst%3DM.%26aulast%3DChaouch%26aufirst%3DA.%26aulast%3DGarrood%26aufirst%3DP.%26aulast%3DStraub%26aufirst%3DV.%26aulast%3DLochm%25C3%25BCller%26aufirst%3DH.%26aulast%3DGinjaar%26aufirst%3DH.%2BB.%26aulast%3DAartsma-Rus%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BOmmen%26aufirst%3DG.%2BJ.%2BB.%26aulast%3Dden%2BDunnen%26aufirst%3DJ.%2BT.%26aulast%3D%25E2%2580%2599t%2BHoen%26aufirst%3DP.%2BA.%2BC.%26atitle%3DSerum%2520Matrix%2520Metalloprotease-9%2520%2528MMP-9%2529%2520as%2520a%2520Biomarker%2520for%2520Monitoring%2520Disease%2520Progression%2520in%2520Duchenne%2520Muscular%2520Dystrophy%2520%2528DMD%2529%26jtitle%3DNeuromuscular%2520Disorders%26date%3D2011%26volume%3D21%26spage%3D569%26epage%3D578%26doi%3D10.1016%2Fj.nmd.2011.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Cruz-Guzmán, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Cruz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar Cedillo, R. E.</span><span> </span><span class="NLM_article-title">Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status</span> <span class="citation_source-journal">BioMed Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="refDoi"> DOI: 10.1155/2015/891972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1155%2F2015%2F891972" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=1&author=O.+R.+Cruz-Guzm%C3%A1nauthor=M.+Rodriguez-Cruzauthor=R.+E.+Escobar+Cedillo&title=Systemic+Inflammation+in+Duchenne+Muscular+Dystrophy%3A+Association+with+Muscle+Function+and+Nutritional+Status&doi=10.1155%2F2015%2F891972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1155%2F2015%2F891972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F891972%26sid%3Dliteratum%253Aachs%26aulast%3DCruz-Guzm%25C3%25A1n%26aufirst%3DO.%2BR.%26aulast%3DRodriguez-Cruz%26aufirst%3DM.%26aulast%3DEscobar%2BCedillo%26aufirst%3DR.%2BE.%26atitle%3DSystemic%2520Inflammation%2520in%2520Duchenne%2520Muscular%2520Dystrophy%253A%2520Association%2520with%2520Muscle%2520Function%2520and%2520Nutritional%2520Status%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2015%26volume%3D2015%26spage%3D1%26doi%3D10.1155%2F2015%2F891972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Sweeney, H. L.</span>, manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sweeney%2C+H.+L.%2C+manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DH.%2BL." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Langen, R. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haegens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernooy, J. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, E. F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Winther, M. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, A. M. W. J.</span><span> </span><span class="NLM_article-title">NF-κB Activation is required for the Transition of Pulmonary Inflammation to Muscle Atrophy</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1165/rcmb.2011-0119OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1165%2Frcmb.2011-0119OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22538866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=288-297&author=R.+C.+J.+Langenauthor=A.+Haegensauthor=J.+H.+J.+Vernooyauthor=E.+F.+M.+Woutersauthor=M.+P.+J.+de+Wintherauthor=H.+Carlsenauthor=C.+Steeleauthor=S.+E.+Shoelsonauthor=A.+M.+W.+J.+Schols&title=NF-%CE%BAB+Activation+is+required+for+the+Transition+of+Pulmonary+Inflammation+to+Muscle+Atrophy&doi=10.1165%2Frcmb.2011-0119OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy</span></div><div class="casAuthors">Langen, Ramon C. J.; Haegens, Astrid; Vernooy, Juanita H. J.; Wouters, Emiel F. M.; de Winther, Menno P. J.; Carlsen, Harald; Steele, Chad; Shoelson, Steven E.; Schols, Annemie M. W. J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-297</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Disease exacerbations and muscle wasting comprise neg. prognostic factors of chronic obstructive pulmonary disease (COPD).  Transient systemic inflammation and malnutrition have been implicated in skeletal muscle wasting after acute exacerbations of COPD.  However, the interactions between systemic inflammation and malnutrition in their contributions to muscle atrophy, as well as the mol. basis underlying the transition of systemic inflammation to muscle atrophy, remain unresolved.  Pulmonary inflammation was induced in mice by an intratracheal instillation of LPS to model acute disease exacerbation.  Systemic inflammation, nutritional intake, and body and muscle wts. were detd.  Muscle inflammatory signaling and atrophy signaling were examd., and the effect of the muscle-specific inactivation of NF-κB on muscle atrophy was assessed in genetically modified mice.  The intratracheal LPS instillation was followed by markedly elevated circulating cytokine concns. and NF-κB activation in extrapulmonary tissues, including skeletal muscle.  The administration of intratracheal LPS increased the expression of muscle E3 ubiquitin ligases, which govern muscle proteolysis, in particular MuRF1, and caused a rapid loss of muscle mass.  Reduced food intake only partly accounted for the obsd. muscle atrophy, and did not activate NF-κB in muscle.  Rather, plasma transfer expts. revealed the presence of NF-κB-signaling and atrophy-signaling properties in the circulation of intratracheal LPS-treated mice.  The genetic inhibition of muscle NF-κB activity suppressed intratracheal LPS-induced MuRF1 expression and resulted in a significant sparing of muscle tissue.  Systemic inflammation and malnutrition contribute to the muscle wasting induced by acute pulmonary inflammation via distinct mechanisms, and muscle NF-κB activation is required for the transition from inflammatory to muscle atrophy signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyL9MluFOTg7Vg90H21EOLACvtfcHk0lgTOCNCtn_DBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrrL&md5=dabf9fa945226e47615d59d4b26175af</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2011-0119OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2011-0119OC%26sid%3Dliteratum%253Aachs%26aulast%3DLangen%26aufirst%3DR.%2BC.%2BJ.%26aulast%3DHaegens%26aufirst%3DA.%26aulast%3DVernooy%26aufirst%3DJ.%2BH.%2BJ.%26aulast%3DWouters%26aufirst%3DE.%2BF.%2BM.%26aulast%3Dde%2BWinther%26aufirst%3DM.%2BP.%2BJ.%26aulast%3DCarlsen%26aufirst%3DH.%26aulast%3DSteele%26aufirst%3DC.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DSchols%26aufirst%3DA.%2BM.%2BW.%2BJ.%26atitle%3DNF-%25CE%25BAB%2520Activation%2520is%2520required%2520for%2520the%2520Transition%2520of%2520Pulmonary%2520Inflammation%2520to%2520Muscle%2520Atrophy%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D288%26epage%3D297%26doi%3D10.1165%2Frcmb.2011-0119OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':[],'ref28':[],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Michele Rossi, Sabrina Petralla, Michele Protti, Monica Baiula, Tereza Kobrlova, Ondrej Soukup, Santi Mario Spampinato, Laura Mercolini, Barbara Monti, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">α-Linolenic Acid–Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2406-2413. <a href="https://doi.org/10.1021/acsmedchemlett.0c00375" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00375%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%2525CE%2525B1-Linolenic%252BAcid%2525E2%252580%252593Valproic%252BAcid%252BConjugates%25253A%252BToward%252BSingle-Molecule%252BPolypharmacology%252Bfor%252BMultiple%252BSclerosis%26aulast%3DRossi%26aufirst%3DMichele%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D23102020%26date%3D27102020%26volume%3D11%26issue%3D12%26spage%3D2406%26epage%3D2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Skylar J. Ferrara, <span class="NLM_string-name hlFld-ContribAuthor">Thomas S. Scanlan</span>. </span><span class="cited-content_cbyCitation_article-title">A CNS-Targeting Prodrug Strategy for Nuclear Receptor Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9742-9751. <a href="https://doi.org/10.1021/acs.jmedchem.0c00868" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00868%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BCNS-Targeting%252BProdrug%252BStrategy%252Bfor%252BNuclear%252BReceptor%252BModulators%26aulast%3DFerrara%26aufirst%3DSkylar%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21052020%26date%3D20082020%26date%3D05082020%26volume%3D63%26issue%3D17%26spage%3D9742%26epage%3D9751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thomas Wong, Silpa Narayanan, David P. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Zhe-Sheng Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxicity Studies of Stilbene Long-Chain Fatty Acid Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (5)
                                     , 1563-1570. <a href="https://doi.org/10.1021/acs.jnatprod.0c00027" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DSynthesis%252Band%252BCytotoxicity%252BStudies%252Bof%252BStilbene%252BLong-Chain%252BFatty%252BAcid%252BConjugates%26aulast%3DWong%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08012020%26date%3D03042020%26volume%3D83%26issue%3D5%26spage%3D1563%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chi B.  Vu</span>, <span class="hlFld-ContribAuthor ">Robert J.  Bridges</span>, <span class="hlFld-ContribAuthor ">Cecilia  Pena-Rasgado</span>, <span class="hlFld-ContribAuthor ">Antonio E.  Lacerda</span>, <span class="hlFld-ContribAuthor ">Curtis  Bordwell</span>, <span class="hlFld-ContribAuthor ">Abby  Sewell</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Nichols</span>, <span class="hlFld-ContribAuthor ">Sachin  Chandran</span>, <span class="hlFld-ContribAuthor ">Pallavi  Lonkar</span>, <span class="hlFld-ContribAuthor ">Dominic  Picarella</span>, <span class="hlFld-ContribAuthor ">Amal  Ting</span>, <span class="hlFld-ContribAuthor ">Allison  Wensley</span>, <span class="hlFld-ContribAuthor ">Maisy  Yeager</span>, and <span class="hlFld-ContribAuthor ">Feng  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 458-473. <a href="https://doi.org/10.1021/acs.jmedchem.6b01539" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01539%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFatty%252BAcid%252BCysteamine%252BConjugates%252Bas%252BNovel%252Band%252BPotent%252BAutophagy%252BActivators%252BThat%252BEnhance%252Bthe%252BCorrection%252Bof%252BMisfolded%252BF508del-Cystic%252BFibrosis%252BTransmembrane%252BConductance%252BRegulator%252B%252528CFTR%252529%26aulast%3DVu%26aufirst%3DChi%2BB.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D18102016%26date%3D23122016%26date%3D12012017%26date%3D15122016%26volume%3D60%26issue%3D1%26spage%3D458%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Richard S.  Finkel</span>, <span class="hlFld-ContribAuthor ">Craig M.  McDonald</span>, <span class="hlFld-ContribAuthor ">H.  Lee Sweeney</span>, <span class="hlFld-ContribAuthor ">Erika  Finanger</span>, <span class="hlFld-ContribAuthor ">Erin  Neil Knierbein</span>, <span class="hlFld-ContribAuthor ">Kathryn R.  Wagner</span>, <span class="hlFld-ContribAuthor ">Katherine D.  Mathews</span>, <span class="hlFld-ContribAuthor ">Warren  Marks</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Statland</span>, <span class="hlFld-ContribAuthor ">Jessica  Nance</span>, <span class="hlFld-ContribAuthor ">Hugh J.  McMillan</span>, <span class="hlFld-ContribAuthor ">Gary  McCullagh</span>, <span class="hlFld-ContribAuthor ">Cuixia  Tian</span>, <span class="hlFld-ContribAuthor ">Monique M.  Ryan</span>, <span class="hlFld-ContribAuthor ">Declan  O’Rourke</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Müller-Felber</span>, <span class="hlFld-ContribAuthor ">Mar  Tulinius</span>, <span class="hlFld-ContribAuthor ">W.  Bryan Burnette</span>, <span class="hlFld-ContribAuthor ">Cam-Tu  Nguyen</span>, <span class="hlFld-ContribAuthor ">Kayal  Vijayakumar</span>, <span class="hlFld-ContribAuthor ">Jessika  Johannsen</span>, <span class="hlFld-ContribAuthor ">Han C.  Phan</span>, <span class="hlFld-ContribAuthor ">Michelle  Eagle</span>, <span class="hlFld-ContribAuthor ">James  MacDougall</span>, <span class="hlFld-ContribAuthor ">Maria  Mancini</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Donovan</span>. </span><span class="cited-content_cbyCitation_article-title">A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuromuscular Diseases</span><span> <strong>2021,</strong> <em>24 </em>, 1-16. <a href="https://doi.org/10.3233/JND-210689" title="DOI URL">https://doi.org/10.3233/JND-210689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JND-210689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJND-210689%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuromuscular%2520Diseases%26atitle%3DA%252BRandomized%25252C%252BDouble-Blind%25252C%252BPlacebo-Controlled%25252C%252BGlobal%252BPhase%252B3%252BStudy%252Bof%252BEdasalonexent%252Bin%252BPediatric%252BPatients%252Bwith%252BDuchenne%252BMuscular%252BDystrophy%25253A%252BResults%252Bof%252Bthe%252BPolarisDMD%252BTrial%26aulast%3DFinkel%26aufirst%3DRichard%2BS.%26date%3D2021%26volume%3D24%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard S.  Finkel</span>, <span class="hlFld-ContribAuthor ">Erika  Finanger</span>, <span class="hlFld-ContribAuthor ">Krista  Vandenborne</span>, <span class="hlFld-ContribAuthor ">H. Lee  Sweeney</span>, <span class="hlFld-ContribAuthor ">Gihan  Tennekoon</span>, <span class="hlFld-ContribAuthor ">Perry B.  Shieh</span>, <span class="hlFld-ContribAuthor ">Rebecca  Willcocks</span>, <span class="hlFld-ContribAuthor ">Glenn  Walter</span>, <span class="hlFld-ContribAuthor ">William D.  Rooney</span>, <span class="hlFld-ContribAuthor ">Sean C.  Forbes</span>, <span class="hlFld-ContribAuthor ">William T.  Triplett</span>, <span class="hlFld-ContribAuthor ">Sabrina W.  Yum</span>, <span class="hlFld-ContribAuthor ">Maria  Mancini</span>, <span class="hlFld-ContribAuthor ">James  MacDougall</span>, <span class="hlFld-ContribAuthor ">Angelika  Fretzen</span>, <span class="hlFld-ContribAuthor ">Pradeep  Bista</span>, <span class="hlFld-ContribAuthor ">Andrew  Nichols</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Donovan</span>. </span><span class="cited-content_cbyCitation_article-title">Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial. </span><span class="cited-content_cbyCitation_journal-name">Neuromuscular Disorders</span><span> <strong>2021,</strong> <em>31 </em>
                                    (5)
                                     , 385-396. <a href="https://doi.org/10.1016/j.nmd.2021.02.001" title="DOI URL">https://doi.org/10.1016/j.nmd.2021.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nmd.2021.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nmd.2021.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuromuscular%2520Disorders%26atitle%3DDisease-modifying%252Beffects%252Bof%252Bedasalonexent%25252C%252Ban%252BNF-%2525CE%2525BAB%252Binhibitor%25252C%252Bin%252Byoung%252Bboys%252Bwith%252BDuchenne%252Bmuscular%252Bdystrophy%25253A%252BResults%252Bof%252Bthe%252BMoveDMD%252Bphase%252B2%252Band%252Bopen%252Blabel%252Bextension%252Btrial%26aulast%3DFinkel%26aufirst%3DRichard%2BS.%26date%3D2021%26volume%3D31%26issue%3D5%26spage%3D385%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Marina  Naldi</span>, <span class="hlFld-ContribAuthor ">Sabrina  Petralla</span>, <span class="hlFld-ContribAuthor ">Silvia  Strocchi</span>, <span class="hlFld-ContribAuthor ">Daniela  Grifoni</span>, <span class="hlFld-ContribAuthor ">Barbara  Monti</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From Combinations to Single-Molecule Polypharmacology—Cromolyn-Ibuprofen Conjugates for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1112. <a href="https://doi.org/10.3390/molecules26041112" title="DOI URL">https://doi.org/10.3390/molecules26041112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041112%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFrom%252BCombinations%252Bto%252BSingle-Molecule%252BPolypharmacology%2525E2%252580%252594Cromolyn-Ibuprofen%252BConjugates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DAlbertini%26aufirst%3DClaudia%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Alessandra  Salerno</span>, <span class="hlFld-ContribAuthor ">Pedro  Sena Murteira Pinheiro</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.1002/med.21699" title="DOI URL">https://doi.org/10.1002/med.21699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21699%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DFrom%252Bcombinations%252Bto%252Bmultitarget%2525E2%252580%252590directed%252Bligands%25253A%252BA%252Bcontinuum%252Bin%252BAlzheimer%252527s%252Bdisease%252Bpolypharmacology%26aulast%3DAlbertini%26aufirst%3DClaudia%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanlan  Liu</span>, <span class="hlFld-ContribAuthor ">Jayaprakasam  Bolleddula</span>, <span class="hlFld-ContribAuthor ">Andrew  Nichols</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Zhiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Chandra  Prakash</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of bioconjugate therapeutics: why, when, and how?. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2020,</strong> <em>52 </em>
                                    (1)
                                     , 66-124. <a href="https://doi.org/10.1080/03602532.2020.1716784" title="DOI URL">https://doi.org/10.1080/03602532.2020.1716784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2020.1716784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2020.1716784%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DMetabolism%252Bof%252Bbioconjugate%252Btherapeutics%25253A%252Bwhy%25252C%252Bwhen%25252C%252Band%252Bhow%25253F%26aulast%3DLiu%26aufirst%3DHanlan%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D1%26spage%3D66%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabrielle N.  Winston-McPherson</span>, <span class="hlFld-ContribAuthor ">Haibo  Xie</span>, <span class="hlFld-ContribAuthor ">Ka  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoxun  Li</span>, <span class="hlFld-ContribAuthor ">Dongxu  Shu</span>, <span class="hlFld-ContribAuthor ">Weiping  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2,3′-diindolylmethanes as a novel class of PCSK9 modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2345-2348. <a href="https://doi.org/10.1016/j.bmcl.2019.06.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2%25252C3%2525E2%252580%2525B2-diindolylmethanes%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252BPCSK9%252Bmodulators%26aulast%3DWinston-McPherson%26aufirst%3DGabrielle%2BN.%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2345%26epage%3D2348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erika  Finanger</span>, <span class="hlFld-ContribAuthor ">Krista  Vandenborne</span>, <span class="hlFld-ContribAuthor ">Richard S.  Finkel</span>, <span class="hlFld-ContribAuthor ">H.  Lee Sweeney</span>, <span class="hlFld-ContribAuthor ">Gihan  Tennekoon</span>, <span class="hlFld-ContribAuthor ">Sabrina  Yum</span>, <span class="hlFld-ContribAuthor ">Maria  Mancini</span>, <span class="hlFld-ContribAuthor ">Pradeep  Bista</span>, <span class="hlFld-ContribAuthor ">Andrew  Nichols</span>, <span class="hlFld-ContribAuthor ">Hanlan  Liu</span>, <span class="hlFld-ContribAuthor ">Angelika  Fretzen</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Donovan</span>. </span><span class="cited-content_cbyCitation_article-title">Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuromuscular Diseases</span><span> <strong>2019,</strong> <em>6 </em>
                                    (1)
                                     , 43-54. <a href="https://doi.org/10.3233/JND-180341" title="DOI URL">https://doi.org/10.3233/JND-180341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JND-180341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJND-180341%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuromuscular%2520Diseases%26atitle%3DPhase%252B1%252BStudy%252Bof%252BEdasalonexent%252B%252528CAT-1004%252529%25252C%252Ban%252BOral%252BNF-%2525CE%2525BAB%252BInhibitor%25252C%252Bin%252BPediatric%252BPatients%252Bwith%252BDuchenne%252BMuscular%252BDystrophy%26aulast%3DFinanger%26aufirst%3DErika%26date%3D2019%26volume%3D6%26issue%3D1%26spage%3D43%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Shanshan  Luo</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules as inhibitors of PCSK9: Current status and future challenges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 212-233. <a href="https://doi.org/10.1016/j.ejmech.2018.11.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecules%252Bas%252Binhibitors%252Bof%252BPCSK9%25253A%252BCurrent%252Bstatus%252Band%252Bfuture%252Bchallenges%26aulast%3DXu%26aufirst%3DShengtao%26date%3D2019%26volume%3D162%26spage%3D212%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leanne M.  Ward</span>, <span class="hlFld-ContribAuthor ">Kathi  Kinnett</span>, <span class="hlFld-ContribAuthor ">Lynda  Bonewald</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Adachi</span>, <span class="hlFld-ContribAuthor ">Laura  Bachrach</span>, <span class="hlFld-ContribAuthor ">Teresita  Bellido</span>, <span class="hlFld-ContribAuthor ">Marco  Brotto</span>, <span class="hlFld-ContribAuthor ">Lynda  Bonewald</span>, <span class="hlFld-ContribAuthor ">Joanne  Donovan</span>, <span class="hlFld-ContribAuthor ">Eric  Hoffman</span>, <span class="hlFld-ContribAuthor ">Kathi  Kinnett</span>, <span class="hlFld-ContribAuthor ">Mary  Leonard</span>, <span class="hlFld-ContribAuthor ">Hugh  McMillan</span>, <span class="hlFld-ContribAuthor ">Susan  Novotny</span>, <span class="hlFld-ContribAuthor ">Jill  Rafael-Fortney</span>, <span class="hlFld-ContribAuthor ">Frank  Rauch</span>, <span class="hlFld-ContribAuthor ">Leanne  Ward</span>, <span class="hlFld-ContribAuthor ">Stuart  Warden</span>. </span><span class="cited-content_cbyCitation_article-title">Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop. </span><span class="cited-content_cbyCitation_journal-name">Neuromuscular Disorders</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 64-76. <a href="https://doi.org/10.1016/j.nmd.2017.05.012" title="DOI URL">https://doi.org/10.1016/j.nmd.2017.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nmd.2017.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nmd.2017.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuromuscular%2520Disorders%26atitle%3DProceedings%252Bof%252Ba%252BParent%252BProject%252BMuscular%252BDystrophy%252BBone%252BHealth%252BWorkshop%26aulast%3DWard%26aufirst%3DLeanne%2BM.%26date%3D2018%26volume%3D28%26issue%3D1%26spage%3D64%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Zimmer</span>, <span class="hlFld-ContribAuthor ">Pradeep  Bista</span>, <span class="hlFld-ContribAuthor ">Ericka L.  Benson</span>, <span class="hlFld-ContribAuthor ">Diana Y.  Lee</span>, <span class="hlFld-ContribAuthor ">Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Dominic  Picarella</span>, <span class="hlFld-ContribAuthor ">Rick B.  Vega</span>, <span class="hlFld-ContribAuthor ">Chi B.  Vu</span>, <span class="hlFld-ContribAuthor ">Maisy  Yeager</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Guosheng  Liang</span>, <span class="hlFld-ContribAuthor ">Jay D.  Horton</span>, <span class="hlFld-ContribAuthor ">Robert  Kleemann</span>, <span class="hlFld-ContribAuthor ">Teake  Kooistra</span>, <span class="hlFld-ContribAuthor ">Martine C.  Morrison</span>, <span class="hlFld-ContribAuthor ">Peter Y.  Wielinga</span>, <span class="hlFld-ContribAuthor ">Jill C.  Milne</span>, <span class="hlFld-ContribAuthor ">Michael R.  Jirousek</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Nichols</span>. </span><span class="cited-content_cbyCitation_article-title">CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice. </span><span class="cited-content_cbyCitation_journal-name">Hepatology Communications</span><span> <strong>2017,</strong> <em>1 </em>
                                    (4)
                                     , 311-325. <a href="https://doi.org/10.1002/hep4.1042" title="DOI URL">https://doi.org/10.1002/hep4.1042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep4.1042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep4.1042%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%2520Communications%26atitle%3DCAT-2003%25253A%252BA%252Bnovel%252Bsterol%252Bregulatory%252Belement-binding%252Bprotein%252Binhibitor%252Bthat%252Breduces%252Bsteatohepatitis%25252C%252Bplasma%252Blipids%25252C%252Band%252Batherosclerosis%252Bin%252Bapolipoprotein%252BE%252A3-Leiden%252Bmice%26aulast%3DZimmer%26aufirst%3DMichael%26date%3D2017%26date%3D2017%26volume%3D1%26issue%3D4%26spage%3D311%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanne M.  Donovan</span>, <span class="hlFld-ContribAuthor ">Michael  Zimmer</span>, <span class="hlFld-ContribAuthor ">Elliot  Offman</span>, <span class="hlFld-ContribAuthor ">Toni  Grant</span>, <span class="hlFld-ContribAuthor ">Michael  Jirousek</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel NF‐κB Inhibitor, Edasalonexent (CAT‐1004), in Development as a Disease‐Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult Subjects. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Pharmacology</span><span> <strong>2017,</strong> <em>57 </em>
                                    (5)
                                     , 627-639. <a href="https://doi.org/10.1002/jcph.842" title="DOI URL">https://doi.org/10.1002/jcph.842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcph.842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcph.842%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DA%252BNovel%252BNF%2525E2%252580%252590%2525CE%2525BAB%252BInhibitor%25252C%252BEdasalonexent%252B%252528CAT%2525E2%252580%2525901004%252529%25252C%252Bin%252BDevelopment%252Bas%252Ba%252BDisease%2525E2%252580%252590Modifying%252BTreatment%252Bfor%252BPatients%252BWith%252BDuchenne%252BMuscular%252BDystrophy%25253A%252BPhase%252B1%252BSafety%25252C%252BPharmacokinetics%25252C%252Band%252BPharmacodynamics%252Bin%252BAdult%252BSubjects%26aulast%3DDonovan%26aufirst%3DJoanne%2BM.%26date%3D2017%26date%3D2017%26volume%3D57%26issue%3D5%26spage%3D627%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David W.  Hammers</span>, <span class="hlFld-ContribAuthor ">Margaret M.  Sleeper</span>, <span class="hlFld-ContribAuthor ">Sean C.  Forbes</span>, <span class="hlFld-ContribAuthor ">Cora C.  Coker</span>, <span class="hlFld-ContribAuthor ">Michael R.  Jirousek</span>, <span class="hlFld-ContribAuthor ">Michael  Zimmer</span>, <span class="hlFld-ContribAuthor ">Glenn A.  Walter</span>, <span class="hlFld-ContribAuthor ">H. Lee  Sweeney</span>. </span><span class="cited-content_cbyCitation_article-title">Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscle. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2016,</strong> <em>1 </em>
                                    (21)
                                     <a href="https://doi.org/10.1172/jci.insight.90341" title="DOI URL">https://doi.org/10.1172/jci.insight.90341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.90341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.90341%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DDisease-modifying%252Beffects%252Bof%252Borally%252Bbioavailable%252BNF-%2525CE%2525BAB%252Binhibitors%252Bin%252Bdystrophin-deficient%252Bmuscle%26aulast%3DHammers%26aufirst%3DDavid%2BW.%26date%3D2016%26volume%3D1%26issue%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Fatty acid niacin conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0021.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) niacin or salicylic acid, EDC/HOBT, Hunig’s base, CH<sub>2</sub>Cl<sub>2</sub>; (b) HCl/1,4-dioxane; (c) R<sub>2</sub>CO<sub>2</sub>H, EDC/HOBT, Hunig’s base, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mouse, rat, beagle, and human plasma stability studies for compounds <b>1</b>–<b>5</b>. Percentage of compounds <b>1</b>–<b>5</b> remaining upon incubation in mouse (A), rat (B), beagle (C), and human plasma (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) HuH-7 cells were treated with <i>cis</i>-parinaric acid (25 μM) and LysoTracker for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI (Molecular Probes). Images taken on a Zeiss 510 LSM confocal microscope. Three lasers were used for DAPI, <i>cis</i>-parinaric acid, and LyosoTracker. (B) HuH-7 cells were treated with CellLight ER-RFP, BacMam 2.0 (Molecular Probes) for 48 h. Cells were treated with Compound <b>10</b> (25 μM) for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI. Three lasers were used for DAPI, compound <b>10</b>, and CellLight. (C) HuH-7 cells were treated with CellLight ER-RFP for 48 h. Cells were then treated with 80 μM of Dynasore and compound <b>10</b> (25 μM) for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI. (D) HuH-7 cells were treated with CellLight ER-RFP, BacMam 2.0 (Molecular Probes) for 48 h. Cells were treated with compound <b>12</b> (25 μM) for 30 min, fixed with 4% formaldehyde for 2 min at 37 °C, and mounted with antifade DAPI. Three lasers were used for DAPI, compound <b>12</b>, and CellLight.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hydrolysis of compound <b>5</b> in rat liver lysate. Percentage of compound <b>5</b> remaining upon incubation in rat liver lysate at 37 °C in the absence of and in the presence of the FAAH inhibitor PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hydrolysis of compound <b>5</b> using recombinant FAAH-1. Measurement of EPA that was being released over time upon hydrolysis of compound <b>5</b> using recombinant FAAH-1 in the absence of and in the presence of the FAAH inhibitor PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hydrolysis of compound <b>5</b> in HepG2 Cells. Percentage of compound <b>5</b> remaining upon incubation in human HepG2 cells over a 20 h period.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hydrolysis of compound <b>9</b> in HepG2 Cells. Measurement of deuterium-labeled EPA-<i>d</i><sub>5</sub> that was being released over time upon incubation of compound <b>9</b> in HepG2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. List of metabolites measured upon oral dosing with compounds <b>5</b>, <b>7</b>, and <b>8</b> in Sprague–Dawley rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Hydrolysis of compounds <b>5</b>, <b>7</b>, and <b>8</b> using recombinant FAAH-1. Measurement of EPA that was being released over time upon hydrolysis of compound <b>5</b>, <b>7</b>, and <b>8</b> using recombinant FAAH-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Liver concentration of the corresponding parent compound upon dosing Sprague–Dawley rats with compounds <b>5</b> and <b>8</b>. Sprague–Dawley rats (<i>n</i> = 6) were dosed with either 300 mg/kg of compound <b>5</b> or 100 mg/kg of compound <b>8</b> once daily for three days. Four hours after the last dose, liver tissues were collected and analyzed for the corresponding parent compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Effect of niacin and compound <b>5</b> on the production of cAMP induced by forskolin in human epidermal A431 cells. Human epidermal A431 cells overexpressed with GPR109A were incubated with either niacin or compound <b>5</b> over the indicated dose range. Cellular cAMP production was induced by forskolin. The corresponding cAMP concentration was measured using the commercially available LANCE Ultra cAMP kit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Synergistic inhibition of SREBP-2 upon incubation of HepG2 cells with compound <b>5</b>. HepG2 cells were treated overnight with compound <b>5</b> at 12.5, 25, and 50 μM as indicated, atorvastatin (10 μM), atorvastatin (10 μM)/compound <b>5</b> (25 μM), and EPA (50 μM)/niacin (50 μM). Immunoblotting of total cell lysates was performed using rabbit antihuman SREBP2 antibody (Abcam ab72856) and analyzed by chemoluminescence using Licor. (A) Representative immunoblot. Atorva = atorvastatin; Combi = combination having 10 μM of atorvastatin and 25 μM of compound <b>5</b>. 50 Nia EPA = 50 μM each of niacin and EPA. (B) Densitometry of mature SREBP2 was normalized such that the averaged target/actin ratio for vehicle control was set to 1. Significance was determined by and one-way ANOVA and <i>t</i> test in comparison to control. Error bars represent standard error of the mean (SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Effect of compound <b>5</b> on PCSK9 mRNA expression in HepG2 cells. HepG2 cells were incubated with compound <b>5</b> at the indicated doses. RNA was reverse-transcribed using the cells to cDNA reagents. Real-time PCR of transcripts was performed with Taqman assays for the specific gene PCSK9 and HPRT-VIC was used as a normalization control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14A" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0016.jpeg" id="rightTab-GRAPHIC-d7e1601-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (A) Effect of compound <b>5</b>, EPA, niacin, or a combination of EPA and niacin on the secretion of PCSK9 in HepG2 cells. Human HepG2 cells were incubated with EPA, niacin, an equimolar mixture of EPA and niacin, or compound <b>5</b> for 16 h over the indicated dose range. Cell culture supernatants were analyzed for secreted PCSK9 using a commercially available PCSK9 ELISA kit. The ELISA was measured on a Victor X5 multilabel plate reader at an absorbance of 450 nm with background correction measured at 550 nm. (B) Effect of compound <b>5</b>, EPA, niacin, or a combination of EPA and niacin on the secretion of ApoB in HepG2 cells. Human HepG2 cells were incubated with EPA, niacin, an equimolar mixture of EPA and niacin, or compound <b>5</b> for 16 h over the indicated dose range. Cell culture supernatants were analyzed for secreted ApoB using a commercially available ELISA kit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig14A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Hydrolysis of compound <b>11</b> in rat liver lysate. Percentage of compound <b>11</b> remaining upon incubation in rat liver lysate at 37 °C in the absence of and in the presence of the FAAH inhibitor PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Potential metabolites deriving from the hydrolysis of the fatty acid salicylate conjugate <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Tissue distribution study for compound <b>11</b> in Sprague–Dawley rats. Sprague–Dawley rats, in groups of four, were dosed orally with 300 mg/kg of compound <b>11</b> once a day for 14 days. On days 1, 3, 7, and 14, plasma and the indicated tissues were collected 4 h after dosing. Another group of animals was subjected to a 7-day washout cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/medium/jm-2015-01961b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Synergistic inhibition of NF-κB by compound <b>11</b> in RAW 264.7 macrophages. RAW 264.7 macrophage cells stably transfected with an NF-κB response element linked to a luciferase reporter were treated with salicylate, DHA, an equimolar mixture of DHA and salicylate, or compound <b>11</b> for 2 h and then with LPS (200 ng/mL, 3 h). NF-κB activity was normalized to LPS-treated vehicle (Sal = salicylic acid).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01961/20160205/images/large/jm-2015-01961b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01961&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">Polypharmacology-Foe or Friend?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8955</span><span class="NLM_x">–</span> <span class="NLM_lpage">8971</span><span class="refDoi"> DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology-Foe+or+Friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0ljDSGwfMC_a1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology-Foe%2520or%2520Friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can We Rationally Design Promiscuous Drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.sbi.2006.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+We+Rationally+Design+Promiscuous+Drugs%3F&doi=10.1016%2Fj.sbi.2006.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0liUnOfuI1Asow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520We%2520Rationally%2520Design%2520Promiscuous%2520Drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136%26doi%3D10.1016%2Fj.sbi.2006.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resta, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno-Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1056/NEJM200104053441401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1056%2FNEJM200104053441401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=11287972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1031-1037&author=B.+J.+Drukerauthor=M.+Talpazauthor=D.+J.+Restaauthor=B.+Pengauthor=E.+Buchdungerauthor=J.+M.+Fordauthor=N.+B.+Lydonauthor=H.+Kantarjianauthor=R.+Capdevilleauthor=S.+Ohno-Jonesauthor=C.+L.+Sawyers&title=Efficacy+and+Safety+of+a+Specific+Inhibitor+of+the+BCR-ABL+Tyrosine+Kinase+in+Chronic+Myeloid+Leukemia&doi=10.1056%2FNEJM200104053441401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia</span></div><div class="casAuthors">Druker, Brian J.; Talpaz, Moshe; Resta, Debra J.; Peng, Bin; Buchdunger, Elisabeth; Ford, John M.; Lydon, Nicholas B.; Kantarjian, Hagop; Capdeville, Renaud; Ohno-Jones, Sayuri; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1031-1037</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML).  Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML.  Methods: We conducted a phase 1, dose-escalating trial of STI571 (formerly known as CGP 57148B), a specific inhibitor of the BCR-ABL tyrosine kinase.  STI571 was administered orally to 83 patients with CML in the chronic phase in whom treatment with interferon alpha had failed.  Patients were successively assigned to 1 of 14 doses ranging from 25 to 1000 mg per day.  Results: Adverse effects of STI571 were minimal; the most common were nausea, myalgias, edema, and diarrhea.  A maximal tolerated dose was not identified.  Complete hematol. responses were obsd. in 53 of 54 patients treated with daily doses of 300 mg or more and typically occurred in the first four weeks of therapy.  Of the 54 patients treated with doses of 300 mg or more, cytogenetic responses occurred in 29, including 17 (31 percent of the 54 patients who received this dose) with major responses (0 to 35 percent of cells in metaphase pos. for the Philadelphia chromosome); 7 of these patients had complete cytogenetic remissions.  Conclusion: STI571 is well tolerated and has significant antileukemic activity in patients with CML in whom treatment with interferon alpha had failed.  Our results provide evidence of the essential role of BCR-ABL tyrosine kinase activity in CML and demonstrate the potential for the development of anticancer drugs based on the specific mol. abnormality present in a human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrprbDzKoC0ubVg90H21EOLACvtfcHk0liUnOfuI1Asow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D&md5=1554407678838243a753aa056ffd4f7c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM200104053441401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200104053441401%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DResta%26aufirst%3DD.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DOhno-Jones%26aufirst%3DS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520a%2520Specific%2520Inhibitor%2520of%2520the%2520BCR-ABL%2520Tyrosine%2520Kinase%2520in%2520Chronic%2520Myeloid%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1031%26epage%3D1037%26doi%3D10.1056%2FNEJM200104053441401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Azmi, A. S.</span><span> </span><span class="NLM_article-title">Network Pharmacology for Cancer Drug Discovery: Are We There Yet?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.4155/fmc.12.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.4155%2Ffmc.12.44" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=931-941&author=A.+S.+Azmi&title=Network+Pharmacology+for+Cancer+Drug+Discovery%3A+Are+We+There+Yet%3F&doi=10.4155%2Ffmc.12.44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.44%26sid%3Dliteratum%253Aachs%26aulast%3DAzmi%26aufirst%3DA.%2BS.%26atitle%3DNetwork%2520Pharmacology%2520for%2520Cancer%2520Drug%2520Discovery%253A%2520Are%2520We%2520There%2520Yet%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D931%26epage%3D941%26doi%3D10.4155%2Ffmc.12.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Seeger, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J. A.,  3rd</span><span> </span><span class="NLM_article-title">Ziprasidone (CP-88,059): A New Antipsychotic with Combined Dopamine and Serotonin Receptor Antagonist Activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=7562537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADyaK2MXovVKntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=101-113&author=T.+F.+Seegerauthor=P.+A.+Seymourauthor=A.+W.+Schmidtauthor=S.+H.+Zornauthor=D.+W.+Schulzauthor=L.+A.+Lebelauthor=S.+McLeanauthor=V.+Guanowskyauthor=H.+R.+Howardauthor=J.+A.+Lowe&title=Ziprasidone+%28CP-88%2C059%29%3A+A+New+Antipsychotic+with+Combined+Dopamine+and+Serotonin+Receptor+Antagonist+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity</span></div><div class="casAuthors">Seeger, T. F.; Seymour, P. A.; Schmidt, A. W.; Zorn, S. H.; Schulz, D. W.; Lebel, L. A.; McLean, S.; Guanowsky, V.; Howard, H. R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-13</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Ziprasidone (CP-88,059) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects in preclin. assays predictive of antipsychotic activity.  Whereas the compd. is a dopamine antagonist in vitro and in vivo, its most potent action is antagonism of 5-HT2A receptors, where its affinity is an order of magnitude greater than that obsd. for dopamine D2 sites.  Lab. and clin. findings have led to a hypothesis that antagonism of 5-HT2A receptors in the brain limits the undesirable motor side effects assocd. with dopamine receptor blockade and improves efficacy against the neg. symptoms of schizophrenia.  Siprasidone possesses an in vitro 5-HT2A/dopamine D2 receptor affinity ratio higher than any clin. available antipsychotic agent.  In vivo, ziprasidone antagonizes 5-HT2A receptor-induced head twitch with 6-fold higher potency than for blockade of d-amphetamine-induced hyperactivity, a measure of central dopamine D2 receptor antagonism.  Ziprasidone also has high affinity for the 5-HT1A, 5-HT1D and 5-HT2C receptor subtypes, which may further enhance its therapeutic potential.  The prediction of antipsychotic efficacy without severe motor side effects is supported by the relatively weak potency of ziprasidone to produce catalepsy in animals, contrasted with its potent antagonism of conditioned avoidance responding and dopamine agonist-induced locomotor activation and stereotypy.  The compd. is well tolerated in animals at doses producing effective dopamine antagonism in the brain.  Ziprasidone should be a valuable addn. to the treatment of psychotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8EaD7ygyZbbVg90H21EOLACvtfcHk0liUnOfuI1Asow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovVKntbw%253D&md5=8d747dd236e65f0ba876e47f27f3ee3f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeger%26aufirst%3DT.%2BF.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DZorn%26aufirst%3DS.%2BH.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DHoward%26aufirst%3DH.%2BR.%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26atitle%3DZiprasidone%2520%2528CP-88%252C059%2529%253A%2520A%2520New%2520Antipsychotic%2520with%2520Combined%2520Dopamine%2520and%2520Serotonin%2520Receptor%2520Antagonist%2520Activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hegde, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinfeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulido-Rios, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mammen, M.</span><span> </span><span class="NLM_article-title">Pharmacologic Characterization of GSK-961081 (TD-5959), a First-In-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1124/jpet.114.216861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1124%2Fjpet.114.216861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=25100753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yksbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=190-199&author=S.+S.+Hegdeauthor=A.+D.+Hughesauthor=Y.+Chenauthor=T.+Steinfeldauthor=J.+R.+Jasperauthor=T.-W.+Leeauthor=A.+McNamaraauthor=W.+J.+Martinauthor=M.+T.+Pulido-Riosauthor=M.+Mammen&title=Pharmacologic+Characterization+of+GSK-961081+%28TD-5959%29%2C+a+First-In-Class+Inhaled+Bifunctional+Bronchodilator+Possessing+Muscarinic+Receptor+Antagonist+and+%CE%B22-Adrenoceptor+Agonist+Properties&doi=10.1124%2Fjpet.114.216861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties</span></div><div class="casAuthors">Hegde, Sharath S.; Hughes, Adam D.; Chen, Yan; Steinfeld, Tod; Jasper, Jeffrey R.; Lee, Tae-Weon; McNamara, Alexander; Martin, William J.; Pulido-Rios, M. Teresa; Mammen, Mathai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-199, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present studies was to characterize the pharmacol. properties of GSK-961081 [TD-5959; (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl) piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate], a novel first-in-class inhaled bifunctional compd. possessing both muscarinic antagonist (MA) and β2-adrenoceptor agonist (BA) properties (MABA).  In competition radioligand binding studies at human recombinant receptors, GSK-961081 displayed high affinity for hM2 (Ki = 1.4 nM), hM3 muscarinic receptors (Ki = 1.3 nM) and hβ2-adrenoceptors (Ki = 3.7 nM).  GSK-961081 behaved as a potent hβ2-adrenoceptor agonist (EC50 = 0.29 nM for stimulation of cAMP levels) with 440- and 320-fold functional selectivity over hβ1- and hβ3-adrenoceptors, resp.  In guinea pig isolated tracheal tissues, GSK-961081 produced smooth muscle relaxation through MA (EC50 = 50.2 nM), BA (EC50 = 24.6 nM), and MABA (EC50 = 11 nM) mechanisms.  In the guinea pig bronchoprotection assay, inhaled GSK-961081 produced potent, dose-dependent inhibition of bronchoconstrictor responses via MA (ED50 = 33.9 μg/mL), BA (ED50 = 14.1 μg/mL), and MABA (ED50 = 6.4 μg/mL) mechanisms.  Significant bronchoprotective effects of GSK-961081 were evident in guinea pigs via MA, BA, and MABA mechanisms for up to 7 days after dosing.  The lung selectivity index of GSK-961081 in guinea pigs was 55- to 110-fold greater than that of tiotropium with respect to systemic antimuscarinic antisialagogue effects and was 10-fold greater than that of salmeterol with respect to systemic β2-adrenoceptor hypotensive effects.  These preclin. findings studies suggest that GSK-961081 has the potential to be a promising next-generation inhaled lung-selective bronchodilator for the treatment of airway diseases, including chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7s7-fKs3E47Vg90H21EOLACvtfcHk0lhPxkBlIbeCCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yksbfJ&md5=f2b92f897950afedc02c62c056824c17</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.216861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.216861%26sid%3Dliteratum%253Aachs%26aulast%3DHegde%26aufirst%3DS.%2BS.%26aulast%3DHughes%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSteinfeld%26aufirst%3DT.%26aulast%3DJasper%26aufirst%3DJ.%2BR.%26aulast%3DLee%26aufirst%3DT.-W.%26aulast%3DMcNamara%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DPulido-Rios%26aufirst%3DM.%2BT.%26aulast%3DMammen%26aufirst%3DM.%26atitle%3DPharmacologic%2520Characterization%2520of%2520GSK-961081%2520%2528TD-5959%2529%252C%2520a%2520First-In-Class%2520Inhaled%2520Bifunctional%2520Bronchodilator%2520Possessing%2520Muscarinic%2520Receptor%2520Antagonist%2520and%2520%25CE%25B22-Adrenoceptor%2520Agonist%2520Properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D190%26epage%3D199%26doi%3D10.1124%2Fjpet.114.216861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Altschul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephen, J. D.</span><span> </span><span class="NLM_article-title">Influence of Nicotinic Acid on Serum Cholesterol in Man</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1016/0003-9861(55)90070-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2F0003-9861%2855%2990070-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1955&pages=558-559&author=R.+Altschulauthor=A.+Hofferauthor=J.+D.+Stephen&title=Influence+of+Nicotinic+Acid+on+Serum+Cholesterol+in+Man&doi=10.1016%2F0003-9861%2855%2990070-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2855%2990070-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252855%252990070-9%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DR.%26aulast%3DHoffer%26aufirst%3DA.%26aulast%3DStephen%26aufirst%3DJ.%2BD.%26atitle%3DInfluence%2520of%2520Nicotinic%2520Acid%2520on%2520Serum%2520Cholesterol%2520in%2520Man%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1955%26volume%3D54%26spage%3D558%26epage%3D559%26doi%3D10.1016%2F0003-9861%2855%2990070-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Villines, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. J.</span><span> </span><span class="NLM_article-title">Niacin: The Evidence, Clinical Use, and Future Directions</span> <span class="citation_source-journal">Curr. Atheroscler. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.1007/s11883-011-0212-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs11883-011-0212-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22037771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=49-59&author=T.+C.+Villinesauthor=A.+S.+Kimauthor=R.+S.+Goreauthor=A.+J.+Taylor&title=Niacin%3A+The+Evidence%2C+Clinical+Use%2C+and+Future+Directions&doi=10.1007%2Fs11883-011-0212-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Niacin: The Evidence, Clinical Use, and Future Directions</span></div><div class="casAuthors">Villines, Todd C.; Kim, Andrew S.; Gore, Rosco S.; Taylor, Allen J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Atherosclerosis Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-59</span>CODEN:
                <span class="NLM_cas:coden">CARUCZ</span>;
        ISSN:<span class="NLM_cas:issn">1523-3804</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The use of FDA-approved niacin (nicotinic acid or vitamin B3) formulations at therapeutic doses, alone or in combination with statins or other lipid therapies, is safe, improves multiple lipid parameters, and reduces atherosclerosis progression.  Niacin is unique as the most potent available lipid therapy to increase high-d. lipoprotein (HDL) cholesterol and it significantly reduces lipoprotein(a).  Through its action on the GPR109A receptor, niacin may also exert beneficial pleiotropic effects independent of changes in lipid levels, such as improving endothelial function and attenuating vascular inflammation.  Studies evaluating the impact of niacin in statin-naive patients on cardiovascular outcomes, or alone and in combination with statins or other lipid therapies on atherosclerosis progression, have been universally favorable.  However, the widespread use of niacin to treat residual lipid abnormalities such as low HDL cholesterol, when used in combination with statins among patients achieving very low (<75 mg/dL) low-d. lipoprotein cholesterol levels, is currently not supported by clin. outcome trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAt6OXedtaK7Vg90H21EOLACvtfcHk0lhPxkBlIbeCCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVeisQ%253D%253D&md5=cfb8d6299c688eb2156e84180052bfe1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11883-011-0212-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11883-011-0212-1%26sid%3Dliteratum%253Aachs%26aulast%3DVillines%26aufirst%3DT.%2BC.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DGore%26aufirst%3DR.%2BS.%26aulast%3DTaylor%26aufirst%3DA.%2BJ.%26atitle%3DNiacin%253A%2520The%2520Evidence%252C%2520Clinical%2520Use%252C%2520and%2520Future%2520Directions%26jtitle%3DCurr.%2520Atheroscler.%2520Rep.%26date%3D2012%26volume%3D14%26spage%3D49%26epage%3D59%26doi%3D10.1007%2Fs11883-011-0212-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gille, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodor, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermanns, S.</span><span> </span><span class="NLM_article-title">Nicotinic Acid: Pharmacological Effects and Mechanisms of Action</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.48.113006.094746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1146%2Fannurev.pharmtox.48.113006.094746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=17705685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFynurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=79-106&author=A.+Gilleauthor=E.+T.+Bodorauthor=K.+Ahmedauthor=S.+Offermanns&title=Nicotinic+Acid%3A+Pharmacological+Effects+and+Mechanisms+of+Action&doi=10.1146%2Fannurev.pharmtox.48.113006.094746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acid: pharmacological effects and mechanisms of action</span></div><div class="casAuthors">Gille, Andreas; Bodor, Erik T.; Ahmed, Kashan; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79-106</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Pharmacol. doses of nicotinic acid induce a profound change in the plasma levels of various lipids and lipoproteins.  The ability of nicotinic acid to strongly increase the plasma concn. of high-d. lipoprotein (HDL) cholesterol has in recent years led to an increased interest in the pharmacol. potential of nicotinic acid.  There is increasing evidence that nicotinic acid alone or in addn. to LDL cholesterol-lowering drugs can reduce the progression of atherosclerosis and reduce the risk of cardiovascular events.  The clin. use of nicotinic acid is, however, hindered by harmless but unpleasant side effects, esp. by a strong cutaneous vasodilation called flushing.  The recent discovery of the G protein-coupled receptor GPR109A (HM74A or PUMA-G) as a receptor for nicotinic acid has allowed for better understanding of the mechanisms underlying the metabolic and vascular effects of nicotinic acid.  On the basis of recent progress in understanding the pharmacol. effects of nicotinic acid, new strategies are in development to better exploit the pharmacol. potential of nicotinic acid.  New drugs acting via the nicotinic acid receptor or related receptors, as well as new co-medications that suppress unwanted effects of nicotinic acid, will most likely be introduced as new therapeutic options in the treatment of dyslipidemia and the prevention of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_g9LIPLsMCLVg90H21EOLACvtfcHk0lhPxkBlIbeCCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFynurY%253D&md5=d5f5bc77aeadb5b3bc8845e06be89003</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.48.113006.094746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.48.113006.094746%26sid%3Dliteratum%253Aachs%26aulast%3DGille%26aufirst%3DA.%26aulast%3DBodor%26aufirst%3DE.%2BT.%26aulast%3DAhmed%26aufirst%3DK.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DNicotinic%2520Acid%253A%2520Pharmacological%2520Effects%2520and%2520Mechanisms%2520of%2520Action%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2008%26volume%3D48%26spage%3D79%26epage%3D106%26doi%3D10.1146%2Fannurev.pharmtox.48.113006.094746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Von Schacky, G.</span><span> </span><span class="NLM_article-title">The Role of Omega-3 Fatty Acids in Cardiovascular Disease</span> <span class="citation_source-journal">Curr. Atheroscler. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1007/s11883-003-0086-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs11883-003-0086-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=12573200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fmtlentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=139-145&author=G.+Von+Schacky&title=The+Role+of+Omega-3+Fatty+Acids+in+Cardiovascular+Disease&doi=10.1007%2Fs11883-003-0086-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of omega-3 fatty acids in cardiovascular disease</span></div><div class="casAuthors">von Schacky Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Current atherosclerosis reports</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-45</span>
        ISSN:<span class="NLM_cas:issn">1523-3804</span>.
    </div><div class="casAbstract">Plant-derived alpha-linolenic acid has been studied in a limited number of investigations.  So far, some epidemiologic and a few mechanistic studies suggest a potential of protection from cardiovascular disease, but this potential remains to be proven in intervention studies.  In contrast, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are prevalent in fish and fish oils, have been studied in thousands of investigations.  A consistent body of evidence has been elaborated in various types of investigations, ultimately demonstrating reduction in total mortality, cardiovascular mortality, and morbidity by ingestion of roughly 1 g/d of EPA plus DHA.  Current guidelines, however, do not discern between the omega-3 fatty acids mentioned; in fact, most even do not differentiate polyunsaturated fatty acids at all.  Unfortunately, this complicates efficient implementation of an effective means of prophylaxis of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPR7KHQfpOttj_Vg2vObihfW6udTcc2ebgcI_KOmIyf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fmtlentw%253D%253D&md5=7244bc322975f99340770875fa7a536a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs11883-003-0086-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11883-003-0086-y%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BSchacky%26aufirst%3DG.%26atitle%3DThe%2520Role%2520of%2520Omega-3%2520Fatty%2520Acids%2520in%2520Cardiovascular%2520Disease%26jtitle%3DCurr.%2520Atheroscler.%2520Rep.%26date%3D2003%26volume%3D5%26spage%3D139%26epage%3D145%26doi%3D10.1007%2Fs11883-003-0086-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sekiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakakuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osuga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, H.</span><span> </span><span class="NLM_article-title">Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis in Obese Mice by SREBP-1 Suppression</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1529</span><span class="NLM_x">–</span> <span class="NLM_lpage">1539</span><span class="refDoi"> DOI: 10.1016/j.hep.2003.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.hep.2003.09.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=1529-1539&author=M.+Sekiyaauthor=M.+Yahagiauthor=T.+Matsuzakaauthor=Y.+Najimaauthor=M.+Nakakukiauthor=R.+Nagaiauthor=S.+Ishibashiauthor=J.+Osugaauthor=N.+Yamadaauthor=H.+Shimano&title=Polyunsaturated+Fatty+Acids+Ameliorate+Hepatic+Steatosis+in+Obese+Mice+by+SREBP-1+Suppression&doi=10.1016%2Fj.hep.2003.09.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.hep.2003.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hep.2003.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DSekiya%26aufirst%3DM.%26aulast%3DYahagi%26aufirst%3DM.%26aulast%3DMatsuzaka%26aufirst%3DT.%26aulast%3DNajima%26aufirst%3DY.%26aulast%3DNakakuki%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DR.%26aulast%3DIshibashi%26aufirst%3DS.%26aulast%3DOsuga%26aufirst%3DJ.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DShimano%26aufirst%3DH.%26atitle%3DPolyunsaturated%2520Fatty%2520Acids%2520Ameliorate%2520Hepatic%2520Steatosis%2520in%2520Obese%2520Mice%2520by%2520SREBP-1%2520Suppression%26jtitle%3DHepatology%26date%3D2003%26volume%3D38%26spage%3D1529%26epage%3D1539%26doi%3D10.1016%2Fj.hep.2003.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanbe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, T.</span><span> </span><span class="NLM_article-title">Eicosapentaenoic Acid Improves Hepatic Steatosis Independent of PPAR alpha Activation through Inhibition of SREBP-1 Maturation in Mice</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.07.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.bcp.2010.07.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1601-1612&author=N.+Tanakaauthor=X.+Zhangauthor=E.+Sugiyamaauthor=H.+Konoauthor=A.+Horiuchiauthor=T.+Nakajimaauthor=H.+Kanbeauthor=E.+Tanakaauthor=F.+J.+Gonzalezauthor=T.+Aoyama&title=Eicosapentaenoic+Acid+Improves+Hepatic+Steatosis+Independent+of+PPAR+alpha+Activation+through+Inhibition+of+SREBP-1+Maturation+in+Mice&doi=10.1016%2Fj.bcp.2010.07.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.07.031%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSugiyama%26aufirst%3DE.%26aulast%3DKono%26aufirst%3DH.%26aulast%3DHoriuchi%26aufirst%3DA.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DKanbe%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DAoyama%26aufirst%3DT.%26atitle%3DEicosapentaenoic%2520Acid%2520Improves%2520Hepatic%2520Steatosis%2520Independent%2520of%2520PPAR%2520alpha%2520Activation%2520through%2520Inhibition%2520of%2520SREBP-1%2520Maturation%2520in%2520Mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1601%26epage%3D1612%26doi%3D10.1016%2Fj.bcp.2010.07.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Moon, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank-Kamenetsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koteliansky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, J. D.</span><span> </span><span class="NLM_article-title">The Scap/SREBP Pathway is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1016/j.cmet.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.cmet.2011.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22326225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=240-246&author=Y.+A.+Moonauthor=G.+Liangauthor=X.+Xieauthor=M.+Frank-Kamenetskyauthor=K.+Fitzgeraldauthor=V.+Kotelianskyauthor=M.+S.+Brownauthor=J.+L.+Goldsteinauthor=J.+D.+Horton&title=The+Scap%2FSREBP+Pathway+is+Essential+for+Developing+Diabetic+Fatty+Liver+and+Carbohydrate-Induced+Hypertriglyceridemia+in+Animals&doi=10.1016%2Fj.cmet.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals</span></div><div class="casAuthors">Moon, Young-Ah; Liang, Guosheng; Xie, Xuefen; Frank-Kamenetsky, Maria; Fitzgerald, Kevin; Koteliansky, Victor; Brown, Michael S.; Goldstein, Joseph L.; Horton, Jay D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-246</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Insulin resistance leads to hypertriglyceridemia and hepatic steatosis and is assocd. with increased SREBP-1c, a transcription factor that activates fatty acid synthesis.  Here, we show that steatosis in insulin-resistant ob/ob mice was abolished by deletion of Scap, an escort protein necessary for generating nuclear isoforms of all three SREBPs.  Scap deletion reduced lipid synthesis and prevented fatty livers despite persistent obesity, hyperinsulinemia, and hyperglycemia.  Scap deficiency also prevented steatosis in mice fed high-fat diets.  Steatosis was also prevented when siRNAs were used to silence Scap in livers of sucrose-fed hamsters, a model of diet-induced steatosis and hypertriglyceridemia.  This silencing reduced all three nuclear SREBPs, decreasing lipid biosynthesis and abolishing sucrose-induced hypertriglyceridemia.  These results demonstrate that SREBP activation is essential for development of diabetic hepatic steatosis and carbohydrate-induced hypertriglyceridemia, but not insulin resistance.  Inhibition of SREBP activation has therapeutic potential for treatment of hypertriglyceridemia and fatty liver disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_UAlxnbdBULVg90H21EOLACvtfcHk0liRYZj8u8oU7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVajsrY%253D&md5=2313f31aa9fca6ea00bec1261688db48</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DY.%2BA.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DFrank-Kamenetsky%26aufirst%3DM.%26aulast%3DFitzgerald%26aufirst%3DK.%26aulast%3DKoteliansky%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DM.%2BS.%26aulast%3DGoldstein%26aufirst%3DJ.%2BL.%26aulast%3DHorton%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520Scap%252FSREBP%2520Pathway%2520is%2520Essential%2520for%2520Developing%2520Diabetic%2520Fatty%2520Liver%2520and%2520Carbohydrate-Induced%2520Hypertriglyceridemia%2520in%2520Animals%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26spage%3D240%26epage%3D246%26doi%3D10.1016%2Fj.cmet.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Eberle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegarty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foufelle, F.</span><span> </span><span class="NLM_article-title">SREBP Transcription Factors: Master Regulators of Lipid Homeostasis</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1016/j.biochi.2004.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.biochi.2004.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=15589694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKksLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2004&pages=839-848&author=D.+Eberleauthor=B.+Hegartyauthor=P.+Bossardauthor=P.+Ferreauthor=F.+Foufelle&title=SREBP+Transcription+Factors%3A+Master+Regulators+of+Lipid+Homeostasis&doi=10.1016%2Fj.biochi.2004.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SREBP transcription factors: master regulators of lipid homeostasis</span></div><div class="casAuthors">Eberle, Delphine; Hegarty, Bronwyn; Bossard, Pascale; Ferre, Pascal; Foufelle, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">839-848</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sterol regulatory element binding proteins (SREBPs) are a family of transcription factors that regulate lipid homeostasis by controlling the expression of a range of enzymes required for endogenous cholesterol, fatty acid (FA), triacylglycerol and phospholipid synthesis.  The three SREBP isoforms, SREBP-1a, SREBP-1c and SREBP-2, have different roles in lipid synthesis.  In vivo studies using transgenic and knockout mice suggest that SREBP-1c is involved in FA synthesis and insulin-induced glucose metab. (particularly in lipogenesis), whereas SREBP-2 is relatively specific to cholesterol synthesis.  The SREBP-1a isoform seems to be implicated in both pathways.  SREBP transcription factors are synthesized as inactive precursors bound to the endoplasmic reticulum (ER) membranes.  Upon activation, the precursor undergoes a sequential two-step cleavage process to release the NH2-terminal active domain in the nucleus (designated nSREBPs).  SREBP processing is mainly controlled by cellular sterol content.  When sterol levels decrease, the precursor is cleaved to activate cholesterogenic genes and maintain cholesterol homeostasis.  This sterol-sensitive process appears to be a major point of regulation for the SREBP-1a and SREBP-2 isoforms but not for SREBP-1c.  Moreover, the SREBP-1c isoform seems to be mainly regulated at the transcriptional level by insulin.  The unique regulation and activation properties of each SREBP isoform facilitate the coordinate regulation of lipid metab.; however, further studies are needed to understand the detailed regulation pathways that specifically regulate each SREBP isoform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLdcYSlGLnmbVg90H21EOLACvtfcHk0liC4rqpwEa-iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKksLfM&md5=f48f242bb3fbf519e80d64f27923d65f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2004.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2004.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DEberle%26aufirst%3DD.%26aulast%3DHegarty%26aufirst%3DB.%26aulast%3DBossard%26aufirst%3DP.%26aulast%3DFerre%26aufirst%3DP.%26aulast%3DFoufelle%26aufirst%3DF.%26atitle%3DSREBP%2520Transcription%2520Factors%253A%2520Master%2520Regulators%2520of%2520Lipid%2520Homeostasis%26jtitle%3DBiochimie%26date%3D2004%26volume%3D86%26spage%3D839%26epage%3D848%26doi%3D10.1016%2Fj.biochi.2004.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Van Rooyen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, G. C.</span><span> </span><span class="NLM_article-title">SREBP-2: A Link between Insulin Resistance, Hepatic Cholesterol, and Inflammation in NASH</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1111/j.1440-1746.2011.06704.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1111%2Fj.1440-1746.2011.06704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=21488942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=789-792&author=D.+M.+Van+Rooyenauthor=G.+C.+Farrell&title=SREBP-2%3A+A+Link+between+Insulin+Resistance%2C+Hepatic+Cholesterol%2C+and+Inflammation+in+NASH&doi=10.1111%2Fj.1440-1746.2011.06704.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH</span></div><div class="casAuthors">Van Rooyen, Derrick M.; Farrell, Geoff C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">789-795</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The research of Zhao et al. (2011) entitled 'Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis' is reviewed with commentary and refs.  Zhao et al. describe the effect of inflammation on hepatic SREBP-2, and subsequent LDLR and HMGR expression in both in vivo and in vitro systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqniTDw4s9PrVg90H21EOLACvtfcHk0liC4rqpwEa-iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlygs7k%253D&md5=787a799ea24dd8447a4d66b1ccaa54c0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2011.06704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2011.06704.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRooyen%26aufirst%3DD.%2BM.%26aulast%3DFarrell%26aufirst%3DG.%2BC.%26atitle%3DSREBP-2%253A%2520A%2520Link%2520between%2520Insulin%2520Resistance%252C%2520Hepatic%2520Cholesterol%252C%2520and%2520Inflammation%2520in%2520NASH%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2011%26volume%3D26%26spage%3D789%26epage%3D792%26doi%3D10.1111%2Fj.1440-1746.2011.06704.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, Ml</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=Ml+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+Characterization+of+a+Highly+Selective+FAAH+Inhibitor+that+Reduces+Inflammatory+Pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0liC4rqpwEa-iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DMl%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520a%2520Highly%2520Selective%2520FAAH%2520Inhibitor%2520that%2520Reduces%2520Inflammatory%2520Pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Enzymatic Pathways that Regulate Endocannabinoid Signaling in the Nervous System</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span><span class="refDoi"> DOI: 10.1021/cr0782067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0782067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFKhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1687-1707&author=K.+Ahnauthor=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Enzymatic+Pathways+that+Regulate+Endocannabinoid+Signaling+in+the+Nervous+System&doi=10.1021%2Fcr0782067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic pathways that regulate endocannabinoid signaling in the nervous system</span></div><div class="casAuthors">Ahn, Kay; McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1687-1707</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of the compn. and regulation of endocannabinoid metabolic pathways, esp. with respect to the nervous system, are reviewed.  The current state of the understanding of the 4 major pathways for endocannabinoid metab. are discussed.  These include (1) anandamide degrdn.; (2) anandamide biosynthesis; (3) 2-arachidonoylglycerol (2-AG) degrdn.; and (4) 2-AG biosynthesis.  Some of these pathways, such as anandamide degrdn., are relatively well characterized, at least in terms of the participating enzymes, esp. fatty acid amide hydrolase (FAAH), and the advent of specific research tools to probe their function in vivo.  For the other pathways, candidate enzymes have been identified, but the specific roles that these proteins play in regulating endocannabinoid metab. in vivo remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcfjZNs7jWWrVg90H21EOLACvtfcHk0lgeXpI4G7yuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFKhs7s%253D&md5=4c74194ab87393de8f0fcbab198d089c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fcr0782067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0782067%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEnzymatic%2520Pathways%2520that%2520Regulate%2520Endocannabinoid%2520Signaling%2520in%2520the%2520Nervous%2520System%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1687%26epage%3D1707%26doi%3D10.1021%2Fcr0782067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">A Review on the Monoacylglycerol Lipase: at the Interface between Fat and Endocannabinoid Signaling</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2607</span><span class="refDoi"> DOI: 10.2174/092986710791859414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.2174%2F092986710791859414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=20491633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2588-2607&author=G.+Labarauthor=J.+Woutersauthor=D.+M.+Lambert&title=A+Review+on+the+Monoacylglycerol+Lipase%3A+at+the+Interface+between+Fat+and+Endocannabinoid+Signaling&doi=10.2174%2F092986710791859414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling</span></div><div class="casAuthors">Labar, G.; Wouters, J.; Lambert, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2588-2607</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Together with anandamide, 2-arachidonoylglycerol (2-AG) constitutes one of the main representatives of a family of endogenous lipids known as endocannabinoids.  These act by binding to CB1 and CB2 cannabinoid receptors, the mol. target of the psychoactive compd. Δ9-THC, both in the periphery and in the central nervous system, where they behave as retrograde messengers to modulate synaptic transmission.  These last years, evidence has accumulated to demonstrate the lead role played by the monoacylglycerol lipase (MAGL) in the regulation of 2-arachidonoylglycerol (2-AG) levels.  Considering the numerous physiol. functions played by this endocannabinoid, MAGL is now considered a promising target for therapeutics, as inhibitors of this enzyme could reveal useful for the treatment of pain and inflammatory disorders, as well as in cancer research, among others.  Here we review the milestones that punctuated MAGL history, from its discovery to recent advances in the field of inhibitors development.  An emphasis is given on the recent elucidation of the tridimensional structure of the enzyme, which could offer new opportunities for rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUHXu1GAauLVg90H21EOLACvtfcHk0lgeXpI4G7yuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK&md5=bff89a0988768b26b17604ec38bf70df</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F092986710791859414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859414%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DA%2520Review%2520on%2520the%2520Monoacylglycerol%2520Lipase%253A%2520at%2520the%2520Interface%2520between%2520Fat%2520and%2520Endocannabinoid%2520Signaling%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2588%26epage%3D2607%26doi%3D10.2174%2F092986710791859414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starodub, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kier, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, F.</span><span> </span><span class="NLM_article-title">Liver Fatty Acid-Binding Protein Targets Fatty Acids to the Nucleus, Real Time Confocal and Multiphoton Fluorescence Imaging in Living Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">29139</span><span class="NLM_x">–</span> <span class="NLM_lpage">29151</span><span class="refDoi"> DOI: 10.1074/jbc.M202923200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M202923200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=29139-29151&author=H.+Huangauthor=O.+Starodubauthor=A.+McIntoshauthor=A.+B.+Kierauthor=F.+Schroeder&title=Liver+Fatty+Acid-Binding+Protein+Targets+Fatty+Acids+to+the+Nucleus%2C+Real+Time+Confocal+and+Multiphoton+Fluorescence+Imaging+in+Living+Cells&doi=10.1074%2Fjbc.M202923200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M202923200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M202923200%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DStarodub%26aufirst%3DO.%26aulast%3DMcIntosh%26aufirst%3DA.%26aulast%3DKier%26aufirst%3DA.%2BB.%26aulast%3DSchroeder%26aufirst%3DF.%26atitle%3DLiver%2520Fatty%2520Acid-Binding%2520Protein%2520Targets%2520Fatty%2520Acids%2520to%2520the%2520Nucleus%252C%2520Real%2520Time%2520Confocal%2520and%2520Multiphoton%2520Fluorescence%2520Imaging%2520in%2520Living%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D29139%26epage%3D29151%26doi%3D10.1074%2Fjbc.M202923200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kirchhausen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelish, H. E.</span><span> </span><span class="NLM_article-title">Use of Dynasore, the Small Molecule Inhibitor of Dynamin, in the Regulation of Endocytosis</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/S0076-6879(07)38006-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2FS0076-6879%2807%2938006-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=18413242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntF2htLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2008&pages=77-93&author=T.+Kirchhausenauthor=E.+Maciaauthor=H.+E.+Pelish&title=Use+of+Dynasore%2C+the+Small+Molecule+Inhibitor+of+Dynamin%2C+in+the+Regulation+of+Endocytosis&doi=10.1016%2FS0076-6879%2807%2938006-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis</span></div><div class="casAuthors">Kirchhausen, Tom; Macia, Eric; Pelish, Henry E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">Small GTPases in Disease, Part A</span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The large GTPase dynamin is essential for clathrin-dependent coated-vesicle formation.  Dynasore is a cell-permeable small mol. that inhibits the GTPase activity of dynamin1, dynamin2 and Drp1, the mitochondrial dynamin.  Dynasore was discovered in a screen of ∼16,000 compds. for inhibitors of the dynamin2 GTPase.  Dynasore is a noncompetitive inhibitor of dynamin GTPase activity and blocks dynamin-dependent endocytosis in cells, including neurons.  It is fast acting (seconds) and its inhibitory effect in cells can be reversed by washout.  Here we present a detailed synthesis protocol for dynasore, and describe a series of expts. used to analyze the inhibitory effects of dynasore on dynamin in vitro and to study the effects of dynasore on endocytosis in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3fjSAdqyqZLVg90H21EOLACvtfcHk0lgeXpI4G7yuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntF2htLY%253D&md5=3a8c5101903595e3a54df410f3bfad75</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2807%2938006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252807%252938006-3%26sid%3Dliteratum%253Aachs%26aulast%3DKirchhausen%26aufirst%3DT.%26aulast%3DMacia%26aufirst%3DE.%26aulast%3DPelish%26aufirst%3DH.%2BE.%26atitle%3DUse%2520of%2520Dynasore%252C%2520the%2520Small%2520Molecule%2520Inhibitor%2520of%2520Dynamin%252C%2520in%2520the%2520Regulation%2520of%2520Endocytosis%26jtitle%3DMethods%2520Enzymol.%26date%3D2008%26volume%3D438%26spage%3D77%26epage%3D93%26doi%3D10.1016%2FS0076-6879%2807%2938006-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McMahon, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucrot, E.</span><span> </span><span class="NLM_article-title">Molecular Mechanism of Physiological Function of Clathrin-Mediated Endocytosis</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.1038/nrm3151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1038%2Fnrm3151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=21779028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1aqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=517-533&author=H.+T.+McMahonauthor=E.+Boucrot&title=Molecular+Mechanism+of+Physiological+Function+of+Clathrin-Mediated+Endocytosis&doi=10.1038%2Fnrm3151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism and physiological functions of clathrin-mediated endocytosis</span></div><div class="casAuthors">McMahon, Harvey T.; Boucrot, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">517-533</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Clathrin-mediated endocytosis is the endocytic portal into cells through which cargo is packaged into vesicles with the aid of a clathrin coat.  It is fundamental to neurotransmission, signal transduction and the regulation of many plasma membrane activities and is thus essential to higher eukaryotic life.  Morphol. stages of vesicle formation are mirrored by progression through various protein modules (complexes).  The process involves the formation of a putative FCH domain only (FCHO) initiation complex, which matures through adaptor protein 2 (AP2)-dependent cargo selection, and subsequent coat building, dynamin-mediated scission and finally auxilin- and heat shock cognate 70 (HSC70)-dependent uncoating.  Some modules can be used in other pathways, and addns. or substitutions confer cell specificity and adaptability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI8oygEoVS9bVg90H21EOLACvtfcHk0ljhS0rnjPmzkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1aqtr4%253D&md5=e402d2c18d475b7949a6ebdfada6f633</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnrm3151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3151%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DH.%2BT.%26aulast%3DBoucrot%26aufirst%3DE.%26atitle%3DMolecular%2520Mechanism%2520of%2520Physiological%2520Function%2520of%2520Clathrin-Mediated%2520Endocytosis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D517%26epage%3D533%26doi%3D10.1038%2Fnrm3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Masui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urade, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kito, M.</span><span> </span><span class="NLM_article-title">Selective Incorporation of n-3 and n-6 Unsaturated Fatty Acids into Animal Cells Phospholipids</span> <span class="citation_source-journal">Biosci., Biotechnol., Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span><span class="refDoi"> DOI: 10.1271/bbb.59.644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1271%2Fbbb.59.644" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1995&pages=644-647&author=H.+Masuiauthor=R.+Uradeauthor=M.+Kito&title=Selective+Incorporation+of+n-3+and+n-6+Unsaturated+Fatty+Acids+into+Animal+Cells+Phospholipids&doi=10.1271%2Fbbb.59.644"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1271%2Fbbb.59.644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.59.644%26sid%3Dliteratum%253Aachs%26aulast%3DMasui%26aufirst%3DH.%26aulast%3DUrade%26aufirst%3DR.%26aulast%3DKito%26aufirst%3DM.%26atitle%3DSelective%2520Incorporation%2520of%2520n-3%2520and%2520n-6%2520Unsaturated%2520Fatty%2520Acids%2520into%2520Animal%2520Cells%2520Phospholipids%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D1995%26volume%3D59%26spage%3D644%26epage%3D647%26doi%3D10.1271%2Fbbb.59.644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Franson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waite, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVia, M.</span><span> </span><span class="NLM_article-title">Identification of Phospholipase A1 and A2 in the Soluble Fraction of Rat Liver Lysosomes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1942</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.1021/bi00786a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00786a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1971&pages=1942-1946&author=R.+Fransonauthor=M.+Waiteauthor=M.+LaVia&title=Identification+of+Phospholipase+A1+and+A2+in+the+Soluble+Fraction+of+Rat+Liver+Lysosomes&doi=10.1021%2Fbi00786a031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fbi00786a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00786a031%26sid%3Dliteratum%253Aachs%26aulast%3DFranson%26aufirst%3DR.%26aulast%3DWaite%26aufirst%3DM.%26aulast%3DLaVia%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Phospholipase%2520A1%2520and%2520A2%2520in%2520the%2520Soluble%2520Fraction%2520of%2520Rat%2520Liver%2520Lysosomes%26jtitle%3DBiochemistry%26date%3D1971%26volume%3D10%26spage%3D1942%26epage%3D1946%26doi%3D10.1021%2Fbi00786a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Fatty Acid Amide Hydrolase, an Enzyme with many Bioactive Substrates. Possible Therapeutic Implications</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.2174/1381612023395655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.2174%2F1381612023395655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=11945157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Omtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=533-547&author=T.+Bisognoauthor=L.+De+Petrocellisauthor=V.+Di+Marzo&title=Fatty+Acid+Amide+Hydrolase%2C+an+Enzyme+with+many+Bioactive+Substrates.+Possible+Therapeutic+Implications&doi=10.2174%2F1381612023395655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications</span></div><div class="casAuthors">Bisogno, Tiziana; De Petrocellis, Luciano; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">533-547</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 116 refs.  During the last 8 yr, a no. of bioactive lipid mediators, the amides or esters of long chain fatty acids, have been discovered or re-discovered.  These include: anandamide (N-arachidonoylethanolamine) and 2-arachidonoylglycerol, 2 endogenous agonists of cannabinoid receptors; oleamide (cis-9-octadecenoamide), a putative endogenous sleep-inducing factor; and N-palmitoylethanolamine, a compd. with promising anti-inflammatory and immune-modulatory activity.  These compds. are all substrates for the same hydrolytic enzyme, fatty acid amide hydrolase (I), whose mol. characterization was obtained in 1996.  The mol. and enzymic properties, tissue distribution, substrate recognition properties, physiol. regulation, and biol. role of I are discussed here with special emphasis on the possible pharmacol. manipulation of the activity of this enzyme with therapeutic purpose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolw6cvuB972LVg90H21EOLACvtfcHk0ljhS0rnjPmzkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Omtro%253D&md5=8692b343a81c11fb8ea86dfbf6ed2166</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1381612023395655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023395655%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DFatty%2520Acid%2520Amide%2520Hydrolase%252C%2520an%2520Enzyme%2520with%2520many%2520Bioactive%2520Substrates.%2520Possible%2520Therapeutic%2520Implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D533%26epage%3D547%26doi%3D10.2174%2F1381612023395655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Discovery and Molecular Basis of Potent Noncovalent Inhibitors of Fatty Acid Amide Hydrolyase (FAAH)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">7379</span><span class="NLM_x">–</span> <span class="NLM_lpage">7384</span><span class="refDoi"> DOI: 10.1073/pnas.1016167108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1073%2Fpnas.1016167108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7379-7384&author=X.+Minauthor=S.+T.+Thibaultauthor=A.+C.+Porterauthor=D.+I.+Gustinauthor=T.+I.+Carlsonauthor=H.+Xuauthor=M.+Lindstromauthor=G.+Xuauthor=C.+Uyedaauthor=Z.+Maauthor=Y.+Liauthor=F.+Kayserauthor=N.+P.+Walkerauthor=Z.+Wang&title=Discovery+and+Molecular+Basis+of+Potent+Noncovalent+Inhibitors+of+Fatty+Acid+Amide+Hydrolyase+%28FAAH%29&doi=10.1073%2Fpnas.1016167108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016167108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016167108%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DX.%26aulast%3DThibault%26aufirst%3DS.%2BT.%26aulast%3DPorter%26aufirst%3DA.%2BC.%26aulast%3DGustin%26aufirst%3DD.%2BI.%26aulast%3DCarlson%26aufirst%3DT.%2BI.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DUyeda%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DDiscovery%2520and%2520Molecular%2520Basis%2520of%2520Potent%2520Noncovalent%2520Inhibitors%2520of%2520Fatty%2520Acid%2520Amide%2520Hydrolyase%2520%2528FAAH%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7379%26epage%3D7384%26doi%3D10.1073%2Fpnas.1016167108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wei, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">36569</span><span class="NLM_x">–</span> <span class="NLM_lpage">36578</span><span class="refDoi"> DOI: 10.1074/jbc.M606646200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M606646200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=17015445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=36569-36578&author=B.+Q.+Weiauthor=T.+S.+Mikkelsenauthor=M.+K.+McKinneyauthor=E.+S.+Landerauthor=B.+F.+Cravatt&title=A+Second+Fatty+Acid+Amide+Hydrolase+with+Variable+Distribution+among+Placental+Mammals&doi=10.1074%2Fjbc.M606646200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals</span></div><div class="casAuthors">Wei, Binqing Q.; Mikkelsen, Tarjei S.; McKinney, Michele K.; Lander, Eric S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">36569-36578</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fatty acid amides constitute a large and diverse class of lipid transmitters that includes the endogenous cannabinoid anandamide and the sleep-inducing substance oleamide.  The magnitude and duration of fatty acid amide signaling are controlled by enzymic hydrolysis in vivo.  Fatty acid amide hydrolase (FAAH) activity in mammals has been primarily attributed to a single integral membrane enzyme of the amidase signature (AS) family.  Here, we report the functional proteomic discovery of a second membrane-assocd. AS enzyme in humans that displays FAAH activity.  The gene that encodes this second FAAH enzyme was found in multiple primate genomes, marsupials, and more distantly related vertebrates, but, remarkably, not in a no. of lower placental mammals, including mouse and rat.  The two human FAAH enzymes, which share 20% sequence identity and are referred to hereafter as FAAH-1 and FAAH-2, hydrolyzed primary fatty acid amide substrates (e.g., oleamide) at equiv. rates, whereas FAAH-1 exhibited much greater activity with N-acyl ethanolamines (e.g., anandamide) and N-acyl taurines.  Both enzymes were sensitive to the principal classes of FAAH inhibitors synthesized to date, including O-aryl carbamates and α-keto heterocycles.  These data coupled with the overlapping, but distinct tissue distributions of FAAH-1 and FAAH-2 suggest that these proteins may collaborate to control fatty acid amide catabolism in primates.  The apparent loss of the FAAH-2 gene in some lower mammals should be taken into consideration when extrapolating genetic or pharmacol. findings on the fatty acid amide signaling system across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuV_6Ew68-CbVg90H21EOLACvtfcHk0lgf721ZRecMEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP&md5=16273562700ac4fe3ef10c9917f0d3aa</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606646200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606646200%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DB.%2BQ.%26aulast%3DMikkelsen%26aufirst%3DT.%2BS.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520Second%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520with%2520Variable%2520Distribution%2520among%2520Placental%2520Mammals%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D36569%26epage%3D36578%26doi%3D10.1074%2Fjbc.M606646200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sandri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viala, J.</span><span> </span><span class="NLM_article-title">Synthesis of all-(Z)-5,8,11,14,17-Eicosapentaenoic Acid and all-(Z)-4,7,10,13,16,19-Docosahexaenoic Acid from (Z)-1,1,6,6-Tetraisopropoxy-2-hexene</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6627</span><span class="NLM_x">–</span> <span class="NLM_lpage">6630</span><span class="refDoi"> DOI: 10.1021/jo00125a065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00125a065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=6627-6630&author=J.+Sandriauthor=J.+Viala&title=Synthesis+of+all-%28Z%29-5%2C8%2C11%2C14%2C17-Eicosapentaenoic+Acid+and+all-%28Z%29-4%2C7%2C10%2C13%2C16%2C19-Docosahexaenoic+Acid+from+%28Z%29-1%2C1%2C6%2C6-Tetraisopropoxy-2-hexene&doi=10.1021%2Fjo00125a065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo00125a065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00125a065%26sid%3Dliteratum%253Aachs%26aulast%3DSandri%26aufirst%3DJ.%26aulast%3DViala%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520all-%2528Z%2529-5%252C8%252C11%252C14%252C17-Eicosapentaenoic%2520Acid%2520and%2520all-%2528Z%2529-4%252C7%252C10%252C13%252C16%252C19-Docosahexaenoic%2520Acid%2520from%2520%2528Z%2529-1%252C1%252C6%252C6-Tetraisopropoxy-2-hexene%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D6627%26epage%3D6630%26doi%3D10.1021%2Fjo00125a065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Menon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolbert, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cefali, E. A.</span><span> </span><span class="NLM_article-title">Plasma and Urine Pharmacokinetics of Niacin and its Metabolites from an Extended-Release Niacin Formulation</span> <span class="citation_source-journal">Int. J. Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.5414/CPP45448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.5414%2FCPP45448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=17725178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=448-454&author=R.+M.+Menonauthor=M.+H.+Adamsauthor=M.+A.+Gonz%C3%A1lezauthor=D.+S.+Tolbertauthor=J.+H.+Leuauthor=E.+A.+Cefali&title=Plasma+and+Urine+Pharmacokinetics+of+Niacin+and+its+Metabolites+from+an+Extended-Release+Niacin+Formulation&doi=10.5414%2FCPP45448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation</span></div><div class="casAuthors">Menon, R. M.; Adams, M. H.; Gonzalez, M. A.; Tolbert, D. S.; Leu, J. H.; Cefali, E. A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">448-454</span>CODEN:
                <span class="NLM_cas:coden">ICTHEK</span>;
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    
            (<span class="NLM_cas:orgname">Dustri-Verlag Dr. Karl Feistle</span>)
        </div><div class="casAbstract">Objective: To characterize plasma and urine pharmacokinetics of niacin and its metabolites after oral administration of 2,000 mg of extended-release (ER) niacin in healthy male volunteers.  Methods: Niacin ER was administered to 12 healthy male subjects following a low-fat snack.  Plasma was collected for 12 h post dose and was analyzed for niacin, nicotinuric acid (NUA), nicotinamide (NAM) and nicotinamide-N-oxide (NNO).  Urine was collected for 96 h post dose and analyzed for niacin and its metabolites, NUA, NAM, NNO, N-methylnicotinamide (MNA) and N-methyl-2-pyridone-5-carboxamide (2PY).  Results: Mean niacin Cmax and AUC0-t values were 9.3 μg/mL and 26.2 μg × h/mL and were the highest of all analytes measured.  Peak niacin and NUA levels occurred at 4.6 h (median) while tmax for NAM and NNO were 8.6 and 11.1 h, resp.  The mean plasma terminal half-life for niacin (0.9 h) and NUA (1.3 h) was shorter as compared to NAM (4.3 h).  Urine recovery of niacin and metabolites accounted for 69.5% of the administered dose; only 3.2% was excreted as niacin.  The highest recovery was for 2PY (37.9%), followed by MNA (16.0%) and NUA (11.6%).  Mean half-lives for 2PY and MNA calcd. in urine were 12.6 and 12.8 h, resp.  Conclusions: Niacin was extensively metabolized following oral administration, and about 70% of the administered dose is recovered in urine in 96 h as niacin, NUA, MNA, NNO, NAM and 2PY.  The plasma levels of the parent niacin were higher than its metabolites though only about 3% of the unchanged drug is recovered in urine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogOOw0jIa_9bVg90H21EOLACvtfcHk0lj-9vmxE5-bLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqsLrK&md5=f6964e508a7dba0d6c3f4dbd8f2487d1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5414%2FCPP45448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5414%252FCPP45448%26sid%3Dliteratum%253Aachs%26aulast%3DMenon%26aufirst%3DR.%2BM.%26aulast%3DAdams%26aufirst%3DM.%2BH.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%2BA.%26aulast%3DTolbert%26aufirst%3DD.%2BS.%26aulast%3DLeu%26aufirst%3DJ.%2BH.%26aulast%3DCefali%26aufirst%3DE.%2BA.%26atitle%3DPlasma%2520and%2520Urine%2520Pharmacokinetics%2520of%2520Niacin%2520and%2520its%2520Metabolites%2520from%2520an%2520Extended-Release%2520Niacin%2520Formulation%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D45%26spage%3D448%26epage%3D454%26doi%3D10.5414%2FCPP45448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Detailed rat PK data for compounds <b>5</b>, <b>7</b>, and <b>8</b> are shown in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">For the tissue distribution study involving compound <b>8</b>, liver, duodenum, and ileum exposure was assessed over a 3, 7, 10, 14, and 21 days, including a 3-day washout. The entire data set is presented in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span> </span><span class="NLM_article-title">Human Epidermoid A431 Cells Express Funtional Nicotinic Acid Receptor HM74a</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1007/s11010-006-9150-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs11010-006-9150-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2007&pages=243-248&author=L.+Zhouauthor=Y.+Tangauthor=E.+V.+Cryanauthor=K.+T.+Demarest&title=Human+Epidermoid+A431+Cells+Express+Funtional+Nicotinic+Acid+Receptor+HM74a&doi=10.1007%2Fs11010-006-9150-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs11010-006-9150-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-006-9150-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DCryan%26aufirst%3DE.%2BV.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26atitle%3DHuman%2520Epidermoid%2520A431%2520Cells%2520Express%2520Funtional%2520Nicotinic%2520Acid%2520Receptor%2520HM74a%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D294%26spage%3D243%26epage%3D248%26doi%3D10.1007%2Fs11010-006-9150-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Moon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, B. S.</span><span> </span><span class="NLM_article-title">Up-Regulation of Hepatic Low-Density Lipoprotein Receptor-Related Protein 1: A Possible Mechanism of Antiatherogenic Activity of Hydroymethylglutaryl-Coenzyme A Reductase Inhibitor Atorvastatin and Hepatic LRP1 Expression</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.1016/j.metabol.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.metabol.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=20951395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslKmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=930-940&author=J.+H.+Moonauthor=S.+B.+Kangauthor=J.+S.+Parkauthor=B.+W.+Leeauthor=E.+S.+Kangauthor=C.+W.+Ahnauthor=H.+C.+Leeauthor=B.+S.+Cha&title=Up-Regulation+of+Hepatic+Low-Density+Lipoprotein+Receptor-Related+Protein+1%3A+A+Possible+Mechanism+of+Antiatherogenic+Activity+of+Hydroymethylglutaryl-Coenzyme+A+Reductase+Inhibitor+Atorvastatin+and+Hepatic+LRP1+Expression&doi=10.1016%2Fj.metabol.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor</span></div><div class="casAuthors">Moon, Jae Hoon; Kang, Saet Byol; Park, Jong Suk; Lee, Byung Wan; Kang, Eun Seok; Ahn, Chul Woo; Lee, Hyun Chul; Cha, Bong Soo</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">930-940</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Low-d. lipoprotein receptor-related protein 1 (LRP1) binds to apolipoprotein E and serves as a receptor for remnant lipoproteins in the liver, thus playing an important role in clearing these atherogenic particles.  In this study, we investigated the effect of atorvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, on hepatic LRP1 expression.  We used HepG2 and Hep3B cells for in vitro study, and Otsuka Long-Evans Tokushima fatty and Sprague-Dawley rats for in vivo study.  We used relatively high pharmacol. dose of atorvastatin in this study (in vitro, 0.5 μmol/L in culture media, for 48 h; in vivo, 20 mg/[kg d], for 6 wk).  Atorvastatin increased LRP1 and low-d. lipoprotein (LDL) receptor expression in HepG2 and Hep3B cells and induced hepatic LRP1 and LDL receptor expression in chow diet-fed Sprague-Dawley rats and high-fat diet-fed Otsuka Long-Evans Tokushima fatty rats.  Atorvastatin decreased intracellular sterol level and increased the amt. of the nuclear form of sterol response element-binding protein-2 (SREBP-2) in both HepG2 and Hep3B cells as well as in two animal models.  Treatment of HepG2 cells with LDL increased intracellular sterol level and reduced LRP1, LDL receptor, and SREBP-2.  When SREBP-2 in HepG2 cells was knocked down by small interfering RNA, the induction of LRP1 expression by atorvastatin did not take place.  In conclusion, up-regulation of hepatic LRP1 might be a novel mechanism by which statin treatment decreases remnant lipoproteins.  In addn., SREBP-2 acts as a mediator of atorvastatin-induced up-regulation of hepatic LRP1.  Future studies using std. doses of atorvastatin in humans are needed to elucidate clin. relevance of these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOTpsiEbEmArVg90H21EOLACvtfcHk0lj-9vmxE5-bLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslKmtrk%253D&md5=517c3f76a48395264a2f74ed89ebb0f1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BB.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DB.%2BW.%26aulast%3DKang%26aufirst%3DE.%2BS.%26aulast%3DAhn%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DCha%26aufirst%3DB.%2BS.%26atitle%3DUp-Regulation%2520of%2520Hepatic%2520Low-Density%2520Lipoprotein%2520Receptor-Related%2520Protein%25201%253A%2520A%2520Possible%2520Mechanism%2520of%2520Antiatherogenic%2520Activity%2520of%2520Hydroymethylglutaryl-Coenzyme%2520A%2520Reductase%2520Inhibitor%2520Atorvastatin%2520and%2520Hepatic%2520LRP1%2520Expression%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2011%26volume%3D60%26spage%3D930%26epage%3D940%26doi%3D10.1016%2Fj.metabol.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Davignon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubuc, G.</span><span> </span><span class="NLM_article-title">Statins and Ezetimibe Modulate Plasma Proprotein Convertase Subtilisin Kexin-9 (PCSK9) Levels</span> <span class="citation_source-journal">Trans. Am. Clin. Climatol. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=19768174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A280%3ADC%252BD1Mnjs1ejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2009&pages=163-173&author=J.+Davignonauthor=G.+Dubuc&title=Statins+and+Ezetimibe+Modulate+Plasma+Proprotein+Convertase+Subtilisin+Kexin-9+%28PCSK9%29+Levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels</span></div><div class="casAuthors">Davignon Jean; Dubuc Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Transactions of the American Clinical and Climatological Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-73</span>
        ISSN:<span class="NLM_cas:issn">0065-7778</span>.
    </div><div class="casAbstract">PCSK9 is a natural inhibitor of the LDL receptor.  Gain-of-function mutations may cause the familial hypercholesterolemia phenotype, whereas loss-of-function variants associate with reduced LDL-C levels and lower coronary risk.  Statins up-regulate PCSK9 in hepatocytes.  We developed an assay to measure total PCSK9 in human plasma and evaluated the effect of statins and ezetimibe on PCSK9 in vivo and in vitro.  In 254 normal subjects, the mean plasma PCSK9 was 89 +/- 32 ng/ml.  PCSK9 levels correlated with plasma cholesterol, LDL-C, triglycerides, fasting glucose, age and body mass index.  Sequencing PCSK9 from subjects at the extremes of plasma distribution revealed new variants.  In 200 hypercholesterolemic patients, circulating PCSK9 was higher than in controls, increased with increasing statin dose, and further increased when ezetimibe was added.  However, ezetimibe treatment of HepG2 (hepatocytes) and Caco-2 (enterocytes) cells caused a slight increase in PCSK9 and NPC1L1 mRNA, but no significant rise in PCSK9 protein secretion, suggesting that these transformed cells are not ideal model cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0wfF2aDcoc2HOrQ6qeX-mfW6udTcc2eZfQjGbV5aYvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mnjs1ejtQ%253D%253D&md5=e90bbfd919182fe660137ba0db6d8120</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavignon%26aufirst%3DJ.%26aulast%3DDubuc%26aufirst%3DG.%26atitle%3DStatins%2520and%2520Ezetimibe%2520Modulate%2520Plasma%2520Proprotein%2520Convertase%2520Subtilisin%2520Kexin-9%2520%2528PCSK9%2529%2520Levels%26jtitle%3DTrans.%2520Am.%2520Clin.%2520Climatol.%2520Assoc.%26date%3D2009%26volume%3D120%26spage%3D163%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Dubuc, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassef, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davignon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span> </span><span class="NLM_article-title">Statins Upregulate PCSK9, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1459</span><span class="refDoi"> DOI: 10.1161/01.ATV.0000134621.14315.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1161%2F01.ATV.0000134621.14315.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=15178557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtValtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=1454-1459&author=G.+Dubucauthor=A.+Chamberlandauthor=H.+Wassefauthor=J.+Davignonauthor=N.+G.+Seidahauthor=L.+Bernierauthor=A.+Prat&title=Statins+Upregulate+PCSK9%2C+the+Gene+Encoding+the+Proprotein+Convertase+Neural+Apoptosis-Regulated+Convertase-1+Implicated+in+Familial+Hypercholesterolemia&doi=10.1161%2F01.ATV.0000134621.14315.43"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Statins Upregulate PCSK9, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia</span></div><div class="casAuthors">Dubuc, Genevieve; Chamberland, Ann; Wassef, Hanny; Davignon, Jean; Seidah, Nabil G.; Bernier, Lise; Prat, Annik</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1454-1459</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- Neural apoptosis-regulated convertase (NARC)-1 is the newest member of the proprotein convertase family implicated in the cleavage of a variety of protein precursors.  The NARC-1 gene, PCSK9, has been identified recently as the third locus implicated in autosomal dominant hypercholesterolemia (ADH).  The 2 other known genes implicated in ADH encode the low-d. lipoprotein receptor and apolipoprotein B.  As an approach toward the elucidation of the physiol. role(s) of NARC-1, we studied its transcriptional regulation.  Methods and Results- Using quant. RT-PCR, we assessed NARC-1 regulation under conditions known to regulate genes involved in cholesterol metab. in HepG2 cells and in human primary hepatocytes.  We found that NARC-1 expression was strongly induced by statins in a dose-dependent manner and that this induction was efficiently reversed by mevalonate.  NARC-1 mRNA level was increased by cholesterol depletion but insensitive to liver X receptor activation.  Human, mouse, and rat PCSK9 promoters contain 2 typical conserved motifs for cholesterol regulation: a sterol regulatory element (SRE) and an Sp1 site.  Conclusions- PCSK9 regulation is typical of that of the genes implicated in lipoprotein metab.  In vivo, PCSK9 is probably a target of SRE-binding protein (SREBP)-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql59KqiJ7LMrVg90H21EOLACvtfcHk0lhz50gfmPdktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtValtLY%253D&md5=b7731e8a31ff459af5fd8bf016637541</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000134621.14315.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000134621.14315.43%26sid%3Dliteratum%253Aachs%26aulast%3DDubuc%26aufirst%3DG.%26aulast%3DChamberland%26aufirst%3DA.%26aulast%3DWassef%26aufirst%3DH.%26aulast%3DDavignon%26aufirst%3DJ.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DBernier%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26atitle%3DStatins%2520Upregulate%2520PCSK9%252C%2520the%2520Gene%2520Encoding%2520the%2520Proprotein%2520Convertase%2520Neural%2520Apoptosis-Regulated%2520Convertase-1%2520Implicated%2520in%2520Familial%2520Hypercholesterolemia%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D1454%26epage%3D1459%26doi%3D10.1161%2F01.ATV.0000134621.14315.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">van den Maagdenberg, A. M. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofker, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimpenfort, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bruijn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Vlijmen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Boom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havekes, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frants, R. R.</span><span> </span><span class="NLM_article-title">Transgenic Mice Carrying the Apolipoprotein E3-Leiden Gene Exhibit Hyperlipoproteinemia</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">10540</span><span class="NLM_x">–</span> <span class="NLM_lpage">10545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=10540-10545&author=A.+M.+J.+M.+van+den+Maagdenbergauthor=M.+H.+Hofkerauthor=P.+J.+A.+Krimpenfortauthor=I.+de+Bruijnauthor=B.+van+Vlijmenauthor=H.+van+der+Boomauthor=L.+M.+Havekesauthor=R.+R.+Frants&title=Transgenic+Mice+Carrying+the+Apolipoprotein+E3-Leiden+Gene+Exhibit+Hyperlipoproteinemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BMaagdenberg%26aufirst%3DA.%2BM.%2BJ.%2BM.%26aulast%3DHofker%26aufirst%3DM.%2BH.%26aulast%3DKrimpenfort%26aufirst%3DP.%2BJ.%2BA.%26aulast%3Dde%2BBruijn%26aufirst%3DI.%26aulast%3Dvan%2BVlijmen%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BBoom%26aufirst%3DH.%26aulast%3DHavekes%26aufirst%3DL.%2BM.%26aulast%3DFrants%26aufirst%3DR.%2BR.%26atitle%3DTransgenic%2520Mice%2520Carrying%2520the%2520Apolipoprotein%2520E3-Leiden%2520Gene%2520Exhibit%2520Hyperlipoproteinemia%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D10540%26epage%3D10545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zimmer, M.; Picarella, D.; Liu, F.; Bista, P.; Lee, D.; Vu, C.; Jirousek, M.</span> In <span> </span><span class="NLM_article-title">CAT-2003 is a Novel Small Molecule that Inhibits Proprotein Convertase Subtilisin/Kexin Type 9 Production and Lowers Non-High Density Lipoprotein Cholesterol</span>. <span class="NLM_conf-name">Arteriosclerosis, Thrombosis and Vascular Biology</span>, <span class="NLM_conf-loc">Toronto, Ontario, Canada</span>, <span class="NLM_conf-date">May 1–3, 2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zimmer%2C+M.%3B+Picarella%2C+D.%3B+Liu%2C+F.%3B+Bista%2C+P.%3B+Lee%2C+D.%3B+Vu%2C+C.%3B+Jirousek%2C+M.+In+CAT-2003+is+a+Novel+Small+Molecule+that+Inhibits+Proprotein+Convertase+Subtilisin%2FKexin+Type+9+Production+and+Lowers+Non-High+Density+Lipoprotein+Cholesterol.+Arteriosclerosis%2C+Thrombosis+and+Vascular+Biology%2C+Toronto%2C+Ontario%2C+Canada%2C+May+1%E2%80%933%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DM.%26atitle%3DCAT-2003%2520is%2520a%2520Novel%2520Small%2520Molecule%2520that%2520Inhibits%2520Proprotein%2520Convertase%2520Subtilisin%252FKexin%2520Type%25209%2520Production%2520and%2520Lowers%2520Non-High%2520Density%2520Lipoprotein%2520Cholesterol" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wu, K. K.</span><span> </span><span class="NLM_article-title">Novel Mechanism of Aspirin Pharmacologic Actions: A Model for Studying Herbal Natural Products</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/j.thromres.2005.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.thromres.2005.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=16045971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wjur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=61-64&author=K.+K.+Wu&title=Novel+Mechanism+of+Aspirin+Pharmacologic+Actions%3A+A+Model+for+Studying+Herbal+Natural+Products&doi=10.1016%2Fj.thromres.2005.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanisms of aspirin pharmacologic actions: A model for studying herbal natural products</span></div><div class="casAuthors">Wu, Kenneth K.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aspirin and its principal in vivo metabolite, salicylic acid, exhibit concn.-dependent inhibition of gene expressions.  At high concns., they inhibit NF-κB-mediated gene expressions by suppressing IKK kinase activity whereas at therapeutic concns., they inhibit C/EBPβ-mediated gene expression by suppressing RSK kinase activity.  NF-KB and C/EBPβ are key transactivators that drive the promoter activities of pro-inflammatory genes.  Thus, the transcriptional control properties of aspirin may account for its diverse therapeutic actions.  We speculate that natural products isolated from herbal plants exhibit antiinflammatory and antineoplastic actions by a pharmacol. paradigm exemplified by aspirin and salicylate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIXy4mETCcQbVg90H21EOLACvtfcHk0lhz50gfmPdktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wjur3M&md5=8441fea8468955726560cdf7e03dd7d2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2005.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2005.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%2BK.%26atitle%3DNovel%2520Mechanism%2520of%2520Aspirin%2520Pharmacologic%2520Actions%253A%2520A%2520Model%2520for%2520Studying%2520Herbal%2520Natural%2520Products%26jtitle%3DThromb.%2520Res.%26date%3D2005%26volume%3D117%26spage%3D61%26epage%3D64%26doi%3D10.1016%2Fj.thromres.2005.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kopp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span> </span><span class="NLM_article-title">Inhibition of NF-kappa B by Sodium Salicylate and Aspirin</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span><span class="refDoi"> DOI: 10.1126/science.8052854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1126%2Fscience.8052854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1994&pages=956-959&author=E.+Koppauthor=S.+Ghosh&title=Inhibition+of+NF-kappa+B+by+Sodium+Salicylate+and+Aspirin&doi=10.1126%2Fscience.8052854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscience.8052854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8052854%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DE.%26aulast%3DGhosh%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520NF-kappa%2520B%2520by%2520Sodium%2520Salicylate%2520and%2520Aspirin%26jtitle%3DScience%26date%3D1994%26volume%3D265%26spage%3D956%26epage%3D959%26doi%3D10.1126%2Fscience.8052854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Amann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskar, B. A.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Effects of Aspirin and Sodium Salicylate</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/S0014-2999(02)01828-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2FS0014-2999%2802%2901828-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=12106797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFWjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2002&pages=1-9&author=R.+Amannauthor=B.+A.+Peskar&title=Anti-Inflammatory+Effects+of+Aspirin+and+Sodium+Salicylate&doi=10.1016%2FS0014-2999%2802%2901828-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory effects of aspirin and sodium salicylate</span></div><div class="casAuthors">Amann, Rainer; Peskar, Bernhard A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Aspirin (acetylsalicylic acid) is one of the most widely used drugs worldwide.  It acetylates cyclooxygenases thereby irreversibly blocking the conversion of arachidonic acid to prostanoids.  Biotransformation of aspirin yields salicylate, a compd. that possesses similar anti-inflammatory potency as aspirin but lacks aspirin's inhibitory effect on the activity of isolated cyclooxygenase.  This article is aimed at providing an overview about the often conflicting results concerning the mechanisms of action of aspirin and sodium salicylate.  At present, there is no common agreement about the extent to which salicylate contributes to aspirin's anti-inflammatory properties, as well as there is still no final conclusion reached about the mechanisms of action of sodium salicylate.  Several possible sites of action of salicylate have been suggested: It has been shown that in intact cells-but not in purified enzyme prepns.-, sodium salicylate inhibits prostanoid biosynthesis.  This effect seems to be prevented in the presence of high concns. of arachidonic acid, which has been shown to interfere with inhibition by salicylate of cyclooxygenase-2-mediated prostanoid formation in vitro.  Other possible sites of action that are not directly related to cyclooxygenase inhibition have been suggested based on observations made in vitro using high concns. of aspirin and sodium salicylate.  These effects target intracellular signaling mechanisms such as kinases, including the mitogen activated protein-kinases (MAPK) cascade.  With the exception of reported salicylate-induced activation of p38 MAPK, obsd. effects are usually inhibitory.  This may be one reason for the observation that, downstream to kinases, inhibitory effects of salicylates have been obsd. on several nuclear transcription factors, such as nuclear transcription factor kappa B (NF-kB) or activator protein 1 (AP-1).  Several reports have also shown interference by salicylates with the expression of cyclooxygenase-2, which, depending on exptl. models, can be obsd. as inhibitory but also stimulatory effects.  Antioxidant properties of salicylates, adenosine release induced by sodium salicylate and aspirin-triggered lipoxin formation are addnl. mechanisms that may contribute to anti-inflammatory properties of aspirin and/or sodium salicylate.  An addnl. focus of this review is the discussion of interactions between aspirin, sodium salicylate and other non-steroidal anti-inflammatory drugs (NSAIDs), which are of particular relevance in the gastro-intestinal and cardiovascular systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh6lEc-GBWgbVg90H21EOLACvtfcHk0lhBuDZbMvIlzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFWjsrs%253D&md5=9667f1d781f5d2a82db4e3d9fe38e5f1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901828-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901828-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmann%26aufirst%3DR.%26aulast%3DPeskar%26aufirst%3DB.%2BA.%26atitle%3DAnti-Inflammatory%2520Effects%2520of%2520Aspirin%2520and%2520Sodium%2520Salicylate%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D447%26spage%3D1%26epage%3D9%26doi%3D10.1016%2FS0014-2999%2802%2901828-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talukdar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinaga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span> </span><span class="NLM_article-title">GPR120 is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-Inflammatory and Insulin Sensitizing Effects</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.07.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.cell.2010.07.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=687-698&author=D.+Y.+Ohauthor=S.+Talukdarauthor=E.+J.+Baeauthor=T.+Imamuraauthor=H.+Morinagaauthor=W.+Fanauthor=P.+Liauthor=W.+J.+Luauthor=S.+Watkinsauthor=J.+M.+Olefsky&title=GPR120+is+an+Omega-3+Fatty+Acid+Receptor+Mediating+Potent+Anti-Inflammatory+and+Insulin+Sensitizing+Effects&doi=10.1016%2Fj.cell.2010.07.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.07.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.07.041%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DTalukdar%26aufirst%3DS.%26aulast%3DBae%26aufirst%3DE.%2BJ.%26aulast%3DImamura%26aufirst%3DT.%26aulast%3DMorinaga%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DW.%2BJ.%26aulast%3DWatkins%26aufirst%3DS.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3DGPR120%2520is%2520an%2520Omega-3%2520Fatty%2520Acid%2520Receptor%2520Mediating%2520Potent%2520Anti-Inflammatory%2520and%2520Insulin%2520Sensitizing%2520Effects%26jtitle%3DCell%26date%3D2010%26volume%3D142%26spage%3D687%26epage%3D698%26doi%3D10.1016%2Fj.cell.2010.07.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Martinez-Micaelo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Abuín, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terra, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardèvol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blay, M.</span><span> </span><span class="NLM_article-title">Omega-3 Docosahexaenoic Acid and Procyanidins Inhibit Cyclo-Oxygenase Activity and Attenuate NF-κB Activation through a p105/p50 Regulatory Mechanism in Macrophage Inflammation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1042/BJ20110967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1042%2FBJ20110967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=653-663&author=N.+Martinez-Micaeloauthor=N.+Gonz%C3%A1lez-Abu%C3%ADnauthor=X.+Terraauthor=C.+Richartauthor=A.+Ard%C3%A8volauthor=M.+Pinentauthor=M.+Blay&title=Omega-3+Docosahexaenoic+Acid+and+Procyanidins+Inhibit+Cyclo-Oxygenase+Activity+and+Attenuate+NF-%CE%BAB+Activation+through+a+p105%2Fp50+Regulatory+Mechanism+in+Macrophage+Inflammation&doi=10.1042%2FBJ20110967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1042%2FBJ20110967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110967%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Micaelo%26aufirst%3DN.%26aulast%3DGonz%25C3%25A1lez-Abu%25C3%25ADn%26aufirst%3DN.%26aulast%3DTerra%26aufirst%3DX.%26aulast%3DRichart%26aufirst%3DC.%26aulast%3DArd%25C3%25A8vol%26aufirst%3DA.%26aulast%3DPinent%26aufirst%3DM.%26aulast%3DBlay%26aufirst%3DM.%26atitle%3DOmega-3%2520Docosahexaenoic%2520Acid%2520and%2520Procyanidins%2520Inhibit%2520Cyclo-Oxygenase%2520Activity%2520and%2520Attenuate%2520NF-%25CE%25BAB%2520Activation%2520through%2520a%2520p105%252Fp50%2520Regulatory%2520Mechanism%2520in%2520Macrophage%2520Inflammation%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26spage%3D653%26epage%3D663%26doi%3D10.1042%2FBJ20110967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Musiek, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunoldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span> </span><span class="NLM_article-title">Electrophilic Cyclopentenone Neuroprostanes are Anti-Inflammatory Mediators Formed from the Peroxidation of the ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">19927</span><span class="NLM_x">–</span> <span class="NLM_lpage">19935</span><span class="refDoi"> DOI: 10.1074/jbc.M803625200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M803625200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=19927-19935&author=E.+S.+Musiekauthor=J.+D.+Brooksauthor=M.+Jooauthor=E.+Brunoldiauthor=A.+Portaauthor=G.+Zanoniauthor=G.+Vidariauthor=T.+S.+Blackwellauthor=T.+J.+Montineauthor=G.+L.+Milneauthor=B.+McLaughlinauthor=J.+D.+Morrow&title=Electrophilic+Cyclopentenone+Neuroprostanes+are+Anti-Inflammatory+Mediators+Formed+from+the+Peroxidation+of+the+%CF%89-3+Polyunsaturated+Fatty+Acid+Docosahexaenoic+Acid&doi=10.1074%2Fjbc.M803625200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803625200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803625200%26sid%3Dliteratum%253Aachs%26aulast%3DMusiek%26aufirst%3DE.%2BS.%26aulast%3DBrooks%26aufirst%3DJ.%2BD.%26aulast%3DJoo%26aufirst%3DM.%26aulast%3DBrunoldi%26aufirst%3DE.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DVidari%26aufirst%3DG.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DMcLaughlin%26aufirst%3DB.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26atitle%3DElectrophilic%2520Cyclopentenone%2520Neuroprostanes%2520are%2520Anti-Inflammatory%2520Mediators%2520Formed%2520from%2520the%2520Peroxidation%2520of%2520the%2520%25CF%2589-3%2520Polyunsaturated%2520Fatty%2520Acid%2520Docosahexaenoic%2520Acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D19927%26epage%3D19935%26doi%3D10.1074%2Fjbc.M803625200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Fam, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphey, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zackert, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandalai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span> </span><span class="NLM_article-title">Formation of Highly Reactive A-ring and J-ring Isoprostane-like Compounds (A<sub>4</sub>/J<sub>4</sub>-neuroprostanes) <i>in Vivo</i> from Docosahexaenoic Acid</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">36076</span><span class="NLM_x">–</span> <span class="NLM_lpage">36084</span><span class="refDoi"> DOI: 10.1074/jbc.M205638200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M205638200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=36076-36084&author=S.+S.+Famauthor=L.+J.+Murpheyauthor=E.+S.+Terryauthor=W.+E.+Zackertauthor=Y.+Chenauthor=L.+Gaoauthor=S.+Pandalaiauthor=G.+L.+Milneauthor=L.+J.+Robertsauthor=N.+A.+Porterauthor=T.+J.+Montineauthor=J.+D.+Morrow&title=Formation+of+Highly+Reactive+A-ring+and+J-ring+Isoprostane-like+Compounds+%28A4%2FJ4-neuroprostanes%29+in+Vivo+from+Docosahexaenoic+Acid&doi=10.1074%2Fjbc.M205638200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205638200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205638200%26sid%3Dliteratum%253Aachs%26aulast%3DFam%26aufirst%3DS.%2BS.%26aulast%3DMurphey%26aufirst%3DL.%2BJ.%26aulast%3DTerry%26aufirst%3DE.%2BS.%26aulast%3DZackert%26aufirst%3DW.%2BE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DPandalai%26aufirst%3DS.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DRoberts%26aufirst%3DL.%2BJ.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26atitle%3DFormation%2520of%2520Highly%2520Reactive%2520A-ring%2520and%2520J-ring%2520Isoprostane-like%2520Compounds%2520%2528A4%252FJ4-neuroprostanes%2529%2520in%2520Vivo%2520from%2520Docosahexaenoic%2520Acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D36076%26epage%3D36084%26doi%3D10.1074%2Fjbc.M205638200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Straus, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengchanthalangsy, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. K.</span><span> </span><span class="NLM_article-title">15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> Inhibits Multiple Steps in the NF-κB Signaling Pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">4844</span><span class="NLM_x">–</span> <span class="NLM_lpage">4849</span><span class="refDoi"> DOI: 10.1073/pnas.97.9.4844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1073%2Fpnas.97.9.4844" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4844-4849&author=D.+S.+Strausauthor=G.+Pascualauthor=M.+Liauthor=J.+S.+Welchauthor=M.+Ricoteauthor=C.-H.+Hsiangauthor=L.+L.+Sengchanthalangsyauthor=G.+Ghoshauthor=C.+K.+Glass&title=15-Deoxy-%CE%9412%2C14-prostaglandin+J2+Inhibits+Multiple+Steps+in+the+NF-%CE%BAB+Signaling+Pathway&doi=10.1073%2Fpnas.97.9.4844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.9.4844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.9.4844%26sid%3Dliteratum%253Aachs%26aulast%3DStraus%26aufirst%3DD.%2BS.%26aulast%3DPascual%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWelch%26aufirst%3DJ.%2BS.%26aulast%3DRicote%26aufirst%3DM.%26aulast%3DHsiang%26aufirst%3DC.-H.%26aulast%3DSengchanthalangsy%26aufirst%3DL.%2BL.%26aulast%3DGhosh%26aufirst%3DG.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26atitle%3D15-Deoxy-%25CE%259412%252C14-prostaglandin%2520J2%2520Inhibits%2520Multiple%2520Steps%2520in%2520the%2520NF-%25CE%25BAB%2520Signaling%2520Pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4844%26epage%3D4849%26doi%3D10.1073%2Fpnas.97.9.4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Cernuda-Morollón, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda-Molina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caňada, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Sala, D.</span><span> </span><span class="NLM_article-title">15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> Inhibition of NF-κB-DNA Binding through Covalent Modification of the p50 Subunit</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">35530</span><span class="NLM_x">–</span> <span class="NLM_lpage">35536</span><span class="refDoi"> DOI: 10.1074/jbc.M104518200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1074%2Fjbc.M104518200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=35530-35536&author=E.+Cernuda-Moroll%C3%B3nauthor=E.+Pineda-Molinaauthor=F.+J.+Ca%C5%88adaauthor=D.+P%C3%A9rez-Sala&title=15-Deoxy-%CE%9412%2C14-prostaglandin+J2+Inhibition+of+NF-%CE%BAB-DNA+Binding+through+Covalent+Modification+of+the+p50+Subunit&doi=10.1074%2Fjbc.M104518200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M104518200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M104518200%26sid%3Dliteratum%253Aachs%26aulast%3DCernuda-Moroll%25C3%25B3n%26aufirst%3DE.%26aulast%3DPineda-Molina%26aufirst%3DE.%26aulast%3DCa%25C5%2588ada%26aufirst%3DF.%2BJ.%26aulast%3DP%25C3%25A9rez-Sala%26aufirst%3DD.%26atitle%3D15-Deoxy-%25CE%259412%252C14-prostaglandin%2520J2%2520Inhibition%2520of%2520NF-%25CE%25BAB-DNA%2520Binding%2520through%2520Covalent%2520Modification%2520of%2520the%2520p50%2520Subunit%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D35530%26epage%3D35536%26doi%3D10.1074%2Fjbc.M104518200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Liu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. C.</span><span> </span><span class="NLM_article-title">Direct Analysis of Salicylic Acid, Salicyl Acyl Glucuronide, Salicyluric Acid and Gentisic Acid in Human Plasma and Urine by High-Performance Liquid Chromatography</span> <span class="citation_source-journal">J. Chromatogr., Biomed. Appl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">675</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/0378-4347(95)00337-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2F0378-4347%2895%2900337-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=8634769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADyaK28XnslSjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=675&publication_year=1996&pages=61-70&author=J.+H.+Liuauthor=P.+C.+Smith&title=Direct+Analysis+of+Salicylic+Acid%2C+Salicyl+Acyl+Glucuronide%2C+Salicyluric+Acid+and+Gentisic+Acid+in+Human+Plasma+and+Urine+by+High-Performance+Liquid+Chromatography&doi=10.1016%2F0378-4347%2895%2900337-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography</span></div><div class="casAuthors">Liu, Jian-Hua; Smith, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography, B: Biomedical Applications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">675</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-70</span>CODEN:
                <span class="NLM_cas:coden">JCBBEP</span>;
        ISSN:<span class="NLM_cas:issn">0378-4347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A method for the simultaneous direct detn. of salicylate (SA), its labile, reactive metabolite, salicyl acyl glucuronide (SAG), and two other major metabolites, salicyluric acid and gentisic acid in plasma and urine is described.  Isocratic reversed-phase high performance liq. chromatog. (HPLC) employed a 15-cm C18 column using methanol-acetonitrile-25 mM acetic acid as the mobile phase, resulting in HPLC anal. time of less than 20 min.  UV detection at 310 nm permitted anal. of SAG in plasma, but did not provide sensitivity for measurement of salicyl phenol glucuronide.  Plasma or urine samples are stabilized immediately upon collection by adjustment of pH to 3-4 to prevent degrdn. of the labile acyl glucuronide metabolite.  Plasma is then deproteinated with acetonitrile, dried and reconstituted for injection, whereas urine samples are simply dild. prior to injection on HPLC. m-Hydroxybenzoic acid served as the internal std.  Recoveries from plasma were greater than 85% for all four compds. over a range of 0.2-20 μg/mL and linearity was obsd. from 0.1-200 μg/mL and 5-2000 μg/mL for SA in plasma and urine, resp.  The method was validated to 0.2 μg/mL, thus allowing accurate measurement of SA, and three major metabolites in plasma and urine of subjects and small animals administered salicylates.  The method is unique by allowing quantitation of reactive SAG in plasma at levels well below 1% that of the parent compd., SA, as is obsd. in patients administered salicylates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ97SsqvuzwrVg90H21EOLACvtfcHk0lir_dAVrxaBHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnslSjsg%253D%253D&md5=033bd2a6be6d4693fc6da42dcd3d0a78</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0378-4347%2895%2900337-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4347%252895%252900337-1%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BC.%26atitle%3DDirect%2520Analysis%2520of%2520Salicylic%2520Acid%252C%2520Salicyl%2520Acyl%2520Glucuronide%252C%2520Salicyluric%2520Acid%2520and%2520Gentisic%2520Acid%2520in%2520Human%2520Plasma%2520and%2520Urine%2520by%2520High-Performance%2520Liquid%2520Chromatography%26jtitle%3DJ.%2520Chromatogr.%252C%2520Biomed.%2520Appl.%26date%3D1996%26volume%3D675%26spage%3D61%26epage%3D70%26doi%3D10.1016%2F0378-4347%2895%2900337-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Kiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervinka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeberényi, J.</span><span> </span><span class="NLM_article-title">Sodium Salicylate Inhibits NF-kappa B and Induces Apoptosis in PC12 Cells</span> <span class="citation_source-journal">J. Biochem. Biophys. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1016/j.jbbm.2004.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.jbbm.2004.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=15560939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=229-240&author=K.+Kissauthor=J.+Kissauthor=E.+Rudolfauthor=M.+Cervinkaauthor=J.+Szeber%C3%A9nyi&title=Sodium+Salicylate+Inhibits+NF-kappa+B+and+Induces+Apoptosis+in+PC12+Cells&doi=10.1016%2Fj.jbbm.2004.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium salicylate inhibits NF-κB and induces apoptosis in PC12 cells</span></div><div class="casAuthors">Kiss, K.; Kiss, J.; Rudolf, E.; Cervinka, M.; Szeberenyi, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Biophysical Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">229-240</span>CODEN:
                <span class="NLM_cas:coden">JBBMDG</span>;
        ISSN:<span class="NLM_cas:issn">0165-022X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sodium salicylate (NaSal) is an effective analgetic and antiinflammatory drug.  Beside its well-known inhibitory effect on the cyclooxygenase enzymes, it influences the activity of other signal transduction proteins including nuclear factor kappa B (NF-κB) transcription factor.  NF-κB is found in the cytoplasm bound to an inhibitory protein, inhibitory kappa B (IκB).  After its phosphorylation, IκB is degraded and the released NF-κB translocates into the nucleus.  Sodium salicylate inhibits the degrdn. of IκB, thus, NF-κB activation cannot occur.  According to previous observations, the inhibition of this activation can lead to apoptosis.  The main goals of this study were to demonstrate that inhibition of NF-κB by sodium salicylate decreases the viability of rat phaeochromocytoma PC12 cells and to investigate the nature of cell damage and death.  PC12 cells were treated with different concns. of sodium salicylate (1-20 mM).  Higher concns. (10-20 mM) killed PC12 cells in a dose-dependent manner.  The assessments were done by direct cell counting in a Buerker chamber and by the WST-1 cytotoxicity assay.  The authors also found a decreased NF-κB activity after sodium salicylate treatment by electrophoretic mobility shift assay (EMSA).  The cells treated with sodium salicylate were undergoing apoptosis as seen on the authors' records obtained by time-lapse videomicroscopy as well as shown by DNA fragmentation expts.  The decreased DNA binding activity of NF-κB indicates that the inhibition of NF-κB can play a role in these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7u03Oaq4317Vg90H21EOLACvtfcHk0ljOKrcoRSTVFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr%252FK&md5=57239af5f759830d05e66929cbfc7758</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jbbm.2004.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbbm.2004.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DK.%26aulast%3DKiss%26aufirst%3DJ.%26aulast%3DRudolf%26aufirst%3DE.%26aulast%3DCervinka%26aufirst%3DM.%26aulast%3DSzeber%25C3%25A9nyi%26aufirst%3DJ.%26atitle%3DSodium%2520Salicylate%2520Inhibits%2520NF-kappa%2520B%2520and%2520Induces%2520Apoptosis%2520in%2520PC12%2520Cells%26jtitle%3DJ.%2520Biochem.%2520Biophys.%2520Methods%26date%3D2004%26volume%3D61%26spage%3D229%26epage%3D240%26doi%3D10.1016%2Fj.jbbm.2004.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavasani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilstra, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedernhofer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttridge, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, J.</span><span> </span><span class="NLM_article-title">NF-κB Negatively Impacts the Myogenic Potential of Muscle-Derived Stem Cells</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span><span class="refDoi"> DOI: 10.1038/mt.2011.261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1038%2Fmt.2011.261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22158056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SkurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=661-668&author=A.+Luauthor=J.+D.+Protoauthor=L.+Guoauthor=Y.+Tangauthor=M.+Lavasaniauthor=J.+S.+Tilstraauthor=L.+J.+Niedernhoferauthor=B.+Wangauthor=D.+C.+Guttridgeauthor=P.+D.+Robbinsauthor=J.+Huard&title=NF-%CE%BAB+Negatively+Impacts+the+Myogenic+Potential+of+Muscle-Derived+Stem+Cells&doi=10.1038%2Fmt.2011.261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB Negatively Impacts the Myogenic Potential of Muscle-derived Stem Cells</span></div><div class="casAuthors">Lu, Aiping; Proto, Jonathan D.; Guo, Lulin; Tang, Ying; Lavasani, Mitra; Tilstra, Jeremy S.; Niedernhofer, Laura J.; Wang, Bing; Guttridge, Denis C.; Robbins, Paul D.; Huard, Johnny</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-668</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of the inhibitor of kappa B kinase (IKK)/nuclear factor-kappa B (NF-κB) pathway enhances muscle regeneration in injured and diseased skeletal muscle, but it is unclear exactly how this pathway contributes to the regeneration process.  In this study, we examd. the role of NF-κB in regulating the proliferation and differentiation of muscle-derived stem cells (MDSCs).  MDSCs isolated from the skeletal muscles of p65+/- mice (haploinsufficient for the p65 subunit of NF-κB) had enhanced proliferation and myogenic differentiation compared to MDSCs isolated from wild-type (wt) littermates.  In addn., selective pharmacol. inhibition of IKKβ, an upstream activator of NF-κB, enhanced wt MDSC differentiation into myotubes in vitro.  The p65+/- MDSCs also displayed a higher muscle regeneration index than wt MDSCs following implantation into adult mice with muscular dystrophy.  Addnl., using a muscle injury model, we obsd. that p65+/- MDSC engraftments were assocd. with reduced inflammation and necrosis.  These results suggest that inhibition of the IKK/NF-κB pathway represents an effective approach to improve the myogenic regenerative potential of MDSCs and possibly other adult stem cell populations.  Moreover, our results suggest that the improved muscle regeneration obsd. following inhibition of IKK/NF-κB, is mediated, at least in part, through enhanced stem cell proliferation and myogenic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbnLi2i0T_bVg90H21EOLACvtfcHk0ljOKrcoRSTVFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SkurvF&md5=fc050d8c8add4238785bb0cb2e5bf9a4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fmt.2011.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2011.261%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DA.%26aulast%3DProto%26aufirst%3DJ.%2BD.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLavasani%26aufirst%3DM.%26aulast%3DTilstra%26aufirst%3DJ.%2BS.%26aulast%3DNiedernhofer%26aufirst%3DL.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DGuttridge%26aufirst%3DD.%2BC.%26aulast%3DRobbins%26aufirst%3DP.%2BD.%26aulast%3DHuard%26aufirst%3DJ.%26atitle%3DNF-%25CE%25BAB%2520Negatively%2520Impacts%2520the%2520Myogenic%2520Potential%2520of%2520Muscle-Derived%2520Stem%2520Cells%26jtitle%3DMol.%2520Ther.%26date%3D2012%26volume%3D20%26spage%3D661%26epage%3D668%26doi%3D10.1038%2Fmt.2011.261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Mourkioti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, N.</span><span> </span><span class="NLM_article-title">NF-κB Signaling in Skeletal Muscle: Prospects for Intervention in Muscle Diseases</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">759</span><span class="refDoi"> DOI: 10.1007/s00109-008-0308-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1007%2Fs00109-008-0308-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=18246321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnslGkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=747-759&author=F.+Mourkiotiauthor=N.+Rosenthal&title=NF-%CE%BAB+Signaling+in+Skeletal+Muscle%3A+Prospects+for+Intervention+in+Muscle+Diseases&doi=10.1007%2Fs00109-008-0308-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB signaling in skeletal muscle: prospects for intervention in muscle diseases</span></div><div class="casAuthors">Mourkioti, Foteini; Rosenthal, Nadia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">747-759</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Muscle remodeling is an important physiol. process that promotes adaptive changes in cytoarchitecture and protein compn. after exercise, aging, or disease conditions.  Numerous transcription factors have been reported to regulate skeletal muscle homeostasis.  NF-κB is a major pleiotropic transcription factor modulating immune, inflammatory, cell survival, and proliferating responses; however, its role in muscle development, physiol., and disease has just started to be elucidated.  The current review article aims to summarize the literature on the role of NF-κB signaling in skeletal muscle pathophysiol., investigated over the last years using in vitro and more recently in vivo systems.  Understanding the exact role of NF-κB in muscle cells will allow better therapeutic manipulations in the setting of human muscle diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqezTJ833RQH7Vg90H21EOLACvtfcHk0ljOKrcoRSTVFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnslGkur8%253D&md5=621d469a8d8964d3e5a809f91ab60a02</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00109-008-0308-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-008-0308-4%26sid%3Dliteratum%253Aachs%26aulast%3DMourkioti%26aufirst%3DF.%26aulast%3DRosenthal%26aufirst%3DN.%26atitle%3DNF-%25CE%25BAB%2520Signaling%2520in%2520Skeletal%2520Muscle%253A%2520Prospects%2520for%2520Intervention%2520in%2520Muscle%2520Diseases%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2008%26volume%3D86%26spage%3D747%26epage%3D759%26doi%3D10.1007%2Fs00109-008-0308-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Nadarajah, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Putten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaouch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochmüller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginjaar, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aartsma-Rus, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ommen, G. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">den Dunnen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">’t Hoen, P. A. C.</span><span> </span><span class="NLM_article-title">Serum Matrix Metalloprotease-9 (MMP-9) as a Biomarker for Monitoring Disease Progression in Duchenne Muscular Dystrophy (DMD)</span> <span class="citation_source-journal">Neuromuscular Disorders</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span><span class="refDoi"> DOI: 10.1016/j.nmd.2011.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1016%2Fj.nmd.2011.05.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=569-578&author=V.+D.+Nadarajahauthor=M.+van+Puttenauthor=A.+Chaouchauthor=P.+Garroodauthor=V.+Straubauthor=H.+Lochm%C3%BCllerauthor=H.+B.+Ginjaarauthor=A.+M.+Aartsma-Rusauthor=G.+J.+B.+van+Ommenauthor=J.+T.+den+Dunnenauthor=P.+A.+C.+%E2%80%99t+Hoen&title=Serum+Matrix+Metalloprotease-9+%28MMP-9%29+as+a+Biomarker+for+Monitoring+Disease+Progression+in+Duchenne+Muscular+Dystrophy+%28DMD%29&doi=10.1016%2Fj.nmd.2011.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.nmd.2011.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nmd.2011.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DNadarajah%26aufirst%3DV.%2BD.%26aulast%3Dvan%2BPutten%26aufirst%3DM.%26aulast%3DChaouch%26aufirst%3DA.%26aulast%3DGarrood%26aufirst%3DP.%26aulast%3DStraub%26aufirst%3DV.%26aulast%3DLochm%25C3%25BCller%26aufirst%3DH.%26aulast%3DGinjaar%26aufirst%3DH.%2BB.%26aulast%3DAartsma-Rus%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BOmmen%26aufirst%3DG.%2BJ.%2BB.%26aulast%3Dden%2BDunnen%26aufirst%3DJ.%2BT.%26aulast%3D%25E2%2580%2599t%2BHoen%26aufirst%3DP.%2BA.%2BC.%26atitle%3DSerum%2520Matrix%2520Metalloprotease-9%2520%2528MMP-9%2529%2520as%2520a%2520Biomarker%2520for%2520Monitoring%2520Disease%2520Progression%2520in%2520Duchenne%2520Muscular%2520Dystrophy%2520%2528DMD%2529%26jtitle%3DNeuromuscular%2520Disorders%26date%3D2011%26volume%3D21%26spage%3D569%26epage%3D578%26doi%3D10.1016%2Fj.nmd.2011.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Cruz-Guzmán, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Cruz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar Cedillo, R. E.</span><span> </span><span class="NLM_article-title">Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status</span> <span class="citation_source-journal">BioMed Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="refDoi"> DOI: 10.1155/2015/891972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1155%2F2015%2F891972" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=1&author=O.+R.+Cruz-Guzm%C3%A1nauthor=M.+Rodriguez-Cruzauthor=R.+E.+Escobar+Cedillo&title=Systemic+Inflammation+in+Duchenne+Muscular+Dystrophy%3A+Association+with+Muscle+Function+and+Nutritional+Status&doi=10.1155%2F2015%2F891972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1155%2F2015%2F891972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F891972%26sid%3Dliteratum%253Aachs%26aulast%3DCruz-Guzm%25C3%25A1n%26aufirst%3DO.%2BR.%26aulast%3DRodriguez-Cruz%26aufirst%3DM.%26aulast%3DEscobar%2BCedillo%26aufirst%3DR.%2BE.%26atitle%3DSystemic%2520Inflammation%2520in%2520Duchenne%2520Muscular%2520Dystrophy%253A%2520Association%2520with%2520Muscle%2520Function%2520and%2520Nutritional%2520Status%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2015%26volume%3D2015%26spage%3D1%26doi%3D10.1155%2F2015%2F891972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Sweeney, H. L.</span>, manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sweeney%2C+H.+L.%2C+manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DH.%2BL." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Langen, R. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haegens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernooy, J. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, E. F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Winther, M. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, A. M. W. J.</span><span> </span><span class="NLM_article-title">NF-κB Activation is required for the Transition of Pulmonary Inflammation to Muscle Atrophy</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1165/rcmb.2011-0119OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=10.1165%2Frcmb.2011-0119OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=22538866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=288-297&author=R.+C.+J.+Langenauthor=A.+Haegensauthor=J.+H.+J.+Vernooyauthor=E.+F.+M.+Woutersauthor=M.+P.+J.+de+Wintherauthor=H.+Carlsenauthor=C.+Steeleauthor=S.+E.+Shoelsonauthor=A.+M.+W.+J.+Schols&title=NF-%CE%BAB+Activation+is+required+for+the+Transition+of+Pulmonary+Inflammation+to+Muscle+Atrophy&doi=10.1165%2Frcmb.2011-0119OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy</span></div><div class="casAuthors">Langen, Ramon C. J.; Haegens, Astrid; Vernooy, Juanita H. J.; Wouters, Emiel F. M.; de Winther, Menno P. J.; Carlsen, Harald; Steele, Chad; Shoelson, Steven E.; Schols, Annemie M. W. J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-297</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Disease exacerbations and muscle wasting comprise neg. prognostic factors of chronic obstructive pulmonary disease (COPD).  Transient systemic inflammation and malnutrition have been implicated in skeletal muscle wasting after acute exacerbations of COPD.  However, the interactions between systemic inflammation and malnutrition in their contributions to muscle atrophy, as well as the mol. basis underlying the transition of systemic inflammation to muscle atrophy, remain unresolved.  Pulmonary inflammation was induced in mice by an intratracheal instillation of LPS to model acute disease exacerbation.  Systemic inflammation, nutritional intake, and body and muscle wts. were detd.  Muscle inflammatory signaling and atrophy signaling were examd., and the effect of the muscle-specific inactivation of NF-κB on muscle atrophy was assessed in genetically modified mice.  The intratracheal LPS instillation was followed by markedly elevated circulating cytokine concns. and NF-κB activation in extrapulmonary tissues, including skeletal muscle.  The administration of intratracheal LPS increased the expression of muscle E3 ubiquitin ligases, which govern muscle proteolysis, in particular MuRF1, and caused a rapid loss of muscle mass.  Reduced food intake only partly accounted for the obsd. muscle atrophy, and did not activate NF-κB in muscle.  Rather, plasma transfer expts. revealed the presence of NF-κB-signaling and atrophy-signaling properties in the circulation of intratracheal LPS-treated mice.  The genetic inhibition of muscle NF-κB activity suppressed intratracheal LPS-induced MuRF1 expression and resulted in a significant sparing of muscle tissue.  Systemic inflammation and malnutrition contribute to the muscle wasting induced by acute pulmonary inflammation via distinct mechanisms, and muscle NF-κB activation is required for the transition from inflammatory to muscle atrophy signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyL9MluFOTg7Vg90H21EOLACvtfcHk0ljsi0lJBoHorQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCjsrrL&md5=dabf9fa945226e47615d59d4b26175af</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2011-0119OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2011-0119OC%26sid%3Dliteratum%253Aachs%26aulast%3DLangen%26aufirst%3DR.%2BC.%2BJ.%26aulast%3DHaegens%26aufirst%3DA.%26aulast%3DVernooy%26aufirst%3DJ.%2BH.%2BJ.%26aulast%3DWouters%26aufirst%3DE.%2BF.%2BM.%26aulast%3Dde%2BWinther%26aufirst%3DM.%2BP.%2BJ.%26aulast%3DCarlsen%26aufirst%3DH.%26aulast%3DSteele%26aufirst%3DC.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DSchols%26aufirst%3DA.%2BM.%2BW.%2BJ.%26atitle%3DNF-%25CE%25BAB%2520Activation%2520is%2520required%2520for%2520the%2520Transition%2520of%2520Pulmonary%2520Inflammation%2520to%2520Muscle%2520Atrophy%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D288%26epage%3D297%26doi%3D10.1165%2Frcmb.2011-0119OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i21"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01961">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_05281"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01961">10.1021/acs.jmedchem.5b01961</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional PK data for compounds <b>5</b>, <b>7</b>, and <b>8</b>, along with the detailed procedures for preparing compounds <b>1</b>–<b>4</b> and spectroscopic data for compounds <b>5</b> and <b>11</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_001.pdf">jm5b01961_si_001.pdf (1.26 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01961/suppl_file/jm5b01961_si_002.csv">jm5b01961_si_002.csv (0.81 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01961%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-3%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01961" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679991b62e463c0a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
